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This thesis describes the development of direct enantioselective vinylogous 
reaction of furanones and phthalide derivatives with bifunctional and trifunctional 
organocatalysis. 
Chapter 1 presents a brief historical background and development of asymmetric 
organocatalysis. Paticularly, chiral hydrogen-bonding based organocatalysis are 
introduced in detail. A selection of examples showing recent advancements in this 
field of catalysis is described, including monofunctional, bifunctional and 
multifunctional organocatalysis. 
In Chapter 2, the direct asymmetric vinylogous aldol reaction of furanones with 
-ketoesters will be demonstrated using L-tryptophan derived bifunctional thiourea 
catalyst. The synthetic method provides an easy access to biologically important 
-substituted butenolides and chiral glycerol derivatives.  
In Chapter 3, asymmetric vinylogous mannich-type reaction of phthalide 
derivatives will be shown employing a cinchona derived trifunctional catalyst. The 
reaction proceeds smoothly with only 1-5 mol% catalyst employed. Moreover, the 
mannich adduct could be easily transformed into chiral substituted isoquinolines and 
isoquinolinones. 
In Chapter 4, the highly diastereoselective and enantioselective vinylogous 
Michael addition of phthalide derivatives to nitroolefins and chalcones will be 
discussed, which allows a facial generation of biologically important substituted 
phthalides. 
List of Tables 
Table 1.1    Average numbers of chiral centers in synthetics, drugs and natural 
products. 
 
Table 2.1    Screening of bifunctional catalysts for the vinylogous aldol reaction 
 
Table 2.2    Substrate scope of Trp-2 catalyzed direct vinylogous aldol reaction 
 
Table 3.1    Screening of bifunctional and trifunctional catalysts for the vinylogous 
mannich reaction 
 
Table 3.2    Scope of the direct vinylogous mannich reaction catalyzed by 
trifunctional catalyst Q-2 
 
Table 4.1    Screening of bifunctional and trifunctional catalysts for the vinylogous 
Michael reaction 
 
Table 4.2    Scope of the direct vinylogous Michael reaction catalyzed by 
trifunctional catalyst 
 
Table 4.3    Initial screening results employing primary amine as the catalyst 
 
Table 4.4    Catalyst screening results of the vinylogous Michael addition to 
chalcone 
 
Table 4.5    Solvent and additive screening of the vinylogous Michael addition 
 
Table 4.6    Substrate scope of the vinylogous Michael addition to chalcone 
 
Table 5.1    Catalyst screening of Michael addition of ketoester to nitrostyrene 
 
Table 5.2    Influence of solvent on the Michael addition to nitrostyrene 
 
Table 5.3    Screening of other donors for the Michael addition to nitrostyrene 
 







List of Schemes 
Scheme 1.1   Structures of some representative ligands 
 
Scheme 1.2   Early examples of asymmetric reactions using organic catalysts 
 
Scheme 1.3   L-Proline catalyzed Robinson annulation 
 
Scheme 1.4   Selected examples of chiral organocatalysts 
 
Scheme 1.5   Different types of hydrogen-bonding organocatalysts 
 
Scheme 1.6   Kelly and Jørgensen’s activation models 
 
Scheme 1.7   Structures of orgnaocatalysts TADDOL 1-20 and derivatives of 
BINOL 1-21 
 
Scheme 1.8   TADDOL catalyzed hetero-Diels-Alder reaction 
 
Scheme 1.9   TADDOL catalyzed Mukaiyama aldol reaction 
 
Scheme 1.10  TADDOL catalyzed nitroso aldol reaction of enamine 
 
Scheme 1.11  BINOL derivative catalyzed Morita-Baylis-Hillman reaction 
 
Scheme 1.12  BINOL derivative catalyzed Nitroso Diels-Alder-type reaction 
 
Scheme 1.13  Hydrogen bonding interactions in urea catalyst 
 
Scheme 1.14  Diaryl urea catalyzed radical alkylation reaction 
 
Scheme 1.15  Diaryl urea catalyzed Claisen rearrangement 
 
Scheme 1.16  Jacobsen’s monofunctional thiourea catalysts 
 
Scheme 1.17  Various reaction catalyzed by Jacobsen’s monofunctional catalysts 
 
Scheme 1.18  The second generation of Jacobsen catalyst 
 
Scheme 1.19  Chiral bis-thiourea catalyzed Baylis-Hillman and Friedel-Crafts 
reaction 
 
Scheme 1.20  Enantioselective Michael addition reaction catalyzed by a tertiary 
amine thiourea 
Scheme 1.21  Pápai’s proposed activation model 
 
Scheme 1.22  Enantioselective 1, 4-additions and aza-Henry reactions catalyzed by 
Takemoto bifunctional catalyst 
 
Scheme 1.23  Reactions catalyzed by Jacobsen’s bifunctional thiourea catalysts 
 
Scheme 1.24  Iodolactonization reactions catalyzed by tertiary aminourea catalyst 
 
Scheme 1.25  Wang’s binaphthyl containing bifunctional thiourea catalyst 
 
Scheme 1.26  Friedel-Crafts alkylation of indoles and nitroalkenes 
 
Scheme 1.27  Chiral bifunctional thiourea catalysts derived from cinchona alkaloid 
 
Scheme 1.28  Chiral cinchona derived bifunctional catalyzed conjugate addition 
reactions 
 
Scheme 1.29  Reactions catalyzed by cinchona derived bifunctional catalysts 
 
Scheme 1.30  Cascade Michael-aldol reaction catalyzed by cinchona alkaloid 
catalyst 
 
Scheme 1.31  Strecker synthesis of amino acids employing guanidine catalysts 
 
Scheme 1.32  Axially chiral guanidinium catalysts for1, 3-dicarbonyl addition 
reactions and α-hydrazination of -ketoesters 
Scheme 1.33  Selected examples of chiral phosphoric acids 
 
Scheme 1.34  Mannich reactions catalyzed by chiral phosphoric acids 
 
Scheme 1.35  Hydrophosphonylation and aza-Friedel-Crafts reaction catalyzed by 
chiral phosphoric acid 
 
Scheme 1.36  Phosphoric acid catalyzed alkylation of diazoester and aza-ene 
reaction 
 
Scheme 1.37  Phosphoric acid catalyzed Diels-Alder reactions 
 
Scheme 1.38  Phosphoric acid catalyzed Pictet-Spengler reaction 
 
Scheme 1.39  Phosphoric acid catalyzed Biginelli reaction 
 
Scheme 1.40  Phosphoric acid catalyzed imine amidation 
 
Scheme 1.41  Diels-Alder reaction catalyzed by Yamamoto’s phosphoramide 
 
Scheme 1.42  BINOL derivative catalyzed aza-Morita-Baylis-Hillman reaction 
 
Scheme 1.43  Amino-thiocarbamate catalyzed bromocyclization reactions 
 
Scheme 1.44  Peptide catalyzed remote desymmetrizaiton 
 
Scheme 1.45  anti-Selective asymmetric nitro-mannich reaction 
 
Scheme 1.46  Multifunctional organocatalytic Michael addition of nitroalkanes 
 
Scheme 2.1   Selected examples of pharmaceuticals containing glycerol core 
structure 
 
Scheme 2.2   The direct vinylogous aldol reaction reported in literature 
 
Scheme 2.3   Construction of -butenolides and glycerols via vinylogous aldol 
reaction 
 
Scheme 2.4   List of bifunctional catalysts screened in the reaction 
 
Scheme 2.5   Proposed transition-state model 
 
Scheme 2.6   Vinylogous aldol reaction with -dibromo--butenolide 
 
Scheme 2.7   Synthetic manipulations of the vinylogous aldol adduct 
 
Scheme 2.8   Synthesis of antifungal agent 
 
Scheme 3.1   Examples of the biologically important isoquinolinones and 
isoquinolines 
 
Scheme 3.2   Literature reported methods for the synthesis of isoquinolinones 
 
Scheme 3.3   Construction of isoquinolines and isoquinolinones via vinylogous 
mannich reaction 
 
Scheme 3.4   List of catalysts screened in the reaction 
 
Scheme 3.5   Plausible trasition-state model 
 
Scheme 3.6   Vinylogous mannich reaction in gram scale 
 
Scheme 3.7   Synthesis of chiral isoquinolinones 
 
Scheme 3.8   Synthesis of chiral isoquinolines 
 
Scheme 4.1   Examples of the biologically important phthalide containing 
compounds 
 
Scheme 4.2   Reaction design for the vinylogous Michael reaction 
 
Scheme 4.3   Catalysts screened in the vinylogous Michael addition to nitroolefins 
 
Scheme 4.4   Synthetic manipulations for the vinylogous Michael adduct 
 
Scheme 4.5   Catalysts screened in the vinylogous Michael addition to chalcones 
 
Scheme 5.1   Strategies employed in the cinchona derived bifunctional catalysts 
 

























List of Figures 
Figure 2.1    ORTEP structure of aldol adduct 2-14f 
 
Figure 4.1    ORTEP structure of Michael adduct 4-3f 
 






List of Abbreviations 
AIBN        2, 2'-azobisisobutyronitrile 
Ar         aryl 
BINAP        2, 2'-bis(diphenylphosphino)-1,1'-binaphthyl 
BINOL        1, 1'-bi-2-naphthol 
Bn         benzyl 
Bu         butyl 
Bz         bzenzoyl 
Boc         tert-butoxycarbonyl 
CAM        ceric ammonium molybdate 
CAN        ceric ammonium nitrate  
Cbz         benzyloxycarbonyl 
DABCO    1, 4-diazabicyclo-[2.2.2]octane 
DBU     1, 8-diazabicyclo-[5.4.0]undec-7-ene 
DCC     dicyclohexyl carbodiimide 
DCM     dichloromethane 
DDQ     2, 3-dichlro-5, 6-dicyano-1, 4-benzoquinone 
DEAD     diethyl azodicarboxylate 
DIAD     diisopropylcarbodiimide 
DIC        diisopropylcarbodiimide 
DIPEA     diisopropylethylamine 
DMAP     dimethylaminopyridine 
DMF     dimethylformamide 
DMSO     dimethylsulfoxide 
dr         diastereomeric ratio 
EA         ethyl acetate 
ee         enantiomeric excesses 
HOBt     1-hydroxybenzotriazole 
HMDS     hexamethyldisilazine 
HPLC     high performance liquid chromatography 
HRMS     high resolution mass spectra 
IBX        1-Hydroxyl-1, 2-benziodoxol-3(1H)-one 
IPA         isopropanol 
LRMS     low resolution mass spectra 
LAH     lithium aluminum hydride 
LDA     lithium diisopropylamide 
m-CPBA    m-chloroperoxybenzoic acid 
NBS     N-bromosuccinimide 
NCS     N-chlorosuccinimide 
NMM     N-methylmorpholine 
NMP     N-methylpyrrolidone 
NMR     nuclear magnetic resonance 
PCC     pyridinium chlorochromate 
PDC     pyridinium dichromate 
Ph         phenyl 
PMP     p-methoxyphenyl 
SMP     (S)-2-methoxymethylpyrrolidine 
TBAF     tetrabutylammonium fluoride 
TBDPS        tert-butyldiphenylsilyl  
TBS     tert-butyldimethylsilyl 
t-Bu     tert-butyl 
TEA     triethylamine 
Tf                  trifluoromethyl sulfonyl 
TFA     trifluoroacetic acid                                                 
TFAA     trifluoroacetic anhydride 
TIPS     triisopropylsilyl 
TMS     tetramethylsilane 
TMSCl        trimethylsilyl chloride 
TMSOTf    trimethylsilyl triflate 
Ts         toluenesulfonyl 
Tr         trityl 
 
 
List of Publications 
1. Luo, J.; Wang, H.; Han, X.; Xu, L-W.; Kwiatkowski, J.; H, K-W.; Lu, Y. “The Direct Asymmetric 
Vinylogous Aldol Reaction of Furanones with -Ketoesters: Access to Chiral -Butenolides and 
Glycerol Derivatives”, Angew. Chem. Int. Ed. 2011, 50, 1861. (Highlighted in SYNFACTS 2011, 4, 
445.) 
2. Luo, J.; Xu, L.; Hay, A. S.; Lu, Y. "Asymmetric Michael addition mediated by novel cinchona 
alkaloid-derived bifunctional catalysts containing sulfonamides", Org. Lett. 2009, 11, 437. 
(Highlighted in SYNFACTS 2009, 3, 331. With 46 citations by August 2011). 
3. Luo, J.; Wang, H.; Zhong, F.; Kwiatkowski, J.; Xu, L-W.; Lu, Y. “Direct Asymmetric Vinylogous 
Mannich-Type Reaction of Phthalide Derivatives: Facial Access to Chiral Substituted Isoquinolines 
and Isoquinolinones”, Angew. Chem. Int. Ed. Manuscript in preparation. 
4. Luo, J.; Wang, H.; Zhong, F.; Kwiatkowski, J.; Xu, L-W.; Lu, Y. “Highly Diastereoselective and 
Enantioselective Direct Vinylogous Michael Addition of Phthalide Derivatives to Nitroolefins”, Org. 
Lett. Manuscript in preparation. 
5. Luo, J.; Zhong, F.; Xu, L-W.; Lu, Y. “Direct Asymmetric Vinylogous Michael Addition of Phthalide 
Derivatives to Chalcones” Adv. Synth. Catal. Manuscript in preparation. 
6. Luo, J.; Wu, W.; Xu, L-W.; Lu, Y. “Direct Phase Transfer Catalyzed Asymmetric Fluorination and 
Chlorination of -ketoesters “ Org. Lett. Manuscript in preparation. 
7. Wang, H.; Luo, J.; Han, X.; Lu, Y. “Enantioselective Synthesis of Chromanones via a 
Tryptophan-Derived Bifunctional Thiourea Catalyzed Oxa-Michael-Michael Cascade Reaction” Adv. 
Synth. Catal. Submitted. 
8. Ghosh, A.; Luo, J.; Liu, C.; Weltrowska, G.; Lemieux, C.; Chung, N.; Lu, Y.; Schiller, P.W. "Novel 
Opioid Peptide Derived Antagonists Containing (2S)-2-Methyl-3-(2,6-dimethyl-4-carbamoylphenyl)- 
propanoic Acid [(2S)-Mdcp]", J. Med. Chem. 2008, 51, 5866.  
9. Han, X.; Luo, J.; Liu, C.; Lu, Y. "Asymmetric Generation of Fluorine-Containing Quaternary Carbons 
Adjacent to Tertiary Stereocenters: Uses of Fluorinated Methines as Nucleophiles", Chem. Commun. 
2009, 2044. (Highlighted in SYNFACTS 2009, 564, one of the top ten most cited ChemComm 
communications in 2009. With 46 citations by August 2011).  
10. Xu, L.; Luo, J.; Lu, Y. "Asymmetric catalysis with primary amine-based organocatalysts", Chem. 
Commun. 2009, 1807. (One of the top ten most cited ChemComm feature articles in 2009. With 
122 citations by August 2011). 
11. Jiang, Z.; Yang, H.; Han, X.; Luo, J.; Wong, M. W.; Lu, Y. ” Direct asymmetric aldol reactions 
between aldehydes and ketones catalyzed by L-tryptophan in the presence of water.” Org. Biomol. 
Chem. 2010, 8, 1368. 
12. Wang, Y.; Luo, J.; Chen, H.; He, Q.; Gan, N.; Li, T. “A microchip-based flow injection-amperometry 
system with mercaptopropionic acid modified electroless gold microelectrode for the selective 
determination of dopamine“, Anal. Chim. Acta. 2008, 625, 180. 








1.1 Asymmetric organocatalysis 
1.1.1    Introduction 
Chiral molecules are optically active compounds that lack an internal plane of 
symmetry and have a non-superimposable mirror image.1 Such molecules are 
extraordinarily prevalent in most natural products and pharmaceutical agents. According 
to a chirality analysis by Dictionary of Natural Products (DNP), the average chiral centers 
existing in drugs and natural products are estimated to be 2.82 and 5.19, respectively 
(Table 1.1). About 80% of the natural products have at least one chiral center, and 15% 
of them have 11 stereocenters or more.2 Similarly, most new drugs and those under 
development consist of at least one chiral center. Hence, chirality is now becoming an 
extremely important topic for the drug development. Due to this increased interest in the 
optically active compounds, the preparation of pure chiral molecules has become a topic 
of great importance, and the methods to access such compounds are being intensively 
pursued. 
Two main synthetic approaches have been developed to access chiral molecules, 
namely chiral auxiliary-based method and asymmetric catalysis. Between these two 
approaches, chiral auxiliaries used to be the main method to access chiral compounds.3 
Some famous examples include Evans’s oxazolidinones,4 camphor-derived auxiliaries,5 
sulfinamides,6 sulfoxides,7 bis(sulfoxides)8 and carbohydrate-derived auxiliaries9. 
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However, this approach is considered to be less efficient since the auxiliaries have to be 
cleaved after the reaction. 
Table 1.1   Average numbers of chiral centers in synthetics, drugs and natural products. 
Source Synthetic compounds Drugs
Natural 
products
Subgroups of Natural products 
Plantea Fungi Animalia Monera
Number of 
compounds 24728 8561 161278 64314 3206 8594 6626 
Average chiral 
centers 0.39 2.82 5.19 6.03 4.02 4.62 7.24 
 
Compared to chiral auxiliaries, asymmetric catalysis has become a more promising 
and effective method because the catalyst could be recycled in the synthesis. Asymmetric 
catalysis can be further divided into three catagories: enzyme catalysis, transition metal 
mediated catalysis and asymmetric organocatalysis.  
Enzyme catalysis has traditionally been used to access chiral molecules.10 Enzymes 
are naturally occurring gifts that can be used to synthesize biological molecules in the 
human body. Likewise, they can also be used to produce chiral organic compounds 
because perfect enantioselectivities are often observed. Biological catalysis is now widely 
used in an industrial scale. However, enzyme-based asymmetric method is subjected to 
the availability of enzymes and limited to the production of specific stereoisomers. 
In addition to enzyme catalysis, transition metal-based asymmetric synthetic 
methods are widely used to achieve high enantioseletivity. Metal catalyst provides a 
flexible ground for almost all types of reactions. Great progress has been achieved for the 
past decades, making this area attractive for the synthesis of chiral molecules. In 1980, 
Sharpless and Katsuki disclosed a highly enantioselective epoxidation of allylic alcohols 
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by a titanium-tartrate complex, and this method was quickly established as a routine 
reaction in organic synthesis.11 Later, the introduction of ruthenium(II)/binap (1-1) 
complex by Noyori and co-workers has opened the asymmetric hydrogenation towards 
practical synthetic applications (Scheme 1.1).12 Other famous examples include the 
asymmetric epoxidation of alkenes with chiral salen (1-2)-Mn complexes,13 and 
asymmetric cyclopropanation of alkenes with chiral bisoxazoline (1-3)-copper (II) 
complexes.14 Meanwhile the use of chiral Lewis acids15 became more routine.  
 
Scheme 1.1    Structures of some representative ligands 
 
However, metal-based catalytic methods do suffer from some key drawbacks, such 
as high cost and toxicity of the metals, and sensitivity to air and moisture. Thus, it is 
highly desirable to develop another efficient method allowing for the easy access to chiral 
molecules. 
In this context, asymmetric organocatalysis has become a hot research area in the 
past few years, and has quickly been established as another important method in the 
preparation of chiral compounds. Organocatalysts are pure “organic” molecules which 
are mainly composed of carbon, hydrogen, oxygen, nitrogen, sulfur, and phosphorus.16 
The catalytic activity of organocatalysts is originated from the low molecular weight 
organic molecule itself, and no transition metals are required. The advantages of 
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organocatalysts are quite obvious: inexpensive，robust, readily available, and non-toxic. 
In most cases, reactions can be performed under an open-flask atmosphere in wet 
solvents. Sometimes, the presence of water is even favorable to the reaction rate and the 
stereoselectivity.17 The operational simplicity and ready accessibility of these low-cost 
stable catalysts make organocatalysis an attractive method for the synthesis of complex 
structures. Unlike any other asymmetric methods, organocatalytic reactions offer a rich 
platform for multi-component, tandem, or domino-type reactions, allowing higher 
structural complexity of products in an enantioselective manner. 
 
1.1.2    Historical background of organocatalysis 
Although organocatalysis was only well recognized in recent years, the 
organocatalytic reactions actually have a long history. As early as 1908, the first example 
of asymmetric reaction under non-enzymatic conditions was introduced by Georg 
Breding, in which enantiomeric enrichment was observed in the thermal decarboxylation 
reaction.18 A kinetic resolution version of this reaction was developed later in the 
presence of chiral alkaloids.19 Then, the groundbreaking work was again done by Breding 
in the hydorcynation reaction of benzaldehyde (Scheme 1.2). Although poor 
enantioselectivity was obtained with the tested cinchona alkaloid, this work undoubtedly 
could be considered as the milestone discovery in the history of organocatalysis.20 After 
the research, Vavon and Wegler, respectively, reported the acylative kinetic resolution of 
racemic secondary alcohols.21  
Encouraged by Breding’s work, Pracejus and co-workers reported the O-
acetylquinine catalyzed addition of methanol to methyl phenyl ketene. The product 
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methyl (-)--phenyl propionate was formed in high yield with 74% ee.22 This impressive 
result has stimulated other researchers for the further explorations using the cinchona 
alkaloid scaffolds. Wynberg did an extensive modification on the C-9 hydroxyl group of 
cinchona alkaloid and successfully applied them in the 1,2- and 1,4-additions of various 
nucleophiles to carbonyl compounds.23   





































Scheme 1.2 Early examples of asymmetric reactions using organic catalysts 
 
Another milestone in the field of organocatalytic reaction was Stork’s introduction of 
stoichiometric enamine in the 1950s,24 and the general utility of enamines as nucleophiles 
was established in their elegant studies. In the 1970s, two industrial groups disclosed the 
Hajos-Parrish-Eder-Sauer-Wiechert reaction,25 in which proline-catalyzed intramolecular 
aldol reactions via the enamine intermediates accounting for the observed high 
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enantioselectivity. This reaction has found wide applications, including the synthesis of 


















Scheme 1.3 L-Proline catalyzed Robinson annulation 
 
The late 1970s and early 1980s witnessed the advent of ion-pairing mediated 
catalysis. The representative examples included chiral Bronsted acids for the asymmetric 
hydrocyanation reactions27 and phase-transfer catalyzed asymmetric alkylation 
reactions.28  
However, the ‘golden age of organocatalysis’ did not begin until the late 1990s.29 
Inspired by the elegant studies of Jacobsen,29 List and Barbas,30 MacMillan31 and 
Maruoka,32 the field of organocalysis has become a hot research area and a vast large 
number of organic catalysts have appeared in the past few years, and some selected 
examples are shown in Scheme 1.4. The known organocatalysts can be divided into the 
following categories: 
1)  Primary or secondary amine-mediated aminocatalysts.33 The substrate (typically 
aldehyde or ketone) is activated through enamine or iminium intermediate. The 
SOMO activation could also fall into this category; 
2)  Hydrogen-bonding-based organocatalysts.34 The catalysts usually contain chiral 
hydrogen-bond donors (e.g. hydroxyl, urea and thiourea moiety), which can 
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activate the substrate during the reaction and is essential for the high 
enantioselectivity; 
3)  Phase transfer catalysts. The reaction usually proceeds through an ion-pairing 
interaction between the catalyst and substrate, which is important for the 
observed high selectivity. 
4)  N-Heterocyclic carbene catalysts.35 This type catalyst provids an unusual 
reactivity pattern: conjugate umpolung of -unsaturated aldehydes. It is widely 
studied in the benzoin condensation and Stetter reactions. 
5) Phosphine based organocatalysts. The nucleophilicity of phosphine makes them to 
be powerful catalysts in a number of reaction like Morita-Baylis-Hillman 
reaction and cycloaddition. 




Scheme 1.4 Selected examples of chiral organocatalysts 
 
1.2 Chiral hydrogen-bonding-based organocatalysis 
Enantioselective synthesis of organocatalysts with chiral hydrogen-bond donors has 
emerged as a frontier in the field of asymmetric catalysis. It has been demonstrated that 
small molecules possessing hydrogen-bond donor motifs along with complementary 
functional frameworks (e.g. tertiary amine moiety and binaphthyl scaffold) could catalyze 
a variety of organic reactions with high enantioselectivity and with broad substrate scope. 
These hydrogen bond donors have been extensively demonstrated to be useful in 
organocatalysis. Some representative examples of hydrogen-bonding organocatalysts are 
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listed in Scheme 1.5. 
 
 
Scheme 1.5 Different types of hydrogen-bonding organocatalysts 
 
1.2.1  Chiral monofunctional organocatalysis 
1.2.1.1  Hydroxy-containing organocatalysts 
The Diels-Alder reaction is arguably one of the most powerful reactions in organic 
synthesis and early studies have found that the aqueous media could accelerate the 
reaction rate significantly.36
 
Encouraged by this finding, Kelly synthesized electron 
deficient biphenylenediols and applied them to accelerate the Diels-Alder reactions 
between cyclopentadiene and acrolein. It was proposed that the aldehyde moiety was 
activated by two hydrogen bonds to form the intermediate 1-15.37 In a separate study, 
Jørgensen carried out calculations to explain the rate acceleration phenomenon of Claisen 
rearrangements and Diels-Alder reactions. He also drew a similar activation model 
compared to Kelly’s explanation (Scheme 1.6).38 





















Scheme 1.6  Kelly and Jørgensen’s activation models 
From these initial studies, two new types of hydrogen-bond donor organocatalysts 
emerged: TADDOL 1-20 and BINOL derivative 1-21 (Scheme 1.7). 
 
 
Scheme 1.7 Structures of orgnaocatalysts TADDOL 1-20 and derivatives of BINOL 1-21 
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In 2003, Rawal reported a TADDOL 1-22 catalyzed hetero-Diels-Alder reaction of 
benzaldehyde and aminosiloxydiene to give a single diastereomer of cycloadduct 1-29.  
Treatment of 1-29 with AcCl could afford the hetero-Diels-Alder product in good yield 

















81% yield, 98% ee
1-29 1-301-27 1-28
 
Scheme 1.8 TADDOL catalyzed hetero-Diels-Alder reaction 
Shortly after, the same group reported a highly diastereoselective and 
enantioselective Mukaiyama aldol reactions of O-silyl-N, O-ketene acetals to aldehydes, 
mediated by TADDOL derived hydrogen bonding catalyst 1-23. The aldol adducts were 
formed in high yield and with excellent enantioselectivity after the treatment of HF to 
remove TBS protecting group (Scheme 1.9).40 
 
 
Scheme 1.9 TADDOL catalyzed Mukaiyama aldol reaction 
The TADDOL derived catalyst was also effective for the enantioselective nitroso 
aldol reactions. In 2005, Yamamoto et al. reported a nitroso aldol reaction between 
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nitrosobenzene and enamines catalyzed by TADDOL 1-22 to give N-nitroso aldol 
product in 77-91% ee. In addition to N-selective aldol adducts, O-nitroso aldol products 
could also be formed when the reactions were catalyzed by glycolic acid derivative 1-37 
(Scheme 1.10).41 
 
Scheme 1.10 TADDOL catalyzed nitroso aldol reaction of enamine 
The Morita-Baylis-Hillman reaction represents an important method for the C-C 
bond formation. The generated functionalized allylic alcohol is of considerable value for 
the synthesis of complex natural products. Morita-Baylis-Hillman reaction is usually very 
slow; hence significant effort has been made to improve its reaction efficiency. In 2003, 
Schaus reported an enantioselective Morita-Baylis-Hillman reaction of cyclohexenone 
with aldehydes, using BINOL derivative 1-24 and 1-25 as the catalyst and 
triethylphosphine as the nucleophilic promoter (Scheme 1.11).42 
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Scheme 1.11 BINOL derivative catalyzed Morita-Baylis-Hillman reaction 
Recently, Yamamoto and co-workers developed a BINOL derived catalyst and 
applied it to the Nitroso Diels-Alder-type reaction of nitrosobenzene with diene (Scheme 
1.12).43 With the hydrogen bonding of two hydroxyl groups in the bulky catalyst 1-26, 2-
oxa-3-aza-bicycloketones were synthesized in single regioisomer and with high 
enentioselectivities. 
 
Scheme 1.12 BINOL derivative catalyzed Nitroso Diels-Alder-type reaction 
1.2.1.2  Monofunctional urea and thiourea-based catalysts 
The ability that urea and thiourea can act as catalysts to activate electrophiles 
through double hydrogen-bonding has been investigated by many research groups. In 
1988, Etter reported that 1,3-bis(m-nitrophenyl)urea could serve as a good complexing 
agent for proton acceptors. A more detailed study was done later by the same group using 
co-crystallization to probe hydrogen bond donor and acceptor selectivity.44 The author 
proposed that the two NH···O hydrogen-bondings may be accounted for the observed 
intermolecular interactions (Scheme 1.13). 




Scheme 1.13 Hydrogen bonding interactions in urea catalyst 
In 1994, Curran found that urea 1-47 could improve both reaction rate and 
diastereoselectivity in the radical allylations of 2-(phenylseleno) tetrahydrothiophene 
oxide 1-45 with allyltributylstannane. The urea was shown to be selective at promoting 
formation of trans-1-48 as the major product. The stereochemistry and the rate 
acceleration are attributed to the double activation of the radical intermediate (Scheme 
1.14).45  
 
             Scheme 1.14 Diaryl urea catalyzed radical alkylation reaction 
       Following this work, the same group employed the diaryl urea catalyst in the Claisen 
rearrangement. The reaction rate was found to be increased by 34 times at 50 oC (Scheme 
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1.15).46 It should be noted that thiourea catalyst was not effective in promoting the same 





1-49 1-50  
           Scheme 1.15 Diaryl urea catalyzed Claisen rearrangement 
       The most famous example of monofunctional catalyst is probably Jacobsen’s Schiff 
base derived urea or thiourea catalyst (Scheme 1.16). The catalyst is consisted of four 
parts: the amino acid unit, urea or thiourea moiety, trans-diamino cyclohexane and the 
salicylaldimine unit. 
 
Scheme 1.16 Jacobsen’s monofunctional thiourea catalysts 
In 1998, a library of Schiff base derived thiourea catalysts were synthesized and 
reported by Jacobsen and co-works.47 These catalysts were initially designed as potential 
ligands for Lewis acidic metals. Surprisingly, the study showed that high 
enantioselectivity could be achieved in the absence of metal ion when being employed in 
the Strecker reaction of hydrogen cyanide with N-allylaldimine (Scheme 1.17). Based on 
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the structure modification and computational study, they proposed a activation model 
where double hydrogen bonding is formed between the imine lone pair and the acidic N-
H proton.48 This catalyst system was also effectively applicable to a wide range of 
reactions such as Mannich-type reaction of N-Boc-aldimine with ketene silyl acetals,49 
hydrophosphonylation of imines50 and aza Baylis-Hillman reaction51 (Scheme 1.17). 
 
Scheme 1.17 Various reactions catalyzed by Jacobsen’s monofunctional catalysts 
Jacobsen and co-workers have also carried out further developments on this type 
monofunctional thiourea catalyst. Catalysts 1-64 and 1-65 were synthesized and utilized 
in cationic polycyclization reaction and enantioselective additions to oxocarbenium ions, 
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respectively (Scheme 1.18).52 It is believed the anion binding of thiourea group and 



































































           Scheme 1.18 The second generation of Jacobsen catalysts 
In 2004, Nagasawa reported the use of chiral bis-thiourea to promote the DMAP 
mediated asymmetric Baylis-Hillman addition of cyclohexenone to aldehydes with high 
enantioselectivities (Scheme 1.19).53a This high selectivity is proposed to come from bis-
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thiourea moiety, which binds to the substrate during the transition state. This type of 
organocatalyst has later been modified and applied to Friedel-Crafts addition of N-methyl 
indole and nitro olefins (Scheme 1.19).53b 
 
Scheme 1.19 Chiral bis-thiourea catalyzed Baylis-Hillman and Friedel-Crafts reaction 
 
1.2.2 Chiral bifunctional organocatalysis 
1.2.2.1   Bifunctional urea and thiourea-based catalysts 
The first elegant example of bifunctional catalyst bearing tertiary amine was reported 
by Takemoto in 2003, which gave excellent enantioselectivity in the Michael reaction of 
malonate esters with nitro alkenes.54
 
The activation model proposed by their study 
showed that nitro olefin interacts with the thiourea moiety via double hydrogen-bonding, 
while the tertiary amine holds the malonate via a hydrogen-bond in the activated enol 
form (Scheme 1.20).  




































Scheme 1.20 Enantioselective Michael addition reaction catalyzed by a tertiary amine 
thiourea 
Later, in 2006, an alternative mode of this reaction was proposed based on density 
functional theory calculations by Pápai et al.55
 
They reported that the nitro olefin is 
activated by the protonated tertiary amine and the enolate is activated by the double 
hydrogen bonding of thiourea group (Scheme 1.21). Both activation modes predict the 
same (R)-configuration and the tightly organized transition state yields the Michael 
adducts in high enantioselectivity. 
 
                     Scheme 1.21 Pápai’s proposed activation model 
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Other reactions have also been explored using this bifunctional thiourea catalyst, 
such as 1,4-addition of malonitrile to ,-unsaturated imides56 and aza-Henry reactions 
(Scheme 1.22).57 
 
Scheme 1.22 Enantioselective 1,4-additions and aza-Henry reactions catalyzed by 
Takemoto bifunctional catalyst 
Jacobsen et al. also synthesized a series of bifunctional thiourea catalysts (Scheme 
1.23). These catalysts have been used in various reactions such as nitro-Mannich 
reaction,58 acyl-Picter-Spengler reaction,59 hydrocyanation,60 Pictet-Spengler-Type 
cyclizations of hydroxylactams61 and acyl-mannich reactions of isoquinolines62 (Scheme 
1.23). 


























































































































Scheme 1.23 Reactions catalyzed by Jacobsen’s bifunctional thiourea catalysts 
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Later, a tertiary amine-urea bifunctional catalyst derived from trans-1,2-diamino 
cyclohexane was developed by Jacobsen and used to promote the enantioselective 
iodolactonization reaction, which afforded 5- and 6-membered iodolactones with high 
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Scheme 1.24 Iodolactonization reactions catalyzed by tertiary aminourea catalyst 
Meanwhile, a novel bifunctional thiourea catalyst with binaphthyl moiety was 
developed by Wang for the enantioselective Baylis–Hillman reactions. This catalyst was 
found to promote the addition of cyclohexenone to a range of aldehydes in high yield and 
with good selectivities.64 Subsequently, it was found that the same catalyst is applicable 
in the enantioselective Michael addition of 2,4-pentadione to nitro olefins (Scheme 
1.25).65 
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Scheme 1.25 Wang’s binaphthyl containing bifunctional thiourea catalyst 
Later, in 2005, a novel thiourea catalyst was reported by Ricci in the Friedel-Crafts 
alkylation of indoles with nitroalkenes (Scheme 1.26).66 The catalyst could be easily 
accessed in both enantiomeric forms from commercially available materials. In their 
proposed transition state model, the thiourea interacts with the nitro group and the free 
alcohol activates the indole proton via weak hydrogen bond. The exceptionally simple 
operational procedure and the highly synthetic versatility of the products make this new 
approach highly attractive for the synthesis of optically active compounds such as 
tryptamines and 1,2,3,4-tetrahydro--carbolines. 




Scheme 1.26 Friedel-Crafts alkylation of indoles and nitroalkenes 
Recently, a series of bifunctional thiourea catalysts, bearing cinchona alkaloid 
backbone, were synthesized (Scheme 1.27).67 These catalysts have been proven to be 




Scheme 1.27 Chiral bifunctional thiourea catalysts derived from cinchona alkaloid 
In 2005, Soόs et al. disclosed a highly enantioselective 1,4-addition of nitromethane 
to -unsaturated ketones catalyzed by cinchonine derived catalyst.68 In the following 
year, Wang et al. also reported 1,4-addition of malonate esters to -unsaturated ketones 
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using the same catalyst.69 Almost at the same time, Dixon and Connon respectively 
reported the 1,4-addition of malonate esters to nitro olefin catalyzed by cinchona alkaloid 
(Scheme 1.28).70  
 
 
Scheme 1.28 Chiral cinchona derived bifunctional catalyzed conjugate addition reactions 
Then, in the subsequent year, Deng et al. documented the alkylation addition of 
malonate esters and indoles to N-Boc-imines and N-Ts-imines.71 They also found that 
replacement of the phenolic functional group in cinchona alkaloid with a thiourea led to a 
substantially improved catalyst for the Henry reaction.72 The same type catalyst was also 
effective for the conjugate addition of simple alkyl thiols to -unsaturated N-acylated 
oxazolidin-2-ones73 (Scheme 1.29). 
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Scheme 1.29 Reactions catalyzed by cinchona derived bifunctional catalysts 
Among the various reported catalysts, the cinchona alkaloid thiourea 1-114b is the 
most effective for the cascade Michael-aldol reaction between 2-mercaptobenzaldehyde 
and -unsaturated oxazolidinones.74 With only 1 mol% of catalyst employed, the 
product was formed as a single regioisomer and excellent enantioselectivity was obtained 
(Scheme 1.30). 
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Scheme 1.30 Cascade Michael-aldol reaction catalyzed by cinchona alkaloid catalyst 
1.2.2.2  Guanidines 
Chiral guanidines represent another important class of bifunctional catalysts. In 1996, 
Lipton and his co-workers reported the Strecker reaction of imine for the synthesis of 
amino acids employing cyclic dipeptide containing guanidine 1-136 as catalyst, allowing 
the formation of substituted imines into (S)-amino nitriles in high yields and with good 
enantioselectivities.75 Later, Corey developed a C2-symmetric guanidine 1-137 and 
applied it in the same reaction.76 In his proposed transitional state, HCN bonds to the 
catalyst, generating a guanidinium cyanide salt which can provide hydrogen bonding to 
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Scheme 1.31 Strecker synthesis of amino acids employing guanidine catalysts 
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        Based on Corey’s work, Tan et al. did further modifications on the bicyclic 
guanidines and employed them in a number of reactions, including anthrone Diels-Alder 
reaction,77 enantioselective protonation reaction,78 conjugate addition of fluorocarbon 
nucleophiles79 and isomerization of alkynes.80  
In 2006, Terada and co-workers designed axially chiral guanidine 1-139 as an 
effective organocatalyst to promote the highly enantioselective Michael addition of 1,3-
dicarbonyl compounds with nitroolefins.81 Also in the same year, a modified axially 
chiral seven-membered guanidine 1-140 was synthesized and used in the electrophilic 
amination reaction of ketoesters and di-ketones with high catalytic activity (Scheme 
1.32).82 
 
Scheme 1.32 Axially chiral guanidinium catalysts for 1,3-dicarbonyl addition reactions 
and -hydrazination of -ketoesters 
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1.2.2.3 Chiral phosphoric acids   
The past few years have witnessed the dramatic development of phosphoric acids as 
bifunctional catalysts. The easily tunable ability of the two aromatic substitutions makes 
them ideal catalysts in various asymmetric transformations. A wide variety of chiral 
phosphoric acids have been developed in the past few years. Some selected examples are 





































Scheme 1.33 Selected examples of chiral phosphoric acids 
In 2004, Akiyama83 and Terada84 independently reported enantioselective Mannich 
reactions of aldimines with silyl enolates, and acetyl acetone to N-Boc-protected 
arylimines (Scheme 1.34). The phosphoric acids were shown to be superior catalysts for 
these reactions and it provided an attractive way to construct -aminoketones under 
extremely mild conditions. It is also demonstrated that modifications on the 3,3’-bisaryl 
substituents of the catalysts have immense effect on the enantioselectivity.  



































Mannich reactions of silyl enolates
Mannich reactions of acetyl acetone
 
Scheme 1.34 Mannich reactions catalyzed by chiral phosphoric acids 
Akiyama later disclosed a hydrophosphonylation reaction of imines catalyzed by 1-
146c to afford the product in good yields and with high enantioselectivitivies (Scheme 
1.35).85 A nine-membered transition state was proposed, where the phosphoric acid 
hydrogen activates the imine as a Brønsted acid and the phosphoryl oxygen activates the 
nucleophile by coordinating with the hydrogen of the phosphate as a Brønsted base. 
Terada and co-workers described a new asymmetric aza-Friedel-Crafts reaction of furan 
with N-Boc imines catalyzed by the chiral phosphoric acid 1-146d (Scheme 1.35).86 
Highly enantioselective furan-2-ylamine derivatives were synthesized according to their 
methodology. The synthetic utility of these alkylation products was further displayed by 
oxidative cleavage of the furan ring (aza-Achmatowicz reaction) to form a 1,4-dicarbonyl 
compound that could be easily derivatized to a -butenolide. 
 
 




Scheme 1.35 Hydrophosphonylation and aza-Friedel-Crafts reaction catalyzed by chiral 
phosphoric acid 
Terada reported a phosphoric acid-catalyzed direct alkylation of -diazoester, via C-
H bond cleavage. The resulting products are highly functionalized and useful synthetic 
precursors to various types of -amino acids.87 One year later, the same group developed 
a highly efficient enantioselective aza-ene-type reaction of N-benzoyl imines with 
enecarbamates. The reaction can be performed at extremely low loading of the chiral 
Brøsted acid catalyst. The method provides a practical route to synthetically useful -
amino-imine derivatives with biological importance (Scheme 1.36).88 
 
Scheme 1.36 Phosphoric acid catalyzed alkylation of diazoester and aza-ene reaction 
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In 2006, Akiyama developed a chiral Brønsted acid-catalyzed inverse electron-
demand aza Diels-Alder reaction of aldimines with electron-rich alkenes. The afforded 
tetrahydroquinolines products were obtained with high to excellent enantioselectivity.89 
Rueping90 and Gong91 also disclosed a Diels-Alder reaction of cyclohexenone for the 
enantioselective synthesis of various aromatic and heteroaromatic substituted 
isoquinuclidines (Scheme 1.37). 
 
Scheme 1.37 Phosphoric acid catalyzed Diels-Alder reactions 
List and co-workers developed a catalytic asymmetric Pictet-Spengler reaction for 
the facial access to enantioenriched tetrahydro--carbolines. Both aromatic and aliphatic 
aldehydes were suitable substrates for this reaction (Scheme 1.38).92 




Scheme 1.38 Phosphoric acid catalyzed Pictet-Spengler reaction 
Gong discovered the first organocatalytic asymmetric Biginelli reaction. The 
products were formed in high yields with excellent enantioselectivities (Scheme 1.39).93 
 
 Scheme 1.39 Phosphoric acid catalyzed Biginelli reaction 
Antilla designed a novel Brønsted acid and applied in the asymmetric imine 
amidation reaction. Chiral N,N-aminals are produced in high yields and in excellent 









up to 99% ee
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Scheme 1.40 Phosphoric acid catalyzed imine amidation 
Yamamoto developed a novel N-triflyl phosphoramide catalyst for the highly 
enantioselective Diels-Alder reaction of -unsaturated ketone with silyloxydiene. It 
should be noted that traditional phosphoric acid catalyst was not effective for this 
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reaction, indicating the stronger Brønsted acidity of the N-triflyl amide is essential for the 
reactivity (Scheme 1.41).95 
 
Scheme 1.41 Diels-Alder reaction catalyzed by Yamamoto’s phosphoramide 
Phosphoric acid was also suitable catalyst for the reductive amination reactions in 
the presence of Hantzsch ester. Various reactions were reproted by different research 
groups, such as reduction of imines,96 reductive amination of aldehydes via dynamic 
kinetic resolution97 and enantioselective hydrogenation of heteroaromatic compounds.98 
 
1.2.2.4  Other examples 
Other bifunctional catalysts have also been developed. In 2005, Sasai and co-
workers developed a series of bifunctional BINOL-derived catalysts for the aza-Morita-
Baylis-Hillman reaction (Scheme 1.42).99 In their proposed transition state, the 2-
hydroxyl groups worked as Brønsted acid to activate imine, while the pyridine moiety 
functioned as a Lewis base for the nucleophiles. The position of the Lewis base attached 
to BINOL greatly affected the reactivity and selectivity of the reaction. It was also 
demonstrated that the acid-base-mediated functions and the conformation of the 
organocatalyst can cooperate harmoniously to promote the reaction in a highly 
enantioselective manner. 

























Scheme 1.42 BINOL derivative catalyzed aza-Morita-Baylis-Hillman reaction 
Recently, Yeung and co-workers designed two novel amino-thiocarbamate catalysts 
1-188 and 1-189. The reported mono-hydrogen bonding catalysts were superior in the 
bromolactonization of unsaturated carboxylic acids and bromoaminocyclization of 
unsaturated sulfonamides, respectively (Scheme 1.43).100 The novel catalyst 1-188 was 
applicable to promote the bromolactonization with up to 99% yield and 93% ee, which 
allows an easy formation of -lactones. Furthermore, this protocol was applied in the 
enantioselective synthesis of the key intermediates of VLA-4 antagonists.100a 
Modification on this catalyst led to a more efficient catalyst 1-189, which was employed 
in the bromoaminocyclization of sulfonamides for the formation of enantioenriched 
pyrrolidines. These pyrrolidiens could be transformed into corresponding lactams through 
a simple oxidation.100b 
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Bromolactonization of unsaturated sulfonamides
 
Scheme 1.43 Amino-thiocarbamate catalyzed bromocyclization reactions 
 
1.2.3  Chiral multifunctional organocatalysis 
The most well-known example of multifunctional catalyst in nature should be 
enzymes. The intricate macromolecular structure of enzymes makes them to possess 
extraordinary degrees of stereoselectivity and display remarkable substrate specificity. 
Hence, peptides are synthesized by chemists to mimic such process.101 Miller and co-
workers investigated the use of small-molecule peptide organocatalysts for 
enantioselective acyl, phosphoryl, and sulfinyl transfer reactions (Scheme 1.44).102 




Scheme 1.44 Peptide catalyzed remote desymmetrizaiton 
In 2008, Wang reported a highly anti-selective and excellent enantioselective nitro-
Mannich reaction catalyzed by a trifunctional thiourea catalyst (Scheme 1.45).103 The 





























Scheme 1.45 anti-Selective asymmetric nitro-mannich reaction 
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Liang developed a cinchona alkaloid derived primary amine thiourea catalyst 1-192 
and employed in the Michael addition of nitroalkanes to enones in good yield and with 
high enantioselectivity (Scheme 1.46).104 This method offered a new way to construct 
quaternary stereocenters from nitroalkanes. 
 
 
Scheme 1.46 Multifunctional organocatalytic Michael addition of nitroalkanes 
 
1.3  Project objectives 
Many organocatalysts have been developed over the past few years. These include 
amino acids, peptides, alkaloids, and many other catalysts. Among these, bifunctional and 
multifunctional organic molecules containing a tertiary amino functionality and a 
hydrogen bonding moiety are remarkably useful organic catalysts. These structures have 
proven to be useful in an astonishingly wide variety of important enantioselective 
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transformations. Despite their tremendous utility, these catalysts are derived from a very 
limited range of chiral structural scaffolds, which could be mainly divided into two types: 
the diamine catalysts and cinchona alkaloids.  
The reported diamine catalysts have mainly focused on cyclohexane-1,2-diamine and 
1,1’-binaphthyl-2,2’-diamine. However, further modifications on these structures have 
turned out to be difficult because of the limited availability of these compounds. On the 
other hand, very few reports are available on the amino acids-derived bifunctional 
catalysts, which are only with moderate catalytic ability. This is rather surprising since 
the easily available natural and unnatural amino acids provide a simple route to access 
tunable bifunctional or multifunctional catalysts. 
In addition to diamine catalysts, the reported cinchona alkaloid catalysts have mainly 
focused on the modification at the C’-6 position in the cinchona scaffold, or on the 
conversion of C-9 hydroxyl into NH2 and thiourea group. Further modification on this 
structure would still be highly desirable.  
The main aim of this project was to design and synthesize bifunctional or 
multifunctional catalysts derived from amino acids or cinchona alkaloids, to employ them 
in the vinylogous reactions of furanones and phthalide derivatives, and also to apply the 
new methodology to the synthesis of biologically useful molecules. 
The results of this project should provide an easy route to access different types of 
bifunctional or multifunctional catalysts with unique reactivity and selectivity. It may 
also contribute significantly to the understanding of how the catalysts function in the 
reaction, thus offering a potential way to improve the catalytic ability.  
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In chapter 2, direct asymmetric vinylogous aldol reaction of furanones with -
ketoesters for the feasible access to chiral -butenolides and glycerol derivatives will be 
demonstrated using L-tryptophan derived bifunctional catalyst. In chapter 3, asymmetric 
vinylogous mannich-type reaction of phthalide derivatives will be shown employing a 
cinchona derived trifunctional catalyst. The method offers a new route to chiral 
substituted isoquinolines and isoquinolinones. In chapter 4, highly diastereoselective and 
enantioselective vinylogous Michael addition of phthalide derivatives to nitroolefins and 
chalcones will be discussed.  
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Chapter 2 Direct Asymmetric Vinylogous Aldol Reaction of Furanones 




The stereoselective construction of quaternary stereogenic centers is an enormous 
challenging task in organic synthesis, and significant progresses have been made in the 
past few decades.105 Among them, tertiary alcohol-containing structures are particularly 
important molecules in biological sciences and pharmaceutical industry.106 It is not 
surprising, therefore, the direct synthesis of such compounds has drawn increasing 
attentions in recent years. A number of approaches based on metal catalysis have been 
reported recently, including kinetic resolution,107 1,2-metallate rearrangement of boronate 
complexes,108 organozinc addition to ketones109 and aldol type reactions.110 Another 
approach that has met with some degree of success is through organocatalysis, such as 
enamine catalysis,111 Brønsted acids,112 or chiral base catalyzed organic 
transformations.113 
Scheme 2.1 Selected examples of pharmaceuticals containing glycerol core structure 
Despite all these excellent methods devised for the synthesis of chiral tertiary 
alcohols, asymmetric preparation of glycerol derivatives bearing a quaternary 
stereocenter is still a formidable task. Optically active 2-substituted glycerols are key 
chiral structural motifs that present in a number of pharmaceuticals like Ravuconazole, 
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vitamin D3 metabolites and HIV-1 protease inhibitors (Scheme 2.1).114 To the best of our 
knowledge, only two examples have been reported in the literature. In 1992, Harada, Oku 
and coworkers utilized menthone as a chiral auxiliary to prepare optically enriched 2-
substituted glycerol derivatives.115 Very recently, Kang and coworkers elegantly 
employed chiral copper complexes to carry out enantioselective desymmetrization of 
meso-2-substituted glycerols, and obtained 2-substituted 3-benzoxy-1,2-propanediols 
with excellent enantioselectivity.116 It is thus our goal to develop an efficient 
organocatalytic variant to allow for the easy access to 2-substituted chiral glycerol 
derivatives. 
 
Scheme 2.2 The direct vinylogous aldol reaction reported in literature 
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On the other hand, vinylogous aldol reaction has been investigated intensively in the 
past several decades.117 While it is commonplace to employ 2-silyloxyfurans as the 
nucleophiles,118 the direct utilization of 2-furanone derivatives in the vinylogous aldol 
reactions is rare, probably due to their low reactivity.119 In 2007, Zhang and coworkers 
employed -dichloro--butenolides for the direct vinylogous aldol reaction for the first 
time.120 Very recently, Terada and coworkers reported an enantioselective vinylogous 
aldol reaction of furanone derivatives with aldehydes catalyzed by a chiral guanidine.121 
Feng et al. subsequently disclosed a bifunctional thiourea-catalyzed direct vinylogous 
aldol reaction of furanones with aldehydes (Scheme 2.2).122  
 
Scheme 2.3 Construction of  -butenolides and glycerols via vinylogous aldol reaction 
Herein, we intend to report a direct asymmetric vinylogous aldol reaction between 
-ketoesters and 3,4-dichlorofuran-2(5H)-one, rather than using 2-silyloxyfuran as the 
preformed nucleophile, with high enantio- and diastereoselectivities. The -butenolides 
resulted from such reactions are common structural motifs in natural products and 
biologically significant molecules.123 Moreover, the aldol products can be readily 
converted to tertiary alcohol-containing glycerol derivatives (Scheme 2.3). 
 
2.2 Results and discussions 
2.2.1 Reaction optimization 
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     We selected the vinylogous aldol reaction of ,-dichloro--butenolide with different 
-ketoesters as the model reaction, and several bifunctional catalysts derived from 










Trp-1: R1 = Me, R2 = Et, Ar = 3,5-CF3Ph;
Trp-2: R1 = H, R2 = Et, Ar = 3,5-CF3Ph;
Trp-3: R1 = H, R2 = Me, Ar = 3,5-CF3Ph;
Trp-4: R1 = H, R2 = (CH2)4, Ar = 3,5-CF3Ph;
Trp-5: R1 = H, R2 = Et, Ar = 4-FPh;






QD-1: R = CH3;
















Scheme 2.4 List of bifunctional catalysts screened in the vinylogous aldol reaction 
The L-tryptophan-derived bifunctional thiourea was firstly employed in this reaction, 
using 2-12a and 2-13a as the substrates. However, the reaction turned out to be quite 
slow and only moderate diastereoselectivity was achieved even with 20 mol% catalyst 
employed (entry 1). This result is not surprising since the aldol acceptor 2-13a is less 
reactive compared to aldehyde, which was used in Terada and Feng’s study.121,122 Some 
additives were then added in order to reduce the reaction time. Both 3Ǻ and 4Ǻ 
molecular sieve were showed to be effective in the reaction (entries 2-3). The reaction 
rate was substantially improved. 4Ǻ molecular sieve was finally selected as the ideal 
additive since the reaction could be completed within one day and the enantioselectivity 
remained at the same level (entry 2). 
 
Chapter 2 Vinylogous Aldol Reaction of Furanones 
45 
 
Table 2.1   Screening of bifunctional catalysts for the vinylogous aldol reaction[a] 
 
Entry R Catalyst Solvent Time Yield[b] dr[c] ee/%[d] 
1[e] Me (2-12a) Trp-1 THF 48h <50 % 82:18 75 
2 Me (2-12a) Trp-1 THF 15h 83 % 80:20 74 
3[f] Me (2-12a) Trp-1 THF 24h 76 % 79:21 73 
4 Et (2-12b) Trp-1 THF 24h 89 % 81:19 82 
5 t-Bu (2-12c) Trp-1 THF 24h 92 % >91:9 87 
6 Ph (2-12d) Trp-1 THF 24h 79 % 91:9 61 
7[g] t-Bu (2-12c) Trp-1 THF 24h 85 % >91:9 91 
8[g] t-Bu (2-12c) QD-1 THF 24h 84 % >91:9 -11 
9[g] t-Bu (2-12c) QD-2 THF 24h 85 % >91:9 12 
10[g] t-Bu (2-12c) QD-3 THF 24h <50 %  >91:9 0 
11[g] t-Bu (2-12c) QD-4 THF 24h 92 % >91:9 -65 
12[g] t-Bu (2-12c) Trp-2 THF 24h 91 % >91:9 92 
13[g] t-Bu (2-12c) Trp-3 THF 24h 87 % >91:9 80 
14[g] t-Bu (2-12c) Trp-4 THF 24h 89 % >91:9 71 
15[g] t-Bu (2-12c) Trp-5 THF 24h 84 % >91:9 65 
16[g] t-Bu (2-12c) Trp-6 THF 24h 87 % >91:9 29 
17[g,h] t-Bu (2-12c) Trp-2 THF 40h 83 % 95:5 90 
18[h,i] t-Bu (2-12c) Trp-2 THF 24h 89 % 94:6 88 
19[h,i] t-Bu (2-12c) Trp-2 THF/acetone (1:1) 24h 88 % 97:3 93 
20[h,i] t-Bu (2-12c) Trp-2 acetone 40h 73 % 97:3 93 
[a] Reactions were carried out using 1 (0.1 mmol), 2 (0.05 mmol), catalyst (0.01 mmol), and 4Ǻ molecular 
sieve in 0.35 ml solvent at room temperature. [b] Yield of isolated product. [c] Determined by 1H NMR 
analysis. [d] Determined by chiral HPLC analysis. [e] Without 4Ǻ molecular sieve. [f] 3Ǻ molecular sieve 
added. [g] Reaction was performed in 0.5 mL solvent. [h] With 10 mol% catalyst. [i] Reaction was performed 
in 0.2 mL solvent. THF = tetrahydrofuran. 
 
Chapter 2 Vinylogous Aldol Reaction of Furanones 
46 
 
A number of -ketoesters bearing different ester groups were then prepared and 
screened for the reaction (entries2 and 4-6). When ethyl phenylglyoxylate 2-13b was 
used, the enantioselectivity was a little higher with the former, whilst the 
diastereoselectivity unaffected (entry 4). Phenyl ester 2-13d resulted in the lowest 
enantioselectivity, although high diastereoselectivity was attained (entry 6).  To our 
delight, the t-butyl phenylglyoxylate 2-13c gave both the highest diastereo- and 
enantioselectivity (entry 5). These results showed that the increase of steric hindrance of 
-ketoester 2-13 could offer improved selectivity. Further tuning on the reaction 
concentration attained 91% ee (entry 7).  
After the initial screening on the substrate, we then did further explorations on 
different bifunctional catalysts (entries 8-16). The commercial available quinidine gave 
disappointing results (entry 8). 6’-Demethylated quinidine and quinidine-derived 
sulfonamide were also found to be poor catalysts (entries 9 and 10). The quinidine-
derived thiourea catalyst only gave moderate enantioselectivity (entry 11). Compared 
with N-methylated catalyst Trp-1, the NH catalyst Trp-2 afforded slightly better result 
(entry 12). Either change on the tertiary amine moiety of the tryptophan-derived catalyst 
(entries 13, 14) or modification on the thiourea group (entries 15, 16) only led to 
decreased enantioselectivity. All these results demonstrated that the proper combination 
of tertiary amine moiety and hydrogen-bonding part is crucial to achieve high diastereo- 
and enantioselectivity. 
In order to make the methodology more practical, catalyst loading was lowered to 10 
mol% (entry 17). The reaction became slower and the enantioselectivity slightly dropped 
to 90%. Hence, different solvents and reaction concentrations were screened (entries 18-
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20). Among them, the THF/acetone mixed-solvent system offered the best result and 
under the optimized reaction condition, the desired vinylogous aldol product could be 
obtained in an excellent yield and with 97:3 d.r. and 93% ee (entry 19). 
 
 
2.2.2 Substrate scope 
With the established best reaction conditions in hand, we next studied the scope of 
the direct vinylogous aldol addition of -butenolide to an array of differently substituted 
-ketoesters (Table 2.2).  
Consistent diastereoselectivity and enantioselectivity were observed for a wide range 
of aromatic substituted -ketoesters (entries 1-12). Vinylic substituents on the -
ketoesters were well-tolerated and high d.r. and ee values were attainable (entries 13–14). 
With alkyl-substituted ketoesters somewhat decreased diastereoselectivities observed, 
and the enantioselectivities were comparable (entries 15–19).  
The high diastereoselectivity for aromatic substituted -ketoesters may be attributed 
to the  interaction between ketoesters (2-13e to 2-13p) and the aromatic moiety of the 
catalyst. Such interaction becomes much weaker for aliphatic substituted -ketoester (2-
13q – 2-13w). The unsubstituted butenolide also provided satisfactory results, although a 
much longer reaction time was required (entry 20). The decreased reactivity of 2-12b 
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Table 2.2   Substrate scope of Trp-2-catalyzed direct vinylogous aldol reaction [a] 
 
Entry 2-12 R’ 2-14 t [h] Yield/%[b] d.r[c] ee/%[d] 
1 2-12a 4-PhC6H4 2-14e 24 92 96:4 93 
2 2-12a 2-naphthyl 2-14f 40 86 94:6 94 
3[e] 2-12a 4-MeC6H4 2-14g 48 86 95:5 95 
4[e] 2-12a 3-MeC6H4 2-14h 48 81 96:4 94 
5[e] 2-12a 4-tBuC6H4 2-14i 72 80 95:5 94 
6[e] 2-12a 4-OMeC6H4 2-14j 72 76 94:6 95 
7 2-12a 4-ClC6H4 2-14k 24 85 97:3 92 
8 2-12a 3-ClC6H4 2-14l 24 84 93:7 88 
9 2-12a 4-BrC6H4 2-14m 24 93 95:5 90 
10 2-12a 4-FC6H4 2-14n 36 81 94:6 92 
11[f] 2-12a 4-CNC6H4 2-14o 20 93 92:8 82 
12[f] 2-12a 4-CO2MeC6H4 2-14p 20 86 97:3 87 
13 2-12a  2-14q 20 86 92:8 85 
14 2-12a 
 2-14r 20 87 90:10 81 
15[g] 2-12a  2-14s 10 41 88:12 90 
16 2-12a 
 2-14t 12 73 89:11 88 
17 2-12a PhCH2 2-14u 8 61 85:15 80 
18 2-12a PhCH2CH2 2-14v 5 53 86:14 85 
19 2-12a 
 2-14w 12 70 87:13 80 
20 2-12b Ph 2-14x 144 69 91:9 82 
[a] Reactions were carried out using 1 (0.1 mmol), 4 (0.05 mmol), catalyst (0.005 mmol), and 4Ǻ molecular sieve in 
0.2 ml THF/acetone (1:1) at room temperature. [b] Yield of isolated product. [c] Determined by 1H NMR analysis. [d] 
Determined by chiral HPLC analysis. [e] 20 mol% catalyst used. [f] Reaction performed in 0.35 Ml solvent. [g] The 
double bond in the allyl group was shifted to yield the 2-methylvinyl-substituted product. 
Ph
Ph
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2.2.3 Plausible reaction mechanisms 
To explain the stereochemical outcome of the vinylogous aldol reaction, a plausible 
transition-state model is proposed in Scheme 2.5. The tertiary amine moiety of the 
catalyst first deprotonates the dichlorofuranone to generate the corresponding ammonium 
ion and dienolate. At the same time, -ketoester is activated by the thiourea moiety 
through double hydrogen bonding, which also plays a key role in the substrate binding. 
The attack of enolate from the si face of the ketone leads to the formation of the major 
stereoisomer.  
The presence of the two chlorine atoms is believed to contribute significantly to the 
observed high diastereoselectivity. If the chlorine atoms were replaced by the more bulky 
bromine atoms, an increase in diastereoselectivity would be anticipated. Moreover, the 
introduction of bromine atoms to the furanones would result in the formation of a tighter 
ion pair as a result of the higher electron density on the enolate oxygen atom, therefore 
leading to aldol products with improved diastereoselectivity. 
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Scheme 2.5 Proposed transition-state model 
Based on these speculations, we did further studies employing ,-dibromo--
butenolide as the aldol donor. The additional experiments, illustrated in Scheme 2.6, 
supported this proposal. When 3,4-dibromofuranone (2-12c) was employed in the 
vinylogous aldol reaction under otherwise identical reaction conditions, a 98:2 d.r. was 























2-15c: 48h, 78% yield,








2-15b: 24h, 80% yield,








2-15a: 24h, 84% yield,
d.r. 98:2, 90% ee  
Scheme 2.6 Vinylogous aldol reaction with ,-dibromo--butenolide 
 
2.2.4 Synthetic manipulations of the vinylogous aldol adduct 
The vinylogous aldol reaction described here represents a novel asymmetric 
preparation of biologically important substituted butenolides.123 Furthermore, these aldol 
products are versatile chiral building blocks due to diverse functionalization of both the 
butenolide moiety and the ester group. Compound 2-14c served as a model to illustrate 
this synthetic potential (Scheme 2.7). 




Scheme 2.7 Synthetic manipulations of the vinylogous aldol adduct 
Reduction of the -substituted butenolide 2-14c with NaBH4 according to the 
literature procedure afforded the chiral -butyrolactone 2-16,124 and subsequent 
chemoselective reduction of the tert-butyl ester using LiAl(Ot-Bu)3H yielded lactone 2-
17,125 which contains an adjacent tertiary hydroxy group. Chiral glycerol derivatives were 
accessed by treating 2-16 with LiBH4 at 60oC to effect a global reduction and give the 2-
substituted glycerol derivative 2-18. Alternatively, exposing 2-16 to LiBH4 at 0oC 
selectively reduced the lactone moiety to triol 2-19. 
Among all these products, the triol 2-19 is a very important intermediate, which 
could be easily transformed into antifungal analogue 2-22 in several steps (Scheme 
2.8).126 




Scheme 2.8 Synthesis of antifungal agent 
 
2.3 Conclusion 
In conclusion, the first highly diastereo- and enantioselective direct vinylogous aldol 
reactions between furanones and -ketoesters catalyzed by a tryptophan derived 
bifunctional organic catalyst was developed. The described synthetic method provides 
easy access to biologically important -substituted butenolides and chiral glycerol 
derivatives containing a tertiary alcohol moiety. Moreover, the synthetic utility towards 
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2.4 Experimental section 
2.4.1 General information 
1H and 13C NMR spectra were recorded on a Bruker ACF300 or DPX300 (300 
MHz) or AMX500 (500 MHz) spectrometer. Chemical shifts were reported in parts per 
million (ppm), and the residual solvent peak was used as an internal reference. 
Multiplicity was indicated as follows: s (singlet), d (doublet), t (triplet), q (quartet), m 
(multiplet), dd (doublet of doublet), br s (broad singlet). Coupling constants were 
reported in Hertz (Hz). Low resolution mass spectra were obtained on a Finnigan/MAT 
LCQ spectrometer in ESI mode, and a Finnigan/MAT 95XL-T mass spectrometer in 
FAB mode. All high resolution mass spectra were obtained on a Finnigan/MAT 95XL-T 
spectrometer. Flash chromatography separation was performed on Merck 60 (0.040 - 
0.063 mm) mesh silica gel. 
The enantiomeric excesses of products were determined by chiral-phase HPLC 
analysis, using a Daicel Chiralcel AD-H column (250 x 4.6 mm), or Chiralpak IA column, 
or IC column (250 x 4.6 mm). 
Catalysts QD-2,127 QD-3,128 QD-4,129 Trp-1 to Trp-6130 were prepared according to 
the literature procedures. Substrates 2-13a to 2-13d,131 2-13e to 2-13p,132 2-13q to 2-
13r133 and 2-13s to 2-13w134 were prepared according to the literature procedure. 
The absolute configuration of 2-14f was assigned by X-ray crystallographic analysis, 
and configurations of other aldol products were assigned by analogy. For the aldol 
products 2-14a to 2-14x and 2-15a to 2-15c, syn- and anti- diastereomers were easily 
separated by column, only the major diastereomers were subjected to chiral HPLC 
analysis. 
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2.4.2 Representative procedure for the vinylogous aldol reaction 
Vinylogous aldol reaction of 3,4-dichloro-2-(5H)-furanone 2-12a with t-butyl 




























To a solution of 3,4-dichloro-2-(5H)-furanone 2-12a (15.3 mg, 0.1 mmol), t-butyl 
phenylglyoxylate 2-13c (10.3 mg, 0.05 mmol) and 4Å molecular sieve (30 mg) in 
THF/acetone (1:1, 0.2 mL) at room temperature was added Trp-2 (2.6 mg, 0.005 mmol). 
The resulting mixture was stirred for 24 h. After removal of the solvents, the residue was 
purified by flash column chromatography (hexane/AcOEt = 10/1 as eluent) to afford 
vinylgous aldol product 2-14c (15.8 mg, 88% yield) as a white solid. The diastereomeric 
ratio was determined by 1H NMR analysis of the crude mixture, and the enantiomeric 
excess by determined by HPLC analysis on a chiral stationary phase. 
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2.4.3 X-ray cryatllographic analysis of 2-14f 
 
Figure 2.1 ORTEP structure of aldol adduct 2-14f 
 
Table  Crystal data 
 
Identification code  a372 
Empirical formula  C20 H18 Cl2 O5 
Formula weight  409.24 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
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Unit cell dimensions a = 9.889(5) Å = 90°. 
 b = 11.177(6) Å = 90°. 
 c = 17.158(9) Å  = 90°. 
Volume 1896.6(17) Å3 
Z 4 
Density (calculated) 1.433 Mg/m3 
Absorption coefficient 0.371 mm-1 
F(000) 848 
Crystal size 0.60 x 0.10 x 0.08 mm3 
Theta range for data collection 2.17 to 27.50°. 
Index ranges -12<=h<=12, -14<=k<=12, -22<=l<=20 
Reflections collected 12810 
Independent reflections 4367 [R(int) = 0.0428] 
Completeness to theta = 27.50° 99.9 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9709 and 0.8080 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4367 / 0 / 248 
Goodness-of-fit on F2 1.066 
Final R indices [I>2sigma(I)] R1 = 0.0565, wR2 = 0.1390 
R indices (all data) R1 = 0.0654, wR2 = 0.1440 
Absolute structure parameter -0.04(8) 
Largest diff. peak and hole 0.815 and -0.265 e.Å-3 
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2.4.4 Derivatizations of the vinylogous aldol adducts 




(S)-tert-Butyl 2-hydroxy-2-((R)-5-oxotetrahydrofuran-2-yl)-2-phenylacetate (2-16) 
 
To a solution of 2-14c (108 mg, 0.3 mmol, 93% ee) in 1:1 THF/MeOH (2 mL) at 0 °C 
were added NiCl2·6H2O (214 mg, 0.9 mmol) and NaBH4 (114 mg, 3 mmol). After 15 min 
at the same temperature, the reaction was quenched with the addition of saturated NH4Cl. 
The mixture was then filtered, and the filtrate was concentrated, and the residue was 
extracted with ethyl acetate several times. The combined organic layers were washed 
with brine, dried over Na2SO4, filtered, and concentrated. The residue was purified by 
column chromatography (hexane/EtOAc = 8/1 as eluent) to give 2-16 (73 mg, 83%) as a 
white solid.  
 
A white solid; 1H NMR (300 MHz, CDCl3) 7.63 (m, 2H), 7.34 (m, 3H), 5.23 (m, 1H), 
4.02 (s, 1H), 2.72 (m, 1H), 2.38 (m, 1H), 1.97 (m, 2H), 1.49 (s, 9H); 13C NMR (75 MHz, 
CDCl3) 177.6, 171.4, 137.2, 128.4, 128.3, 125.8, 84.6, 82.7, 79.5, 28.1, 27.7, 21.3; [α]Drt 
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= -61.6 (c = 0.98, CHCl3); HRMS (ESI) m/z calcd for C16H20O5 [M+Na]+ 315.1208, 
found 315.1196; the ee value of the major isomer was 92%, tR = 16.7 min and 19.8 min 
(Chiralcel IA, λ = 220 nm, 20% iPrOH/hexanes, flow rate = 1.0 mL/min). 
 
 
(S)-2-hydroxy-2-((R)-5-oxotetrahydrofuran-2-yl)-2-phenylacetic acid (2-16a) 
 
 
To a solution of 2-16 (58 mg, 0.20 mmol) in CH2Cl2 (0.5 mL) at 0 oC was added slowly 
TFA (0.1 mL). The reaction mixture was allowed to warm to room temperature and 
stirred for 10 hours. The solvent was removed, and the crude 2-16a was obtained as a 
white solid (46 mg, 98%), which was used directly in the next reaction without further 
purification. 
 
A white solid; 1H NMR (300 MHz, MeOD): 7.62 (m, 2H), 7.31 (m, 3H), 5.38 (dd, J = 
10.0, 3.5, 1H), 2.30-2.58 (m, 2H), 1.90 (m, 2H). 13C NMR (75 MHz, MeOD): 180.4, 
175.3, 139.5, 129.5, 129.3, 127.0, 84.9, 80.6, 29.2, 22.2. [α]Drt = -16.2 (c = 0.93, MeOH); 
HRMS (ESI) m/z calcd for C12H12O5 [M+Na]+ 259.0582, found 259.0586.  
 
(S)-Methyl 2-hydroxy-2-((R)-5-oxotetrahydrofuran-2-yl)-2-phenylacetate (2-16b) 




TMSCHN2 (0.10 mL, 2 M in hexane, 0.2 mmol) was added dropwise to a solution of 2-
16a (35 mg, 0.15 mmol) in MeOH (1.0 mL) at 0 °C, and the mixture was stirred for 
another 0.5 h at the same temperature. Water was then added to the mixture, and the 
layers were separated. The aqueous phase was extracted with CH2Cl2 twice, and the 
combined organic extracts were washed with water and brine, and dried with MgSO4. 
After filtration, the solvent was removed and the residue was purified by flash column 
chromatography on silica (hexane/EtOAc = 5/1 as eluent) to afford 2-16b (31 mg, 85%) 
as a white solid. 
 
A white solid; 1H NMR (500 MHz, CDCl3): 7.68 (m, 2H), 7.39 (m, 3H), 5.32 (m, 1H), 
3.96 (s, 1H), 3.90 (s, 3H), 2.73 (m, 1H), 2.42 (m, 1H), 2.02 (m, 2H). 13C NMR (75 MHz, 
CDCl3): 177.5, 172.9, 136.6, 128.6, 128.5, 125.7, 82.5, 79.6, 53.8, 28.0, 21.2. [α]Drt = -
35.5 (c = 1.33, CHCl3); HRMS (ESI) m/z calcd for C13H14O5 [M+Na]+ 273.0739, found 
273.0721.  
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To a solution of 2-16b (31 mg, 0.12 mmol) in anhydrous THF (1.0 mL) at 0 °C was 
added a solution of LiAl(Ot-Bu)3H (0.65 mL, 1.0 M in THF, 0.65 mmol). The resulting 
mixture was allowed to stir at this temperature for 4 h, after which was quenched by 
addition of a saturated aqueous NH4Cl. The mixture was extracted with ethyl acetate 
three times, and organic layers were combined and washed with brine three times and 
dried over Na2SO4. After concentration, the residue were purified by column 
chromatography (hexane/AcOEt = 1:1 as eluent) to afford lactone 2-17 (20 mg, 72%) as a 
colorless oil. 
 
A colorless oil; 1H NMR (500 MHz, CDCl3): 7.32-7.46 (m, 5H), 4.84 (dd, J = 7.8, 6.2, 
1H), 4.17 (d, J = 11.7, 1H), 3.79 (d, J = 10.8, 1H), 3.30 (s, 1H), 2.60 (m, 1H), 2.40 (m, 
1H), 2.12 (m, 2H), 1.82 (m, 1H); 13C NMR (75 MHz, CDCl3): 177.3, 139.4, 128.8, 128.0, 
125.2, 84.1, 77.2, 68.8, 27.9, 22.0; HRMS (ESI) m/z calcd for C12H14O4 [M+Na]+ 
245.0790, found 245.0775.  
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To a solution of 2-16 (20 mg, 0.07 mmol) in THF (1 mL) at room temperature was added 
LiBH4 (15 mg, 0.7 mmol). The reaction mixture was heated to 60 oC and stirred 
overnight. The reaction mixture was then allowed to cool down to room temperature, and 
quenched with the addition of minimal amount of saturated aqueous NH4Cl solution. 
After concentration, the residue was extracted with ethyl acetate several times. The 
combined organic layers were dried over Na2SO4, filtered, and concentrated. Purification 
by column chromatography (MeOH/CH2Cl2 = 1/10 as eluent) yielded 2-18 (13.2 mg, 
85%) as a colorless oil. 
 
A colorless oil; 1H NMR (500 MHz, MeOD): 7.15-7.42 (m, 5H), 3.84 (m, 2H), 3.78 (m, 
1H), 3.38 (m, 2H), 1.63 (m, 1H), 1.16-1.36 (m, 3H); 13C NMR (75 MHz, MeOD): 144.2, 
129.0, 127.7, 127.0, 79.7, 16.8, 69.4, 63.1, 30.5, 28.6; [α]Drt = +2.6 (c = 0.50, MeOH); 
HRMS (ESI) m/z calcd for C12H16O3 [M+Na]+ 249.1103, found 249.1102. 
 
 
(2S,3R)-tert-Butyl 2,3,6-trihydroxy-2-phenylhexanoate (2-19) 
 
To a solution of 2-16 (70 mg, 0.24 mmol) in THF (1 mL) at 0 oC was added LiBH4 (11 
mg, 0.48 mmol), and the resulting mixture was stirred at 0 oC for 2 hours. Saturated 
aqueous NH4Cl solution was added to quench the reaction. The solvent was removed, and 
the residue was extracted with ethyl acetate several times. The combined organic layers 
were dried over Na2SO4, filtered, and concentrated. Purification by column 
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chromatography (hexane/EtOAc = 3/1 as eluent) afforded 2-19 (55.4 mg, 78%) as a 
colorless oil. 
 
A colorless oil; 1H NMR (300 MHz, CDCl3): 7.59 (m, 2H), 7.30 (m, 3H), 4.29 (dd, J = 
9.9, 2.6, 1H), 4.06 (s, 1H), 3.58 (m, 2H), 1.67 (m, 3H), 1.48 (s, 9H), 1.35 (m, 1H); 13C 
NMR (75 MHz, CDCl3): 173.4, 138.9, 128.2, 127.8, 125.6, 83.9, 81.4, 76.1, 62.9, 29.4, 
27.8, 27.7; [α]Drt = -23.6 (c = 0.99, CHCl3); HRMS (ESI) m/z calcd for C16H22O4 
[M+Na]+ 319.1521, found 319.1514; the ee value of the major isomer was 90%, tR = 19.3 
min and 21.2 min (Chiralcel IC, λ = 220 nm, 10% iPrOH/hexanes, flow rate = 1.0 
mL/min). 
 
2.4.4.3 Preparation of antifungal agent 2-22 
 
 
(2S,3R)-tert-Butyl 2,3-dihydroxy-2-phenyl-5-(trityloxy)pentanoate (2-20) 
 
To a solution of 2-19 (55 mg, 0.19 mmol) in CH2Cl2 (2 mL) at 0 oC were added trityl 
chloride (106 mg, 0.38 mg), Et3N (84 μl, 0.60 mmol) and DMAP (5 mg, 0.04 mmol). The 
reaciton mixture was then allowed to warm to room temperature and stir for an additional 
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12 h. The solvent was removed and the residue was purified by flash column 
chromatography to affrod 2-20 (93 mg, 93%) as a white foam. 
 
A white foam; 1H NMR (500 MHz, CDCl3): 7.59-7.65 (m, 2H), 7.19-7.43 (m, 18H), 4.31 
(t, J = 9.2 Hz, 1H), 4.06 (s, 1H), 3.01 (m, 2H), 2.12-2.26 (m, 1H), 1.80-1.86 (m, 1H), 1.35 
-1.64 (m, 3H), 1.49 (s, 9H); 13C NMR (125 MHz, CDCl3): 173.6, 144.3, 139.0, 128.7, 
128.2, 127.7, 126.8, 125.7, 86.5, 83.7, 81.4, 75.8, 63.4, 27.8, 27.6, 26.4; [α]Drt = - 13.5 (c 





To a solution of 2-20 (92 mg, 0.17 mmol) in anhydrous THF (2 mL) at 0 oC was added 
slowly LiAlH4 (32 mg, 0.85 mmol). The reaction mixture was stirred at 0 oC for 6 h and 
then quenched with the addition of a minimal amount of saturated aqueous NH4Cl. The 
mixture was concentrated, and the residue was extracted with ethyl acetate several times. 
The combined organic layers were dried over Na2SO4, filtered and concentrated. 
Purification by column chromatography (hex/EtOAc = 2/1 as eluent) gave 2-21 (76 mg, 
95%) as a white foam. 
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A white foam; 1H NMR (500 MHz, CDCl3): 7.23-7.38 (m, 20H), 4.11 (d, J = 11.4, 1H), 
4.01 (m, 1H), 3.65 (d, J = 11.4, 1H), 3.43 (br, 2H), 3.05 (m, 2H), 1.69 (m, 1H), 1.60 (m, 
1H), 1.42 (m, 1H), 1.25 (m, 1H); 13C NMR (125 MHz, CDCl3): 143.9, 141.4, 128.6, 
128.4, 127.8, 127.2, 127.0, 125.0, 87.0, 77.8, 77.3, 70.7, 63.7, 28.5, 26.2; [α]Drt = +27.0   
(c = 0.97 , CHCl3); HRMS (ESI) m/z calcd for C31H32O4 [M+Na]+ 491.2198, found 
491.2207.  
 






To a solution of 2-21 (75 mg, 0.16 mmol) in CH2Cl2 (2 mL) at 0 oC were added 
triethylamine (70 μl, 0.5 mmol) and MsCl (33 mg, 0.29 mmol), and the resulting mixture 
was stirred at that temperature for 1 h. The solvent was then removed, and the residue 
was purified by flash column chromatography to affrod 2-21a (78 mg, 89%) as a white 
foam. 
 
A white foam; 1H NMR (500 MHz, CDCl3): 7.17-7.54 (m, 20H), 4.52-4.57 (m, 2H), 3.93 
(d, J = 10.1, 1H), 3.19 (s, 1H), 3.13 (s, 1H), 3.01-3.08 (m, 3H), 2.81 (s, 3H), 1.60-1.70 (m, 
2H), 1.25-1.42 (m, 2H). 13C NMR (125 MHz, CDCl3): 143.9, 139.8, 128.6, 128.4, 127.8, 
127.6, 127.0, 125.4, 87.0, 77.4, 74.8, 74.0, 63.5, 37.3, 27.9, 26.3; HRMS (ESI) m/z calcd 
for C32H34O6S [M+Na]+ 569.1974, found 569.1993.  
 





A mixture of 2-21a (70 mg, 0.13 mmol), 1,2,4-triazole (27 mg, 0.39 mmol), and Na2CO3 
(138 mg, 1.3 mmol) in MeOH (3 mL) was brought to reflux for 12 h. After cooling down 
to room temperature, the mixture was filtered through celite (500 mg), and the precipitate 
was further washed with EtOAc (5 mL). The combined filtrate was concentrated in vacuo, 
and the residue was purified by column chromatography (hex/AcOEt = 1:1 as eluent) to 
afford triazole 2-21b (55 mg, 83% yield) as white foam. 
 
A white foam; 1H NMR (500 MHz, CDCl3): 7.81 (s, 1H), 7.64 (s, 1H), 7.30-7.40 (m, 6H), 
7.19-7.29 (m, 12H), 7.12-7.19 (m, 2H), 4.71 (d, J = 14.2, 1H), 4.53 (d, J = 14.2, 1H), 
4.12 (s, 1H), 3.92 (t, J = 8.0, 1H), 3.13 (d, J = 7.6, 1H), 3.01 (t, J = 6.1, 2H), 1.73-1.83 (m, 
1H), 1.51-1.65 (m, 1H), 1.32-1.47 (m, 1H), 1.20-1.32 (m, 1H); 13C NMR (75 MHz, 
CDCl3): 151.7, 144.3, 144.1, 140.4, 128.6, 128.5, 127.7, 127.6, 126.9, 124.9, 86.7, 78.8, 
75.2, 63.4, 57.5, 28.0, 26.4; [α]Drt = -15.5 (c = 0.91, CHCl3); HRMS (ESI) m/z calcd for 
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To a solution of 2-21b (26 mg, 0.05 mmol) in diethyl ether (1 mL) at 0 oC was added 
formic acid (1 mL). The reaciton mixture was then stirred for 10 minutes, and the solvent 
was removed. The residue was purified by flash column chromatogaphy to afford 2-22 
(13 mg, 98%) as a white foam. 
 
A white foam; 1H NMR (500 MHz, CDCl3): 7.83 (s, 1H), 7.68 (s, 1H), 7.18-7.32 (m, 5H), 
4.75 (d, J = 14.2, 1H), 4.58 (d, J = 14.2, 1H), 4.22 (br, 1H), 3.95 (dd, J = 10.1, 1.9, 1H), 
3.65 (dt, J = 10.7, 5.4, 1H), 3.50-3.59 (m, 1H), 1.60-1.67 (m, 2H), 1.38-1.45 (m, 1H), 
1.32-1.37 (m, 1H).; 13C NMR (125 MHz, CDCl3): 151.6, 144.4, 140.3, 128.6, 127.7, 
125.0, 78.8, 75.4, 62.7, 57.5, 29.1, 28.3.; [α]Drt = +27.8 (c = 0.79, CHCl3); HRMS (ESI) 
m/z calcd for C14H19O3N3 [M+H]+ 278.1505, found 278.1507. 
 






A white solid; diastereomeric ratio is 97:3; 1H NMR (300 MHz, CDCl3): 7.71 (m, 2H), 
7.39 (m, 3H), 5.69 (s, 1H), 4.08 (s, 1H), 1.52 (s, 9H); 13C NMR (75 MHz, CDCl3): 169.8, 
164.9, 148.7, 135.4, 129.0, 128.4, 126.1, 123.0, 85.9, 84.9, 76.9, 27.8; [α]Drt
 
= +19.9 (c = 
1.19, CHCl3); HRMS (ESI) m/z calcd for C16H16Cl2O5 [M+Na]+ 381.0272, found 
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381.0251; the ee value of the major isomer was 93%, tR = 12.4 min and 18.3 min 














A white solid; diastereomeric ratio is 96:4; 1H NMR (500 MHz, CDCl3): 7.80 (m, 2H), 
7.66 (m, 4H), 7.48 (m, 2H), 7.38 (m, 1H), 5.74 (s, 1H), 4.13 (s, 1H), 1.57 (s, 9H); 13C 
NMR (125 MHz, CDCl3): 169.8, 164.9, 148.7, 141.7, 140.0, 134.3, 128.9, 127.7, 127.3, 
127.1, 126.6, 123.1, 85.9, 84.9, 77.2, 27.8; [α]Drt = +52.6 (c = 0.65, CHCl3); HRMS (ESI) 
m/z calcd for C22H20Cl2O5 [M+Na]+ 457.0585, found 457.0565; the ee value of the major 
isomer was 93%, tR = 27.0 min and 29.0 min (Chiralcel IA, λ = 254 nm, 3% 
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A white solid; diastereomeric ratio is 94:6; 1H NMR (500 MHz, CDCl3): 8.23 (d, J = 1.3, 
1H), 7.53-7.90 (m, 6H), 5.84 (s, 1H), 4.21 (s, 1H), 1.54 (s, 9H); 13C NMR (125 MHz, 
CDCl3): 169.7, 164.9, 148.7, 133.3, 132.9, 132.7, 128.6, 128.2, 127.6, 126.9, 126.6, 
126.1, 123.3, 123.0, 86.0, 84.7, 77.7, 27.8; [α]Drt = +49.0 (c = 0.40, CHCl3); HRMS (ESI) 
m/z calcd for C20H18Cl2O5 [M+Na]+ 431.0429, found 431.0417; the ee value of the major 
isomer was 94%, tR = 17.6 min and 19.6 min (Chiralcel AD-H, λ = 254 nm, 8% 








A white solid; diastereomeric ratio is 95:5; 1H NMR (300 MHz, CDCl3): 7.57 (d, J = 8.2, 
2H), 7.20 (d, J = 8.2, 2H), 5.66 (s, 1H), 4.03 (s, 1H), 2.38 (s, 3H), 1.52 (s, 9H); 13C NMR 
(75 MHz, CDCl3): 169.9, 164.9, 148.8, 138.8, 132.4, 129.e, 125.9, 122.9, 85.7, 84.9, 77.2, 
27.8, 21.1; [α]Drt
 
= +20.0 (c = 0.58, CHCl3); HRMS (ESI) m/z calcd for C17H18Cl2O5 
[M+Na]+ 395.0429, found 395.0415; the ee value of the major isomer was 95%, tR = 11.1 












A white solid; diastereomeric ratio is 96:4; 1H NMR (300 MHz, CDCl3): 7.48-7.53 (m, 
2H), 7.26-7.31 (m, 1H), 7.18-7.20 (m, 1H), 5.69 (s, 1H), 4.04 (s, 1H), 2.39 (s, 3H), 1.52 
(s, 9H); 13C NMR (75 MHz, CDCl3): 169.9, 164.9, 148.7, 138.2, 135.2, 129.6, 128.2, 
126.7, 123.2, 123.0, 85.7, 84.9, 77.2, 27.8, 21.6; [α]Drt
 
= -18.5 (c = 0.39, CHCl3); HRMS 
(ESI) m/z calcd for C17H18Cl2O5 [M+Na]+ 395.0429, found 395.0412; the ee value of the 
major isomer was 94%, tR = 9.4 min and 13.7 min (Chiralcel IA, λ = 254 nm, 5% 








A white solid; diastereomeric ratio is 95:5; 1H NMR (500 MHz, CDCl3): 7.60 (d, J = 8.9, 
2H), 7.40 (d, J = 8.2, 2H), 5.64 (s, 1H), 4.03 (s, 1H), 1.53 (s, 9H), 1.33 (s, 9H); 13C NMR 
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(125 MHz, CDCl3): 169.9, 164.9, 152.1, 148.8, 132.2, 125.8, 125.3, 122.9, 85.7, 84.9, 
77.4, 34.6, 31.3, 27.8; [α]Drt
 
= +15.8 (c = 0.62, CHCl3); HRMS (ESI) m/z calcd for 
C20H24Cl2O5 [M+Na]+ 437.0898, found 437.0879; the ee value of the major isomer was 
94%, tR = 9.2 min and 13.4 min (Chiralcel AD-H, λ = 254 nm, 5% iPrOH/hexanes, flow 














A white solid; diastereomeric ratio is 94:6; 1H NMR (500 MHz, CDCl3): 7.61 (d, J = 9.2, 
2H), 6.92 (d, J = 9.0, 2H), 5.63 (s, 1H), 4.03 (s, 1H), 3.83 (s, 3H), 1.56 (s, 9H); 13C NMR 
(75 MHz, CDCl3): 170.0, 165.0, 160.0, 148.8, 127.4, 127.2, 123.0, 113.8, 85.7, 84,8, 77.2, 
55.3, 27,8; [α]Drt
 
= + 9.2 (c = 0.53, CHCl3); HRMS (ESI) m/z calcd for C17H18O6Cl2 
[M+Na]+ 411.0378, found 411.0367; the ee value of the major isomer was 95%, tR = 13.0 











A white solid; diastereomeric ratio is 97:3; 1H NMR (300 MHz, CDCl3): 7.65 (d, J = 8.9, 
2H), 7.38 (d, J = 8.9, 2H), 5.62 (s, 1H), 4.10 (s, 1H), 1.52 (s, 9H); 13C NMR (125 MHz, 
CDCl3): 169.4, 164.7, 148.3, 135.2, 134.0, 128.7, 127.6, 123.2, 86.3, 84.6, 77.2, 27.8; 
[α]Drt = +8.3 (c = 0.55, CHCl3); HRMS (ESI) m/z calcd for C16H15Cl3O5 [M+Na]+ 
414.9883, found 414.9870; the ee value of the major isomer was 92%, tR = 11.0 min and 














A white solid; diastereomeric ratio is 93:7; 1H NMR (500 MHz, CDCl3): 7.33-7.74 (m, 
4H), 5.62 (s, 1H), 4.11 (s, 1H), 1.54 (s, 9H); 13C NMR (125 MHz, CDCl3): 169.2, 164.7, 
148.2, 137.5, 134.7, 129.7, 129.2, 126.6, 124.4, 123.3, 86.4, 84.7, 77.1, 27.8; [α]Drt = -
19.7 (c = 0.61, CHCl3); HRMS (ESI) m/z calcd for C16H15Cl3O5 [M+Na]+ 414.9883, 
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found 414.9877; the ee value of the major isomer was 88%, tR = 7.5 min and 10.2 min 







A white solid; diastereomeric ratio is 95:5; 1H NMR (500 MHz, CDCl3): 7.59 (d, J = 8.8, 
2H), 7.54 (d, J = 8.8, 2H), 5.61 (s, 1H), 4.09 (s, 1H), 1.53 (s, 9H); 13C NMR (125 MHz, 
CDCl3): 169.3, 164.7, 148.3, 134.6, 131.7, 127.9, 123.5, 123.3, 86.3, 84.6, 77.2, 27.8; 
[α]Drt
 
= +30.3 (c = 0.67, CHCl3); HRMS (ESI) m/z calcd for C16H15Cl2BrO5 [M+Na]+ 
458.9378, found 458.9350; the ee value of the major isomer was 90%, tR = 8.3 min and 
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A white solid; diastereomeric ratio is 94:6; 1H NMR (300 MHz, CDCl3): 7.70 (m, 2H), 
7.10 (m, 2H), 5.62 (d, J = 0.5, 1H), 4.09 (d, J = 0.7, 1H), 1.53 (s, 9H); 13C NMR (75 
MHz, CDCl3): 169.5, 164.7, 163.0 (J = 243.8), 148.3, 131.1 (J = 3.3), 128.0 (J = 8.7), 
123.1, 115.4 (J = 21.3), 86.1, 84.6, 76.9, 27.7; [α]Drt = +1.5 (c = 1.04, CHCl3); HRMS 
(ESI) m/z calcd for C16H15Cl2FO5 [M+Na]+ 399.0178, found 399.0164; the ee value of 
the major isomer was 92%, tR = 9.7 min and 13.9 min (Chiralcel IA, λ = 254 nm, 5% 










A white solid; diastereomeric ratio is 92:8; 1H NMR (300 MHz, CDCl3): 7.86 (d, J = 8.4, 
2H), 7.72 (d, J = 8.4, 2H), 5.64 (s, 1H), 4.20 (s, 1H), 1.53 (s, 9H); 13C NMR (75 MHz, 
CDCl3): 168.7, 164.4, 147.8, 140.6, 132.2, 127.1, 123.5, 118.1, 113.2, 86.9, 84.4, 77.3, 
27.8; [α]Drt = +41.6 (c = 0.80, CHCl3); HRMS (ESI) m/z calcd for C17H15Cl2NO5 
[M+Na]+ 406.0225, found 406.0212; the ee value of the major isomer was 82%, tR = 31.8 
min and 46.4 min (Chiralcel AD-H, λ = 254 nm, 5% iPrOH/hexanes, flow rate = 1.0 
mL/min). 
 














A white solid; diastereomeric ratio is 97:3; 1H NMR (500 MHz, CDCl3): 8.08 (d, J = 8.7, 
2H), 7.81 (d, J = 8.7, 2H), 5.70 (s, 1H), 4.17 (s, 1H), 3.94 (s, 3H), 1.52 (s, 9H); 13C NMR 
(75 MHz, CDCl3): 169.2, 166.5, 164.7, 148.2, 140.3, 130.9, 129.7, 126.4, 123.3, 86.4, 
84.6, 77.3, 52.3, 27.8; [α]Drt
 
= + 5.6 (c = 0.71, CHCl3); HRMS (ESI) m/z calcd for 
C18H18O7Cl2 [M+Na]+ 439.0327, found 439.0311; the ee value of the major isomer was 
87%, tR = 14.3 min and 15.6 min (Chiralcel IC, λ = 254 nm, 10% iPrOH/hexanes, flow 








A yellow solid; diastereomeric ratio is 92:8; 1H NMR (300 MHz, CDCl3) 7.33-7.44 (m, 
5H), 7.01 (d, J = 15.5 Hz, 1H), 6.29 (d, J = 15.8, 1H), 5.32 (s, 1H), 3.91 (s, 1H), 1.54 (s, 
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9H); 13C NMR (75 MHz, CDCl3)  169.4, 164.7, 148.7, 135.7, 133.3, 128.7, 128.5, 127.0, 
123.0, 122.9, 85.7, 84.0, 77.2, 27.9; [α]Drt
 
= + 89.1 (c = 0.65, CHCl3); HRMS (ESI) m/z 
calcd for C18H18O5Cl2 [M+Na]+ 407.0424, found 407.0420; the ee value of the major 
isomer was 85%, tR = 16.1 min and 21.7 min (Chiralcel AD-H, λ = 254 nm, 5% 








A yellow solid; diastereomeric ratio is 90:10; 1H NMR (500 MHz, CDCl3) 7.41-7.43 
(m, 2H), 7.32-7.35 (m, 2H), 7.25-7.27 (m, 1H), 6.74-6.85 (m, 2H), 6.65 (d, J = 15.1 Hz, 
1H), 5.90 (d, J = 14.5, 1H), 5.25 (s, 1H), 3.83 (s, 1H), 1.53 (s, 9H); 13C NMR (75 MHz, 
CDCl3)  169.3, 164.7, 148.8, 136.6, 135.2, 133.6, 128.7, 128.1, 126.8, 126.6, 126.2, 
122.9, 85.6, 84.0, 77.1, 27.9; [α]Drt
 
= + 92.4 (c = 0.77, CHCl3); HRMS (ESI) m/z calcd for 
C20H20O5Cl2 [M+Na]+ 433.0580, found 433.0583; the ee value of the major isomer was 
81%, tR = 12.8 min and 15.7 min (Chiralcel IC, λ = 254 nm, 5% iPrOH/hexanes, flow 
rate = 1.0 mL/min). 
 














A yellowish oil; diastereomeric ratio is 88:12; 1H NMR (500 MHz, CDCl3) 6.07-6.14 
(m, 1H), 5.62 (dd, J = 15.2, 1.9 Hz, 1H), 5.17 (s, 1H), 3.70 (s, 1H), 1.78 (dd, J = 6.7, 1.6 
Hz, 3H), 1.51 (s, 9H); 13C NMR (75 MHz, CDCl3)  169.8, 164.8, 148.8, 130.4, 128.8, 
124.9, 85.2, 84.2, 77.2, 27.8, 17.6; [α]Drt
 
= - 2.9 (c = 0.41, CHCl3); HRMS (ESI) m/z 
calcd for C13H16O5Cl2 [M+Na]+ 345.0267, found 345.0264; the ee value of the major 
isomer was 90%, tR = 15.8 min and 23.4 min (Chiralcel IC, λ = 254 nm, 2% 








A colorless oil; diastereomeric ratio is 89:11; 1H NMR (500 MHz, CDCl3) 5.76-5.85 (m, 
1H), 5.07 (s, 1H), 4.99-5.08 (m, 2H), 3.68 (s, 1H), 2.24-2.28 (m, 1H), 2.12-2.17 (m, 1H), 
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2.00-2.03 (m, 1H), 1.89-1.92 (m, 1H), 1.49 (s, 9H); 13C NMR (75 MHz, CDCl3)  170.7, 
164.5, 148.8, 136.8, 123.2, 115.6, 85.1, 83.9, 77.2, 34.4, 27.8, 27.4; [α]Drt
 
= + 1.5 (c = 
0.67, CHCl3); HRMS (ESI) m/z calcd for C14H18O5Cl2 [M+Na]+ 359.0424, found 
359.0425; the ee value of the major isomer was 88%, tR = 7.5 min and 9.0 min (Chiralcel 








A colorless oil; diastereomeric ratio is 85:15; 1H NMR (500 MHz, CDCl3) 7.26-7.29 (m, 
5H), 5.10 (s, 1H), 3.70 (s, 1H), 3.38 (d, J = 13.9 Hz, 1H), 3.17 (d, J = 13.2 Hz, 1H), 1.39 
(s, 9H); 13C NMR (75 MHz, CDCl3)  170.0, 164.5, 149.1, 133.9, 130.9, 130.6, 128.2, 
127.4, 85.3, 83.4, 77.2, 41.3, 27.7; [α]Drt = - 17.7 (c = 0.56, CHCl3); HRMS (ESI) m/z 
calcd for C17H18O5Cl2 [M+Na]+ 395.0424, found 395.0424; the ee value of the major 
isomer was 80%, tR = 11.1 min and 21.6 min (Chiralcel IC, λ = 254 nm, 2% 


















A colorless oil; diastereomeric ratio is 86:14; 1H NMR (300 MHz, CDCl3): 7.16-7.31 (m, 
5H), 5.09 (s, 1H), 3.77 (s, 1H), 2.83 (m, 1H), 2.21-2.45 (m, 2H), 1.51 (s, 9H). 13C NMR 
(75 MHz, CDCl3): 170.8, 164.5, 148.8, 140.6, 128.6, 128.3, 126.3, 123.2, 85.2, 83.9, 77.2, 
37.2, 29.5, 27.9. HRMS (ESI) m/z calcd for C18H20Cl2O5 [M+Na]+ 409.0585, found 
409.0562; the ee value of the major isomer was 85%, tR = 9.9 min and 11.8 min 














A colorless oil; diastereomeric ratio is 87:13; 1H NMR (500 MHz, CDCl3) 5.06 (s, 1H), 
3.65 (s, 1H), 1.97-2.03 (m, 1H), 1.87-1.93 (m, 1H), 1.51 (s, 9H), 1.11-1.31 (m, 9H), 1.08-
1.10 (m, 1H), 0.88 (t, J = 6.7 Hz, 3H); 13C NMR (75 MHz, CDCl3)  171.0, 164.6, 149.0, 
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123.1, 84.8, 84.0, 77.6, 35.1, 31.6, 29.4, 28.9, 27.8, 22.9, 22.6, 14.0; [α]Drt = - 7.8 (c = 
0.62, CHCl3); HRMS (ESI) m/z calcd for C17H26O5Cl2 [M+Na]+ 403.1055, found 
403.1049; the ee value of the major isomer was 80%, tR = 9.5 min and 16.7 min 
(Chiralcel IC, λ = 254 nm, 2% iPrOH/hexanes, flow rate = 1.0 mL/min). 
 
 




A white solid; diastereomeric ratio is 91:9; 1H NMR (500 MHz, CDCl3): 7.37-7.70 (m, 
5H), 6.95 (dd, J = 1.9, 5.7, 1H), 6.15 (dd, J = 1.9, 5.7, 1H), 5.70 (s, 1H), 3.92 (s, 1H), 
1.53 (s, 9H); 13C NMR (125 MHz, CDCl3): 172.7, 170.6, 151.5, 136.9, 128.8, 128.7, 
125.5, 123.8, 86.4, 85.2, 77.2, 27.8; [α]Drt = +21.6 (c = 0.45, CHCl3); HRMS (ESI) m/z 
calcd for C16H18O5 [M+Na]+ 313.1052, found 313.1054; the ee value of the major isomer 
was 82%, tR = 9.0 min and 11.1 min (Chiralcel IC, λ = 220 nm, 30% iPrOH/hexanes, 


















A white solid; diastereomeric ratio 98:2; 1H NMR (500 MHz, CDCl3): 7.59-7.61 (m, 2H), 
7.54-7.56 (m, 2H),  5.62 (s, 1H), 4.09 (s, 1H), 1.52 (s, 9H); 13C NMR (125 MHz, CDCl3): 
169.4, 165.6, 142.5, 134.8, 131.6, 128.2, 123.4, 117.4, 86.9, 86.2, 77.3, 27.8; [α]Drt
 
= 
+21.6 (c = 1.09, CHCl3); the ee value of the major isomer was 90%, tR = 7.8 min and 9.0 






A white solid; diastereomeric ratio 98:2; 1H NMR (500 MHz, CDCl3): 7.69-7.72 (m, 2H), 
7.09-7.12 (m, 2H),  5.63 (s, 1H), 4.09 (s, 1H), 1.52 (s, 9H); 13C NMR (125 MHz, CDCl3): 
169.6, 165.6, 163.4 (J = 247.8), 142.5, 131.4, 128.3 (J = 8.2), 117.4, 115.4 (J = 21.0), 
87.0, 86.1, 77.2, 27.8; [α]Drt = -2.3 (c = 1.02, CHCl3); the ee value of the major isomer 
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was 92%, tR = 7.7 min and 8.9 min (Chiralcel IC, λ = 254 nm, 15% iPrOH/hexanes, flow 














A white solid; diastereomeric ratio 98:2; 1H NMR (300 MHz, CDCl3): 7.58 (d, J = 8.2, 
2H), 7.21 (d, J = 8.2, 2H),  5.67 (s, 1H), 4.03 (s, 1H), 2.38 (s, 3H), 1.51 (s, 9H); 13C NMR 
(75 MHz, CDCl3): 170.0, 165.9, 142.9, 138.9, 132.7, 129.1, 126.2, 117.1, 87.2, 85.6, 77.2, 
27.8, 21.1; [α]Drt
 
= +13.7 (c = 1.08, CHCl3); the ee value of the major isomer was 95%, tR 
= 10.4 min and 13.9 min (Chiralcel IC, λ = 254 nm, 10% iPrOH/hexanes, flow rate = 1.0 
mL/min). 
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Chapter 3 Direct Asymmetric Vinylogous Mannich-Type Reaction 
of Phthalide Derivatives: Facial Access to Chiral Substituted 
Isoquinolines and Isoquinolinones 
 
3.1 Introduction 
Substituted isoquinolines and isoquinolinones, by virtue of their privileged structure, 
chemical stability and relative accessibility, are often used as building blocks in organic 
synthesis and demonstrate special biomimetic characteristics.135 As exemplified in 
previous reports,136 GPR40 antagonist, antitumor agents narciolasine and pancratistatin, 
analgesic compound tetrahydropalmatine and other biologically important agents have 
been found among the derivatives of isoquinolines and isoquinolinones (Scheme 3.1). 
Therefore, stereoselective synthesis of compounds containing an isoquinoline and 
isoquinolinone skeleton is a field of growing interest in synthetic organic chemistry.  
 
Scheme 3.1 Examples of the biologically important isoquinolinones and isoquinolines 
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Although many excellent methods have been devised for the synthesis of 
isoquinoline and isoquinolinone derivatives,137 the preparation of their optical active 3-
substituted compounds is still a formidable task. One approach is through a tandem 1,2-
addition/ring closure sequence employing lithiated ortho-toluamides and imines, either 
using enantiopure imines or employing (–)-sparteine as the base to achieve the high 
enantioselectivity.138 Another method with partial success is to use enantiomerically pure 
amino acids and their derivatives as the staring materials (Scheme 3.2).139 However, no 
organocatalytic method has been reported up to date. It is thus our goal to develop an 
efficient organocatalytic vinylogous Mannich reaction to allow easy access to substituted 
isoquinoline derivatives. 
 
Scheme 3.2 Literature reported methods for the synthesis of isoquinolinones 
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In the past few decades, the vinylogous reaction employing 2-silyloxyfurans as the 
preformed nucleophiles has been investigated intensively.140 Further development for the 
direct vinylogous reaction has become a hot research area recently, and significant 
progress has been made.141 Terada142 and Feng143 independently reported an 
enantioselective vinylogous aldol reaction of furanone derivatives with aldehydes 
catalyzed by chiral guanidine and thiourea. Later, Pansare investigated the same reaction 
employing diamine based bifunctional catalyst.144 Our group recently disclosed a direct 
vinylogous aldol reaction between furanones and -ketoesters for the facile access to -
butenolides and glycerol derivatives.145 Very recently, Ye,146 Li147 and Wang148 reported 
vinylogous Michael reaction of -unsaturated ketones with -butenolides catalyzed by 
primary amine-based catalysts.  
Although many excellent methods have been reported for the vinylogous reaction of 
-butenolides,149 the direct utilization of phthalide derivatives in the asymmetric 
vinylogous reactions is unknown, probably due to their low reactivity. We envisioned 
that an electron withdrawing substitution on the phthalide could improve its nucleophilic 
activity, thus making it an ideal substrate in the vinylogous Mannich-type reaction with 
imines (Scheme 3.3). The substituted phthalides that result from these reactions are 
common structural motifs in bioactive molecules.150 Moreover, they can be readily 
converted into pharmaceutically important chiral isoquinolinones and isoquinolines. 
 




Scheme 3.3 Construction of isoquinolines and isoquinolinones via vinylogous Mannich 
reaction 
 
3.2 Results and discussions 
3.2.1 Reaction optimization 
  We selected the vinylogous Mannich reaction of phthalide derivative 3-1 with 
different imine 3-2 as the model reaction, and a number of bifunctional and trifunctional 
catalysts were screened (Scheme 3.4). The results are shown in Table 3.1. 
 
 
Scheme 3.4 List of catalysts screened in the reaction 
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 When L-tryptophan-derived bifunctional thiourea was employed in the reaction, the 
Mannich adduct was formed as anticipated, but only with moderate diastereoselectivity 
and enantioselectivity (entry 1). Quinidine-derived sulfonamide was totally ineffective on 
the stereoinduction and the yield was less than 50% (entry 2). We then turned to 
quinidine and quinine-derived thiourea catalyst. However, to our disappointment, both 
the diastereoselectivity and the enantioselectivity were quite low (entries 3-4).  
   
Table 3.1   Screening of bifunctional and trifunctional catalysts for the vinylogous 
Mannich reaction[a] 
   
Entry 3-1 3-2 [R2] Catalyst Yield
[b]
 dr[c] ee/%[d] 
1 1a Boc Trp-1 89 78:22 39 
2 1a Boc QD-1 < 50  - - 
3 1a Boc QD-2 91 79:21 27 
4 1a Boc Q-1 92 77:23 40 
5 1a Boc QD-3 86 77:23 -5 
6 1a Boc QD-4 87 74:26 -11 
7 1a Boc QD-5 90 69:31 62 
8 1a Boc C-1 88 61::39 82 
9 1a Boc Q-2 85 63:37 83 
10 1b Boc Q-2 91 55:45 80 
11 1c Boc Q-2 < 50 %  - - 
12 1a Cbz Q-2 93 87:13 92 
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13 1a Bz Q-2 96 77:23 29 
14 1a Ts Q-2 81 91:9 81 
15 1a Cbz Q-3 92 86:14 89 
16 1a Cbz Q-4 90 89:11 71 
17 1a Cbz Q-5 88 85:15 79 
18 1a Cbz Q-6 88 88:12 70 
19[e] 1a Cbz Q-2 90 89:11 93 
20[f] 1a Cbz Q-2 87 87:13 92 
21[g] 1a Cbz Q-2 92 86:14 90 
22[h] 1a Cbz Q-2 83 86:14 90 
23[g,i] 1a Cbz Q-2 91 88:12 94 
24[g,j] 1a Cbz Q-2 90 88:12 95 
[a] Reactions were carried out using 3-1 (0.05 mmol), 3-2 (0.06 mmol), catalyst (0.005 mmol), in 0.1 ml 
solvent at room temperature. [b] Yield of isolated product. [c] Determined by 1H NMR analysis. [d] 
Determined by chiral HPLC analysis. [e] With 5 mol% catalyst. [f] With 2 mol% catalyst. [g] With 1 mol% 
catalyst. [h] With 0.5 mol% catalyst. [i] Reaction in 0.2 ml solvent. [j] Reaction in 0.5 ml solvent. 
 
A series of trifunctional catalysts were then tested. The combination of quinidine 
with L-valine and L-isoleucine gave poor enantioselectivity (entries 5-6). On the other 
hand, when D-valine was incorporated, a substantial improvement was observed, which 
may be attained by the chirality match of the amino acid moiety with the cinchona 
alkaloid scaffold (entry 7). This finding prompted us to test different combinations of 
amino acids and cinchona alkaloids. To our delight, when L-tert-leucine was incorporated, 
promising results were obtained (entries 8-9). Compared to cinchonine, the quinine 
derived catalyst gave slightly better results (entry 9). 
We then further investigated the two reaction partners, hoping to improve the 
selectivity (entries 10-14). Replacement of the tert-butyl group on the phthalide ester by 
methyl or oxazolidinone proved to be ineffective (entries 10-11). Different imines were 
also tested, and it was found that N-Bz and N-Ts imine did not offer better selectivity 
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(entries 13-14). To our delight, when N-Boc imine was changed into N-Cbz imine, both 
the enantioselectivity and diastereoselectivity were improved (entry 12). A series of 
quinine derived trifunctional catalysts were tested with no improvement of the 
stereoselectivity (entries 15-18). 
In order to make the method more practical, the catalyst loading could be further 
decreased to 1 mol% (entries 19-24). Under the optimized reaction conditions, the desired 
vinylogous Mannich product could be obtained in excellent yield with 88:12 d.r. and 95% 
ee (entry 24). 
 
 
3.2.2 Substrate scope 
With the established reaction conditions in hand, we next studied the scope of the 
direct vinylogous Mannich addition of the phthalide to an array of different substituted 
N-Cbz imines. The influence of phthalide as well as the imine structural variation has 
been investigated. The results are shown in Table 3.2. 
Consistently high diastereoselectivity and enantioselectivity were observed for a 
wide range of aromatic substituted imines.  Electron donating groups, halogens as well as 
fluorine substituents are well tolerated in this reaction (entries 1-9). When electron 
withdrawing group was employed, the enantioselectivity was maintained with the slightly 
decreased diastereoselectivity (entry 10). Heterocyclic imines were also suitable 
substrates and the enantioselectivities were maintained (entries 11-12). The reaction was 
also applicable to the aryl imines with different substitution patterns, including ortho- 
(entry 8), meta- (entries 2, 5), para- (entries 1, 4, 6-10) as well as 3, 4-disubstitution 
(entry 9) at the phenyl ring. 
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We also screened differently substituted phthalide esters as the reaction partner with 
N-Cbz imines. When 5-bromophthalide ester was employed, the reaction could be 
completed smoothly to afford the desired product with satisfactory results. Different 
imines such as electron donating and withdrawing groups, as well as halogen substitution 
are well tolerated in this reaction (entries 13-17). The 5-cyano-substituted phthalide 
derivative was also tested, both the diastereoselectivity and enantioselectivity were 
proceeded with comparable diastereoselectivity and enantioselectivity (entry 18). 
 
 





Entry 3-1 R2 3-5 Yield/%[b] d.r[c] ee/%[d] 
1 3-1a 4-OMeC6H4 3-5a 92 88:12 91 
2 3-1a 3-MeC6H4 3-5b 86 86:14 93 
3 3-1a Ph 3-5c 86 91:9 95 
4 3-1a 4-BrC6H4 3-5d 81 88:12 92 
5 3-1a 3-BrC6H4 3-5e 80 83:17 91 
6 3-1a 4-ClC6H4 3-5f 87 89:11 93 
7 3-1a 4-FC6H4 3-5g 85 85:15 93 
8 3-1a 2-FC6H4 3-5h 84 88:12 91 
9[e] 3-1a 3,4-OMeC6H3 3-5i 93 92:8 85 
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10 3-1a 4-CF3C6H4 3-5j 79 82:18 85 
11[e] 3-1a 2-furanyl 3-5k 71 67:33 80 
12 3-1a 3-furanyl 3-5l 86 73:27 83 
13 3-1d Ph 3-5m 92 86:14 91 
14 3-1d 3-MeC6H4 3-5n 80 87:13 86 
15 3-1d 4-ClC6H4 3-5o 93 84:16 93 
16 3-1d 4-FC6H4 3-5p 90 85:15 90 
17 3-1d 4-CF3C6H4 3-5q 81 83:17 80 
18 3-1e Ph 3-5r 88 87:13 83 
[a] Reactions were carried out using 3-1 (0.1 mmol), 3-4 (0.05 mmol), catalyst (0.0005 mmol), and 4Ǻ 
molecular sieve in 0.5 ml toluene at room temperature. [b] Yield of isolated product. [c] Determined by 
1H NMR analysis. [d] Determined by chiral HPLC analysis. [e] 5 mol% catalyst used.  
   
 
3.2.3 Plausible transition-state model 
    Although the mechanism of reaction reported here remains to be clarified, a plausible 
transition-state model is proposed (Scheme 3.5). 
The N-Cbz imine is activated by the thiourea moiety through double hydrogen 
bonding formed from the NH groups of the thiourea in Q-2 and the carbonyl group of 
imine. Meanwhile, tertiary amine moiety of Q-2 deprotonates phthalide derivative 3-1a 
to generate the enolate and the ammonium ion. Hydrogen bonding is subsequently 
formed with the ammonium ion together with amide, which is coordinated with enalate. 
The - interactions between the two aromatic moieties in the imine and the catalyst Q-2 
should also be important for the improved selectivity. These results are supported by the 
observation that the Cbz imine affords the vinygolous product with better diastereo- and 
enantioselectivity as compared with the Boc protected imine.  




Scheme 3.5 Plausible trasition-state model 
 
3.2.4 Large scale synthesis of the vinylogous Mannich adduct 
We also carried out a large scale synthesis of the vinylogous Mannich product, 
employing tert-butyl phthalide ester and the p-methyl substituted Cbz imine (Scheme 3.6). 
The reaction proceeded smoothly with only 2 mol% catalyst, and the product was formed 
in high yield with 87:13 d.r and 93% ee. The experiment illustrates the potential of the 
reported method in the industrial application. 




Scheme 3.6 Vinylogous Mannich reaction at gram scale 
    
3.2.5 Chiral isoquinoline and isoquinolinone synthesis 
The vinylogous Mannich reaction described here represents a novel asymmetric 
preparation of disubstituted phthalides, which are of biological significance. Moreover, 
they are also versatile building blocks. Compound 3-3 served as a model to illustrate the 
synthetic potential.  Treatment of 3-3 with TFA to afford the acid, and it was subjected to 
boron reduction directly to yield alcohol 3-6. In order to access chiral isoquinolinones, 
Cbz was removed under hydrogenolysis condition, followed by the treatment with 
NaOMe, and the chial isoquinolinone 3-7 was obtained in 86% yield (Scheme 3.7).  
 Scheme 3.7 Synthesis of chiral isoquinolinones 
Moreover, compound 3-7 could be readily transformed into chiral isoquinoline 3-8 
by a simple treatment with LiAH4. Both 3-7 and 3-8 represent an important class of 
compounds for the development of antiviral agents. 




Scheme 3.8 Synthesis of chiral isoquinolines 
 
3.3 Conclusions 
  In conclusion, synthetically versatile substituted phthalides were prepared 
stereoselectively by direct asymmetric vinylogous Mannich addition to imines. The 
resulting compounds could be converted readily into chiral substituted isoquinolines and 
isoquinolinones, which are of biological importance. Further investigations for the 
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3.4 Experimental section 
3.4.1 General information 
        1H and 13C NMR spectra were recorded on a Bruker ACF300 or DPX300 (300 MHz) 
or AMX500 (500 MHz) spectrometer. Chemical shifts were reported in parts per million 
(ppm), and the residual solvent peak was used as an internal reference. Multiplicity was 
indicated as follows: s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), dd 
(doublet of doublet), br s (broad singlet). Coupling constants were reported in Hertz (Hz). 
Low resolution mass spectra were obtained on a Finnigan/MAT LCQ spectrometer in ESI 
mode, and a Finnigan/MAT 95XL-T mass spectrometer in FAB mode. All high 
resolution mass spectra were obtained on a Finnigan/MAT 95XL-T spectrometer. Flash 
chromatography separation was performed on Merck 60 (0.040 - 0.063 mm) mesh silica 
gel. 
        The enantiomeric excesses of products were determined by chiral-phase HPLC 
analysis, using a Daicel Chiralcel AD-H column (250 x 4.6 mm), or Chiralpak IA column, 
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3.4.2 Preparaton of phthalide derivatives 
tert-Butyl 3-oxo-1,3-dihydroisobenzofuran-1-carboxylate (3-1a) 
 
To a solution of diisopropyl amine (2.6 mL, 18 mmol) in THF was added BuLi (6.9 mL, 
2.5 M in hexane) at -78 oC under Ar, and the the solution was stirred at -78 oC for 0.5 h. 
Then a solution of phthalide (2.01 g, 15 mmol) in THF (5 mL) was introduced slowly and 
the mixture was further stirred at -78 oC for another 50 min. CO2 was bubbled into the 
solution using balloon for about 1.5 h at the same temperature during which the mixture 
became a clear red solution. Sat. NH4Cl solution (10 mL) was added dropwise to quench 
the reaction, then THF was removed under vacuum. The residue was basified with sat. 
Na2CO3 solution until PH = 14 and the solution was washed with ethyl acetate (2×5 mL). 
The aqueous phase was acidified with conc. HCl solution until PH = 1. The mixture was 
extracted with ethyl acetate (3×15 mL) and the organic phase was dried over Na2SO4. 
The crude acid (2.0 g) was obtained upon concentration under reduced pressure and used 
without purification in the next step. 
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To a solution of the crude acid (2.0 g) in CH2Cl2 (20 mL) was added oxalyl chloride 
(1.31 mL, 15 mmol) at 0 oC, followed by the addition of a few drops of DMF. The 
mixture was stirred at room temperature for 4 hrs. Then solvent was removed under 
reduced pressure and the residue was dissolved in CH2Cl2 (20 mL), and tert-butanol (1.06 
mL, 11 mmol), Et3N (4.2 mL, 30 mmol) and DMAP (61 mg, 0.5 mmol) were added. The 
mixture was stirred at room temperature overnight. Water (20 mL)was added and the 
mixture was extracted with CH2Cl2 (3×15 mL). The organic phase was dried over 
Na2SO4 and concentrated. The residue was purified by column chromatography using 
hexane/ethyl acetate (15:1 to 10:1) as an eluent to afford 3-1a as a white solid (1.44 g, 
41% yield for two steps). 
1H NMR (500 MHz, CDCl3) δ 1.49 (s, 9H), 5.76 (s, 1H), 7.59 (t, J = 7.6 Hz, 1H), 7.64 (d, 
J = 7.6 Hz, 1H), 7.71 (t, J = 7.6 Hz, 1H), 7.92 (d, J = 8.2 Hz, 1H);13C NMR (125 MHz, 
CDCl3) δ 27.93, 77.79, 83.94, 122.44, 125.17. 125.96, 130.04, 134.37, 144.60, 165.49, 
169.55; HRMS (ESI) m/z calcd for C13H14O4 [M+Na]+= 257.0784, found = 257.0788. 
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The substrate was prepared according to the procedure described for 3-1a; 37% yield; A 
while solid; 1H NMR(500 MHz, CDCl3) δ 1.51 (s, 9H), 5.73 (s, 1H), 7.73 (d, J = 8.8 Hz, 
1H), 7.78 (d, J = 8.2 Hz, 1H),7.81 (s, 1H);13C NMR (125 MHz, CDCl3) δ 27.96, 77.56, 
84.56, 124.13, 126.01, 127.18, 129.64, 133.74, 146.23, 164.90, 168.54; HRMS (ESI) m/z 
calcd for C13H1379BrO4 [M+Na]+ = 334.9889, found = 334.9887; C13H1381BrO4 [M+Na]+ 
= 336.9869, found = 336.9869. 
 
tert-Butyl 6-cyano-3-oxo-1,3-dihydroisobenzofuran-1-carboxylate (3-1e) 
 
The substrate was prepared according to the procedure described for 3-1a; 23% yield; A 
while solid; 1H NMR(500 MHz, CDCl3) δ 1.51 (s, 9H), 5.82 (s, 1H), 7.89 (d, J = 7.6 Hz, 
1H), 7.96 (s, 1H), 8.04 (d, J = 8.2 Hz, 1H);13C NMR (125 MHz, CDCl3) δ 27.95, 77.43, 
85.10, 117.19, 118.06, 126.71, 126.87, 128.87, 133.82, 144.90, 164.28, 167.42; HRMS 
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3.4.3 Representative procedure of the vinylogous mannich reaction 
Addition of tert-butyl 3-oxo-1,3-dihydroisobenzofuran-1-carboxylate 3-1a to benzyl 4-
methylbenzylidenecarbamate 3-2b catalyzed by Q-2 
 
 
To a solution of tert-butyl 3-oxo-1,3-dihydroisobenzofuran-1-carboxylate 3-1a (11.7 mg, 
0.05 mmol), benzyl 4-methylbenzylidenecarbamate 3-2b (15.2 mg, 0.06 mmol) in 
toluene (0.5 mL) was added 20 L Q-2 (0.0005 mmol, the catalyst solution was prepared 
in advance by dissolving 17.7 mg Q-2 in 1 mL toluene) at room temperature. The 
resulting mixture stirred for 24h, and the residue was purified by flash column 
chromatography (hexane/AcOEt = 10/1 as eluent) to afford vinylgous mannich product 3-
3 (22.7 mg, 93% yield). The diastereomeric ratio was determined by crude NMR analysis 
and the enantiomeric excess by HPLC analysis. 
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To a solution of 3-3 (97.5 mg, 0.2 mmol) in CH2Cl2 (1 ml) was added TFA (0.2 ml) 
dropwise at 0 oC. The reaction mixture was allowed to warm to room temperature and 
stirred for 5 hours. The solvent was removed, and the crude 3-3a was used directly in 
next step without further purification. 
 
BH3·Me2S (0.20 mL, 2 M in hexane, 0.4 mmol) was added dropwise to a solution of 3-3a 
in THF (1.0 mL) at 0 °C. The mixture was allowed to warm to room temperature and 
stirred for another 40 h. Water was added to the mixture, and the layers were separated. 
Chapter 3 Vinylogous Mannich Reaction of Phthalide Derivatives 
100 
 
The aqueous phase was extracted with CH2Cl2 twice, and the combined organic extracts 
were washed with water and brine, and dried with MgSO4. After filtration, the solvent 
was removed and the residue was purified by flash column chromatography on silica 
(hexane/EtOAc = 3/1 as eluent) to afford 3-6 (48.4 mg, 58%) as a colorless oil. 
 
A colorless oil; 1H NMR (500 MHz, CDCl3) δ 7.77 (d, J = 7.6 Hz, 1H), 7.62 – 7.50 (m, 
2H), 7.48 – 7.26 (m, 6H), 6.97 – 6.82 (m, 4H), 5.69 (d, J = 9.1 Hz, 1H), 5.44 (d, J = 9.2 
Hz, 1H), 5.18 (q, J = 12.1 Hz, 2H), 4.23 (dd, J = 11.8, 5.4 Hz, 1H), 4.06 (dd, J = 9.9, 5.4 
Hz, 1H), 3.50 (t, J = 10.8 Hz, 1H), 2.15 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 169.51, 
157.57, 149.68, 138.01, 135.70, 133.87, 131.70, 129.28, 129.12, 128.66, 128.49, 128.20, 
127.56, 125.81, 125.51, 123.25, 89.10, 67.88, 64.21, 57.07, 20.91; HRMS (ESI) m/z 












To a solution of 3-6 (48.4 mg, 0.12 mmol) in MeOH (0.5 ml) was added Pd/C (10mg, 
10% on charcoal). The reaction mixture was allowed to stir under H2 overnight. After 
filtration, the reaction mixture was added sodium methoxide (12.9 mg, 0.24 mmol) and 
stir at 60 °C for another 20h. The solvent was removed and the residue was purified by 
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flash column chromatography on silica (hexane/EtOAc = 1/1 as eluent) to afford 3-7 
(28.3 mg, 86%) as a colorless oil. 
 
A colorless oil; 1H NMR (500 MHz, CDCl3) δ 7.96 (d, J = 7.7 Hz, 1H), 7.63 (d, J = 7.7 
Hz, 1H), 7.55 (t, J = 7.6 Hz, 1H), 7.38 (t, J = 7.5 Hz, 1H), 7.30 (d, J = 7.6 Hz, 2H), 7.18 
(d, J = 7.8 Hz, 2H), 6.55 (s, 1H), 4.91 (s, 1H), 4.04 (br, 1H), 3.87 (dd, J = 11.7, 3.2 Hz, 
1H), 3.52 (dd, J = 11.8, 7.4 Hz, 1H), 2.34 (s, 3H); 13C NMR (126 MHz, CDCl3) δ 166.07, 
141.67, 138.90, 133.22, 133.07, 129.77, 128.39, 127.93, 127.26, 127.01, 125.09, 73.49, 








To a solution of 3-7 (28 mg, 0.1 mmol) in anhydrous THF (2 mL) at 0 oC was added 
slowly LiAlH4 (38 mg, 1 mmol). The reaction mixture was stirred at 60 oC overnight and 
then quenched with the addition of 10% aq. NaOH (0.1 ml). The mixture was 
concentrated, and the residue was extracted with ethyl acetate several times. The 
combined organic layers were dried over Na2SO4, filtered and concentrated. Purification 
by column chromatography gave 3-8 (23.9 mg, 89%) as a slightly yellow oil. 
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1H NMR (500 MHz, CDCl3) δ 7.70 – 7.64 (m, 1H), 7.44 (d, J = 8.0 Hz, 2H), 7.41 – 7.21 
(m, 4H), 7.11 (d, J = 7.5 Hz, 1H), 4.34 (d, J = 15.1 Hz, 1H), 4.24 (d, J = 15.1 Hz, 1H), 
4.09 (s, 1H), 3.73 – 3.57 (m, 3H), 2.39 (s, 3H); 13C NMR (126 MHz, CDCl3) δ 139.37, 
139.35, 138.31, 135.12, 134.98, 129.59, 127.56, 127.18, 126.16, 125.56, 71.78, 69.10, 
67.75, 49.21, 21.13. 
 
 
3.4.5 Experimental procedure of large scale synthesis 
 
To a solution of tert-butyl 3-oxo-1,3-dihydroisobenzofuran-1-carboxylate 3-1a (0.73 g, 3 
mmol), benzyl 4-methylbenzylidenecarbamate 3-2b (0.91 g, 3.6 mmol) in toluene (30 mL) 
was added Q-2 (42 mg, 0.06 mmol) at room temperature. The resulting mixture stirred 
for 24h, and the residue was purified by flash column chromatography (hexane/AcOEt = 
10/1 as eluent) to afford vinylgous mannich product 3-3 (1.33g, 91% yield). The 
diastereomeric ratio was determined by crude NMR analysis and the enantiomeric excess 
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A white solid; diastereomeric ratio is 88:12; 1H NMR (500 MHz, CDCl3) δ 7.78 (d, J = 
7.7 Hz, 1H), 7.64 (t, J = 7.5 Hz, 1H), 7.58 (d, J = 7.6 Hz, 1H), 7.42 (t, J = 7.5 Hz, 1H), 
7.37 – 7.28 (m, 4H), 6.88 (dd, J = 23.7, 8.1 Hz, 4H), 6.08 (d, J = 10.1 Hz, 1H), 5.71 (d, J 
= 10.2 Hz, 1H), 5.16 (d, J = 12.3 Hz, 1H), 4.99 (d, J = 12.3 Hz, 1H), 2.15 (s, 3H), 1.44 (s, 
9H); 13C NMR (126 MHz, CDCl3) δ 168.30, 165.77, 155.25, 145.26, 137.93, 136.13, 
134.15, 131.58, 130.17, 128.76, 128.48, 128.19, 128.17, 127.78, 125.79, 125.73, 123.00, 
89.43, 84.59, 67.11, 59.91, 27.68, 20.95; HRMS (ESI) m/z calcd for C29H29NO6 [M+Na]+ 
510.1887, found 510.1881; the ee value of the major isomer was 95%, tR (major) = 20.5 
min and 46.1 min, tR (minor) = 10.5 min and 11.4 min (Chiralcel AD-H, λ = 254 nm, 






















A white solid; diastereomeric ratio is 88:12; 1H NMR (500 MHz, CDCl3) δ 7.77 (d, J = 
7.7 Hz, 1H), 7.68 – 7.56 (m, 2H), 7.46 – 7.31 (m, 6H), 6.95 (d, J = 8.6 Hz, 2H), 6.59 (d, J 
= 8.6 Hz, 2H), 6.08 (d, J = 10.1 Hz, 1H), 5.70 (d, J = 10.1 Hz, 1H), 5.16 (d, J = 12.2 Hz, 
1H), 5.00 (d, J = 12.3 Hz, 1H), 3.65 (s, 3H), 1.44 (s, 9H); 13C NMR (126 MHz, CDCl3) δ 
168.28, 165.77, 159.24, 155.25, 145.27, 136.12, 134.19, 130.18, 129.06, 128.53, 128.47, 
128.19, 128.11, 126.72, 125.77, 122.93, 113.46, 89.49, 84.57, 67.10, 59.64, 55.05, 27.67; 
HRMS (ESI) m/z calcd for C29H29NO7 [M+Na]+ 526.1836, found 526.1827; the ee value 
of the major isomer was 93%, tR (major) = 25.9 min and 56.1 min, tR (minor) = 11.4 min 
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A white solid; diastereomeric ratio is 86:14; 1H NMR (500 MHz, CDCl3) δ 7.79 (d, J = 
7.7 Hz, 1H), 7.64 (t, J = 7.5 Hz, 1H), 7.58 (d, J = 7.5 Hz, 1H), 7.43 – 7.30 (m, 6H), 6.97 - 
6.80 (m, 4H), 6.08 (d, J = 10.1 Hz, 1H), 5.70 (d, J = 10.2 Hz, 1H), 5.16 (d, J = 12.2 Hz, 
1H), 5.01 (d, J = 12.3 Hz, 1H), 2.14 (s, 3H), 1.44 (s, 9H); 13C NMR (126 MHz, CDCl3) δ 
168.23, 165.77, 155.28, 145.23, 137.66, 136.12, 134.47, 134.06, 130.15, 128.90, 128.68, 
128.47, 128.19, 128.16, 127.89, 125.76, 125.67, 124.98, 123.07, 89.31, 84.59, 67.12, 
60.12, 27.67, 21.12; HRMS (ESI) m/z calcd for C29H29NO6 [M+Na]+ 510.1887, found 
510.1890; the ee value of the major isomer was 93%, tR (major) = 14.1 min and 18.3 min, 
tR (minor) = 6.1 min and 6.7 min (Chiralcel AD-H, λ = 254 nm, 30% iPrOH/hexanes, 










A white solid; diastereomeric ratio is 91:9; 1H NMR (500 MHz, CDCl3) δ 7.79 (d, J = 7.7 
Hz, 1H), 7.66 – 7.56 (m, 1H), 7.57 (d, J = 7.6 Hz, 1H), 7.46 – 7.27 (m, 6H), 7.18 – 6.98 
(m, 5H), 6.12 (d, J = 10.1 Hz, 1H), 5.75 (d, J = 10.2 Hz, 1H), 5.17 (d, J = 12.2 Hz, 1H), 
5.00 (d, J = 12.3 Hz, 1H), 1.44 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 168.19, 165.76, 
155.30, 145.19, 136.12, 134.19, 130.22, 128.79, 128.67, 128.60, 128.49, 128.34, 128.20, 
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128.06, 127.93, 125.73, 123.04, 89.30, 84.68, 67.17, 60.16, 27.69; HRMS (ESI) m/z 
calcd for C28H27NO6 [M+Na]+ 496.1731, found 496.1721; the ee value of the major 
isomer was 95%, tR (major) = 19.6 min and 30.4 min, tR (minor) = 7.6 min and 8.2 min 











A slightly yellow solid; diastereomeric ratio is 88:12; 1H NMR (500 MHz, CDCl3) δ 7.77 
(d, J = 7.7 Hz, 1H), 7.72 – 7.59 (m, 2H), 7.50 – 7.44 (m, 2H), 7.39 – 7.31 (m, 4H), 7.20 
(d, J = 8.4 Hz, 2H), 6.92 (d, J = 8.3 Hz, 2H), 6.10 (d, J = 9.9 Hz, 1H), 5.69 (d, J = 10.0 
Hz, 1H), 5.16 (d, J = 12.2 Hz, 1H), 5.01 (d, J = 12.2 Hz, 1H), 1.43 (s, 9H); 13C NMR (75 
MHz, CDCl3) δ 167.99, 165.54, 155.23, 144.88, 135.97, 134.38, 131.91, 131.28, 130.50, 
130.35, 129.57, 128.51, 128.25, 126.03, 125.66, 122.88, 122.47, 88.85, 84.90, 67.29, 
59.65, 27.68; HRMS (ESI) m/z calcd for C28H26BrNO6 [M+Na]+ 574.0836, found 
574.0817; the ee value of the major isomer was 92%, tR (major) = 27.8 min and 45.9 min, 
tR (minor) = 10.4 min and 11.0 min (Chiralcel AD-H, λ = 254 nm, 30% iPrOH/hexanes, 
flow rate = 1.0 mL/min). 
 
 










A slightly yellow solid; diastereomeric ratio is 83:17; 1H NMR (500 MHz, CDCl3) δ 7.79 
(d, J = 7.7 Hz, 1H), 7.75 – 7.58 (m, 2H), 7.48 (d, J = 7.5 Hz, 1H), 7.46 – 7.22 (m, 6H), 
7.16 (s, 1H), 7.05 – 6.96 (m, 2H), 6.13 (d, J = 10.0 Hz, 1H), 5.67 (d, J = 10.0 Hz, 1H), 
5.17 (d, J = 12.1 Hz, 1H), 5.02 (d, J = 12.2 Hz, 1H), 1.43 (s, 9H); 13C NMR (126 MHz, 
CDCl3) δ 167.91, 165.55, 155.25, 144.86, 134.40, 131.83, 131.36, 131.23, 130.53, 129.67, 
128.62, 128.52, 128.27, 128.23, 128.20, 126.39, 125.95, 123.00, 122.06, 88.79, 84.94, 
67.33, 59.69, 27.68; HRMS (ESI) m/z calcd for C28H26BrNO6 [M+Na]+ 574.0836, found 
574.0825; the ee value of the major isomer was 91%, tR (major) = 12.7 min and 16.1 min, 
tR (minor) = 5.6 min and 6.1  min (Chiralcel AD-H, λ = 254 nm, 30% iPrOH/hexanes, 













A white solid; diastereomeric ratio is 89:11; 1H NMR (500 MHz, CDCl3) δ 7.77 (d, J = 
7.7 Hz, 1H), 7.71 – 7.59 (m, 2H), 7.47 – 7.44 (m, 1H), 7.38 – 7.30 (m, 4H), 7.05 (d, J = 
8.5 Hz, 2H), 6.98 (d, J = 8.4 Hz, 2H), 6.11 (d, J = 9.9 Hz, 1H), 5.71 (d, J = 10.0 Hz, 1H), 
5.16 (d, J = 12.2 Hz, 1H), 5.01 (d, J = 12.2 Hz, 1H), 1.43 (s, 9H); 13C NMR (126 MHz, 
CDCl3) δ 168.00, 165.53, 155.24, 144.89, 135.96, 134.39, 134.23, 133.30, 130.48, 129.26, 
128.94, 128.51, 128.32, 128.27, 128.23, 126.00, 122.88, 88.93, 84.88, 67.29, 59.58, 27.67; 
HRMS (ESI) m/z calcd for C28H26ClNO6 [M+Na]+ 530.1341, found 530.1325; the ee 
value of the major isomer was 93%, tR (major) = 22.9 min and 37.5 min, tR (minor) = 9.4 












A white solid; diastereomeric ratio is 85:15; 1H NMR (500 MHz, CDCl3) δ 7.77 (d, J = 
7.7 Hz, 1H), 7.71 – 7.57 (m, 2H), 7.45 (d, J = 7.3 Hz, 1H), 7.40 – 7.31 (m, 5H), 7.02 (dd, 
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J = 8.4, 5.3 Hz, 2H), 6.76 (t, J = 8.6 Hz, 2H), 6.10 (d, J = 9.9 Hz, 1H), 5.72 (d, J = 10.0 
Hz, 1H), 5.16 (d, J = 12.2 Hz, 1H), 5.01 (d, J = 12.2 Hz, 1H), 1.43 (s, 9H); 13C NMR 
(126 MHz, CDCl3) δ 168.05, 165.59, 162.36 (J = 247.5 Hz), 155.25, 145.02, 135.99, 
134.34, 130.58, 130.39, 129.67, 129.60, 128.50, 128.40, 128.23, 125.89, 125.69, 122.89, 
115.17, 115.00, 89.08, 84.81, 67.25, 59.53, 27.67; HRMS (ESI) m/z calcd for 
C28H26FNO6 [M+Na]+ 514.1636, found 514.1620; the ee value of the major isomer was 
93%, tR (major) = 16.3 min and 26.7 min, tR (minor) = 6.7 min and 7.6 min (Chiralcel 










A white solid; diastereomeric ratio is 88:12; 1H NMR (500 MHz, CDCl3) δ 7.84 (d, J = 
9.6 Hz, 1H), 7.69 – 7.54 (m, 2H), 7.43 – 7.09 (m, 6H), 7.15 – 7.04 (m, 2H), 6.99 – 6.91 
(m, 1H), 6.70 (t, J = 9.1 Hz, 1H), 6.26 (d, J = 10.2 Hz, 1H), 6.10 (d, J = 10.1 Hz, 1H), 
5.17 (d, J = 12.2 Hz, 1H), 5.01 (d, J = 12.2 Hz, 1H), 1.45 (s, 9H); 13C NMR (126 MHz, 
CDCl3) δ 168.16, 165.43, 155.20, 144.36, 136.06, 134.10, 130.48, 130.37, 130.11, 130.04, 
128.85, 128.49, 128.38, 128.21, 127.72, 125.58, 125.39, 124.19, 123.45, 115.26, 115.08, 
89.28, 84.78, 67.24, 53.06, 27.68; HRMS (ESI) m/z calcd for C28H26FNO6 [M+Na]+ 
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514.1636, found 514.1621; the ee value of the major isomer was 91%, tR (major) = 18.6 
min and 32.2 min, tR (minor) = 7.9 min and 8.6 min (Chiralcel AD-H, λ = 254 nm, 30% 










A white solid; diastereomeric ratio is 92:8; 1H NMR (500 MHz, CDCl3) δ 7.78 (d, J = 7.7 
Hz, 1H), 7.68 – 7.54 (m, 2H), 7.43 – 7.29 (m, 5H), 6.62 – 6.55 (m, 2H), 6.49 (s, 1H), 6.04 
(d, J = 10.0 Hz, 1H), 5.68 (d, J = 10.0 Hz, 1H), 5.17 (d, J = 12.2 Hz, 1H), 5.01 (d, J = 
12.2 Hz, 1H), 3.73 (s, 3H), 3.68 (s, 3H), 1.45 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 
168.27, 165.72, 155.28, 148.76, 148.38, 145.33, 136.11, 134.05, 130.35, 130.21, 128.49, 
128.21, 127.64, 127.12, 125.86, 122.93, 120.59, 110.89, 110.55, 89.48, 84.63, 67.17, 
59.97, 55.76, 55.66, 27.70; HRMS (ESI) m/z calcd for C30H31NO8 [M+Na]+ 556.1942, 
found 556.1926; the ee value of the major isomer was 85%, tR (major) = 18.6 min and 
45.9 min, tR (minor) = 9.9 min and 23.4 min (Chiralcel AD-H, λ = 254 nm, 30% 
iPrOH/hexanes, flow rate = 1.0 mL/min). 
 
 










A white solid; diastereomeric ratio is 82:18; 1H NMR (500 MHz, CDCl3) δ 7.80 (d, J = 
7.7 Hz, 1H), 7.73 – 7.53 (m, 3H), 7.46 (t, J = 7.5 Hz, 1H), 7.37 – 7.31 (m, 6H), 7.19 (d, J 
= 8.0 Hz, 2H), 6.18 (d, J = 9.9 Hz, 1H), 5.78 (d, J = 10.0 Hz, 1H), 5.16 (d, J = 12.2 Hz, 
1H), 5.01 (d, J = 12.2 Hz, 1H), 1.43 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 167.86, 
165.49, 155.25, 144.73, 135.90, 134.47, 130.62, 129.14, 128.53, 128.40, 128.31, 128.26, 
127.71, 126.05, 125.69, 125.59, 125.09, 125.04, 122.90, 88.67, 85.05, 67.38, 59.79, 27.68; 
HRMS (ESI) m/z calcd for C29H26F3NO6 [M+Na]+ 564.1604, found 564.1629; the ee 
value of the major isomer was 85%, tR (major) = 13.9 min and 30.1 min, tR (minor) = 6.6 












A slightly brown solid; diastereomeric ratio is 67:33; 1H NMR (500 MHz, CDCl3) δ 7.72 
(d, J = 8.0 Hz, 2H), 7.65 (t, J = 7.6 Hz, 1H), 7.50 (t, J = 7.6 Hz, 1H), 7.41 – 7.27 (m, 4H), 
7.10 – 7.05 (m, 1H), 6.06 (s, 1H), 5.98 (s, 1H), 5.94 (d, J = 10.3 Hz, 1H), 5.88 (d, J = 
10.3 Hz, 1H), 5.18 (d, J = 12.3 Hz, 1H), 5.05 (d, J = 12.3 Hz, 1H), 1.43 (s, 9H); 13C 
NMR (75 MHz, CDCl3) δ 168.29, 165.25, 155.30, 148.53, 144.77, 142.49, 136.04, 
134.28, 130.40, 128.50, 128.20, 128.15, 125.70, 123.00, 116.51, 110.13, 108.81, 88.63, 
84.73, 67.27, 54.41, 27.65; HRMS (ESI) m/z calcd for C26H25NO7 [M+Na]+ 486.1523, 
found 486.1533; the ee value of the major isomer was 81%, tR (major) = 10.3 min and 
21.1 min, tR (minor) = 8.1 min and 9.3 min (Chiralcel IC, λ = 254 nm, 30% 





















A slightly brown solid; diastereomeric ratio is 71:29; 1H NMR (500 MHz, CDCl3) δ 7.79 
– 7.46 (m, 4H), 7.40 – 7.29 (m, 5H), 7.14 – 7.11 (m, 1H), 7.08 (s, 1H), 6.06 (s, 1H), 5.83 
(d, J = 10.3 Hz, 1H), 5.72 (d, J = 10.3 Hz, 1H), 5.17 (d, J = 12.2 Hz, 1H), 5.03 (d, J = 
12.2 Hz, 1H), 1.41 (s, 9H); 13C NMR (126 MHz, CDCl3) δ 168.41, 165.60, 155.29, 
145.24, 143.24, 140.63, 134.47, 130.49, 130.41, 128.51, 128.39, 128.21, 127.57, 125.94, 
122.64, 110.24, 109.01, 89.12, 84.68, 67.20, 52.99, 27.63; HRMS (ESI) m/z calcd for 
C26H25NO7 [M+Na]+ 486.1523, found 486.1539; the ee value of the major isomer was 
83%, tR (major) = 19.6 min and 37.7 min, tR (minor) = 7.5 min and 10.3 min (Chiralcel 












A slightly yellow solid; diastereomeric ratio is 86:14; 1H NMR (500 MHz, CDCl3) δ 7.97 
(s, 1H), 7.55 (dd, J = 8.1, 1.4 Hz, 1H), 7.42 (d, J = 8.1 Hz, 1H), 7.38 – 7.29 (m, 5H), 7.13 
– 6.96 (m, 5H), 6.08 (d, J = 10.2 Hz, 1H), 5.69 (d, J = 10.2 Hz, 1H), 5.16 (d, J = 12.2 Hz, 
1H), 5.01 (d, J = 12.2 Hz, 1H), 1.45 (s, 9H); 13C NMR (126 MHz, CDCl3) δ 167.17, 
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165.23, 155.22, 146.90, 135.98, 134.29, 133.84, 129.39, 128.84, 128.51, 128.40, 128.26, 
128.22, 127.90, 126.87, 126.52, 124.67, 88.71, 85.22, 67.28, 60.23, 27.70; HRMS (ESI) 
m/z calcd for C28H26BrNO6 [M+Na]+ 574.0836, found 574.0831; the ee value of the 
major isomer was 91%, tR (major) = 21.9 min and 33.8 min, tR (minor) = 6.3 min and 8.0 







A slightly yellow solid; diastereomeric ratio is 87:13; 1H NMR (500 MHz, CDCl3) δ 7.96 
(s, 1H), 7.55 (d, J = 8.0 Hz, 1H), 7.43 (d, J = 8.1 Hz, 1H), 7.39 – 7.30 (m, 5H), 7.01 – 
6.90 (m, 2H), 6.87 – 6.75 (m, 2H), 6.04 (d, J = 10.1 Hz, 1H), 5.64 (d, J = 10.2 Hz, 1H), 
5.16 (d, J = 12.2 Hz, 1H), 5.01 (d, J = 12.2 Hz, 1H), 2.17 (s, 3H), 1.45 (s, 9H); 13C NMR 
(126 MHz, CDCl3) δ 167.23, 165.29, 155.24, 147.01, 137.94, 136.04, 134.20, 133.76, 
129.26, 129.10, 128.73, 128.55, 128.51, 128.22, 128.11, 126.84, 126.63, 124.92, 124.71, 
88.75, 85.16, 67.25, 60.25, 27.71, 21.16; HRMS (ESI) m/z calcd for C29H28BrNO6 
[M+Na]+ 588.0992, found 588.0983; the ee value of the major isomer was 86%, tR (major) 
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= 20.0 min and 28.6 min, tR (minor) = 5.2 min and 6.7 min (Chiralcel AD-H, λ = 254 nm, 







A slightly yellow solid; diastereomeric ratio is 84:16; 1H NMR (500 MHz, CDCl3) δ 7.95 
(s, 1H), 7.59 (d, J = 8.1 Hz, 1H), 7.47 (d, J = 8.1 Hz, 1H), 7.37 – 7.29 (m, 5H), 7.10 (d, J 
= 8.3 Hz, 2H), 7.00 (d, J = 8.3 Hz, 2H), 6.06 (d, J = 10.0 Hz, 1H), 5.65 (d, J = 10.0 Hz, 
1H), 5.15 (d, J = 12.2 Hz, 1H), 5.01 (d, J = 12.2 Hz, 1H), 1.44 (s, 9H); 13C NMR (126 
MHz, CDCl3) δ 166.99, 165.06, 155.17, 146.64, 135.86, 134.49, 134.11, 133.02, 129.61, 
129.25, 128.99, 128.75, 128.53, 128.25, 127.15, 126.38, 124.57, 88.35, 85.43, 67.40, 
59.66, 27.69; HRMS (ESI) m/z calcd for C28H25BrClNO6 [M+Na]+ 608.0446, found 
608.0476; the ee value of the major isomer was 93%, tR (major) = 21.4 min and 53.9 min, 
tR (minor) = 8.0 min and 9.4 min (Chiralcel IA, λ = 254 nm, 30% iPrOH/hexanes, flow 












A slightly yellow solid; diastereomeric ratio is 85:15; 1H NMR (500 MHz, CDCl3) δ 7.95 
(s, 1H), 7.58 (dd, J = 8.1, 1.3 Hz, 1H), 7.47 – 7.22 (m, 6H), 7.09 – 7.01 (m, 2H), 6.82 (t, J 
= 8.6 Hz, 2H), 6.06 (d, J = 10.1 Hz, 1H), 5.66 (d, J = 10.0 Hz, 1H), 5.16 (d, J = 12.2 Hz, 
1H), 5.02 (d, J = 12.2 Hz, 1H), 1.45 (s, 9H); 13C NMR (126 MHz, CDCl3) δ 167.03, 
165.12, 162.47 (J = 248.4 Hz), 155.18, 146.77, 135.89, 134.02, 129.68, 129.62, 129.56, 
128.59, 128.53, 128.30, 128.25, 127.92, 127.05, 126.41, 124.61, 115.41, 115.24, 88.49, 
85.36, 67.37, 59.62, 27.70; HRMS (ESI) m/z calcd for C28H25BrFNO6 [M+Na]+ 
592.0741, found 592.0751; the ee value of the major isomer was 91%, tR (major) = 17.3 
min and 40.5 min, tR (minor) = 6.8 min and 8.8 min (Chiralcel IA, λ = 254 nm, 30% 
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A white solid; diastereomeric ratio is 87:13; 1H NMR (500 MHz, CDCl3) δ 8.09 (s, 1H), 
7.69 (d, J = 4.2 Hz, 2H), 7.40 – 7.29 (m, 5H), 7.18 – 7.04 (m, 3H), 7.02 (d, J = 3.6 Hz, 
2H), 6.07 (d, J = 10.1 Hz, 1H), 5.73 (d, J = 10.2 Hz, 1H), 5.16 (d, J = 12.2 Hz, 1H), 5.02 
(d, J = 12.2 Hz, 1H), 1.46 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 166.16, 164.73, 155.18, 
145.71, 135.87, 133.95, 129.26, 128.97, 128.63, 128.54, 128.45, 128.30, 128.09, 127.85, 
127.10, 126.58, 117.78, 117.16, 89.24, 85.83, 67.41, 60.30, 27.69; HRMS (ESI) m/z 
calcd for C29H26N2O6 [M+Na]+ 521.1683, found 521.1707; the ee value of the major 
isomer was 83%, tR (major) = 27.2 min and 32.3 min, tR (minor) = 5.7 min and 7.0 min 
(Chiralcel IA, λ = 254 nm, 30% iPrOH/hexanes, flow rate = 1.0 mL/min). 
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Chapter 4 Highly Diastereoselective and Enantioselective Direct 




Functionalized phthalides are structural motifs widely present in many natural 
products and therapeutically useful agents.151 Given their biological importance, various 
catalytic methods have been devised for the facile construction of chiral 3-substituted 
phthalides. The first catalytic asymmetric example was reported by Noyori through an 
enantioselective transfer hydrogenation reaction.152 Later, Butsugan and co-workers 
disclosed an approach utilizing a chiral amine alcohol-mediated addition of zinc reagent 
to aldehydes.153 A Ni(II)/(S)-BINAP complex catalyzed tandem (addition-cyclization) 
reaction was subsequently reported by Lin for the synthesis of halogen-substituted 
phthalides.154 Recently, Yamamoto described a Rh(I)-catalyzed one-pot four-component 
coupling method.155 Trost reported an elegant prophenol-promoted enantioselective 
alkynylation as the key step for the formation of enantioenriched phthalides.156 Very 
recently, Cheng devised a cobalt-catalyzed cocyclization reaction of 2-iodobenzoates 
with aldehydes to afford substituted phthalide derivatives in one pot.157 Other than 
organometallic catalysis, Wang recently developed an organocatalytic method through a 
sequential enantioselective aldol-lactonization reaction.158 Despite the above impressive 
achievements for the synthesis of chiral 3-monosubtituted phthalides, the preparation of 
its disubstituted derivatives bearing a quaternary stereogenic center is still a formidable 
task. The 3,3-disubstituted phthalides, however, are widely found in natural products and 
pharmaceutical agents (Scheme 4.1).159  In 2007, Tanaka described a rhodium-catalyzed 
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one-pot transesterification and [2 + 2 + 2] cycloaddition for the construction of 
enantioenriched 3,3-disubstituted phthalides.160 It is thus our goal to develop an efficient 



































Y5 receptor antagonists  
Scheme 4.1 Examples of the biologically important phthalide containing compounds 
 
We focused on the vinylogous Michael additions of phthalide derivatives (Scheme 
4.2). The method reported here should provide an easy route to access disubstituted 
phthalides, which are common structural motifs in bioactive molecules. The direct 
vinylogous reaction through organocatalytic method has been investigated intensively, 
and significant progress has been made. Recently, the direct vinylogous aldol reaction of 
furanone derivatives with aldehydes and -ketoesters was reported with high diastereo- 
and enantioselectivity.142-145 Later, the vinylogous Michael additions to -unsaturated 
ketones based on primany amine catalysts have also been studied.146-148 To further extend 
previous work on the vinylogous Mannich reaction of phthalide derivatives, we intend to 
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explore their applications in the conjugate additions to nitroolefins and chalcones 






















Scheme 4.2 Reaction design for the vinylogous Michael reaction 
 
 
4.2 Vinylogous Michael addition to nitrolefins 
4.2.1 Reaction optimization 
We first tested vinylogous Michael addition of phthalide derivative 4-1a to 
nitroolefins 4-2a as the model reaction, and various catalysts were screened (Scheme 4.3). 




























QD-1: R = Me















QD-5: R = i-Pr
QD-6: R = 1H-indolyl-3-methyl





























C-1: R = H
Q-1: R = OMe
 
Scheme 4.3 Catalysts screened in the vinylogous Michael addition to nitroolefins 
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The commercially available quinidine and 6’-demethylated quinidine led to poor 
enantioselectivity (entries 1-2). The quinidine derived thiourea catalyst QD-3, proven to 
be a powerful catalyst in a number of other enantioselective transformations, also led to 
poor enantioselectivity (entry 3). Quinidine-derived sulfonamide QD-4 and L-tryptophan 
derived catalyst Trp-1 were much less effective catalysts for this reaction (entries 4-5). 
We next turned to a series of trifunctional catalysts, which were reported by our group to 
be powerful catalysts in the conjugate addition of oxindoles to vinyl sulfone, and 
obtained promising results. When different amino acids were incorporated into quinidine, 
a marked increase in enantioselectivity was observed (entries 5-8), and the L-valine 
derived catalyst turned out to be the best (entry 6). Different solvents were then examined, 
and up to 81% ee was obtained when the reaction was carried out in DCE (entries 10-14). 
In order to further improve the enantioselectivity, quinine-derived trifunctional catalysts 
were screened (entries 15-17). It was found that the tert-leucine containing-quinine 
catalyst gave the best results. Under the optimized reaction conditions, the Michael 
adduct could be formed with 93% ee and an excellent diastereoselectivity (entry 17). 
 















Entry Solvent Catalyst Yield[b] dr[c] ee/%[d] 
1 CH2Cl2 QD-1 89 > 19:1 30 
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2 CH2Cl2 QD-2 91 > 19:1 25 
3 CH2Cl2 QD-3 90 > 19:1 33 
4 CH2Cl2 QD-4 < 50 - - 
5 CH2Cl2 Trp-1 93 > 19:1 11 
6 CH2Cl2 QD-5 92 > 19:1 73 
7 CH2Cl2 QD-6 90 > 19:1 70 
8 CH2Cl2 QD-7 88 > 19:1 73 
9 CH2Cl2 QD-8 85 > 19:1 -72 
10 toluene QD-5 92 > 19:1 63 
11 CHCl3 QD-5 91 > 19:1 66 
12 THF QD-5 82 > 19:1 39 
13 Et2O QD-5 88 > 19:1 56 
14 DCE QD-5 95 > 19:1 81 
15 DCE C-1 92 > 19:1 84 
16 DCE Q-1 92 > 19:1 88 
17[e] DCE Q-1 91 > 19:1 93 
[a] Reactions were carried out using 4-1a (0.05 mmol), 4-2a (0.06 mmol), catalyst (0.005 mmol), in 0.5 ml 
solvent at room temperature. [b] Yield of isolated product. [c] Determined by 1H NMR analysis. [d] 




4.2.2 Substrate scope 
With the best reaction conditions in hand, we next studied the scope of the reaction 
by employing different phthalides and nitroolefins (Table 4.2). Consistently high 
enantioselectivity and excellent diastereoselectivity were observed for a wide range of 
aromatic substituted nitroolefins (entries 1−12). Alkyl substituted substrate were also 
tolerated and the Michael adducts were formed virtually as one diastereomer with good 
enantioselectivity (entries 15-16). 
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R Q-1 (10 mol%)
DCE, RT, 30h




Entry R1 R 4-3 Yield/%[b] d.r[c] ee/%[d] 
1 H 4-MeC6H4 4-3b 89 > 19:1 93 
2 H 2-naphthyl 4-3c 86 > 19:1 87 
3 H 1-naphthyl 4-3d 91 > 19:1 85 
4 H 3,4-OMeC6H3  4-3e 85 > 19:1 88 
5 H 4-BrC6H4  4-3f 93 > 19:1 91 
6 H 3-BrC6H4 4-3g 82 > 19:1 91 
7 H 2-BrC6H4 4-3h 83  > 19:1 86 
8 H 4-ClC6H4 4-3i 87 > 19:1 93 
9 H 2-ClC6H4 4-3j 86 > 19:1 98 
10 H 4-FC6H4  4-3k 93 > 19:1 92 
11 H 2-FC6H4  4-3l 91 > 19:1 92 
12 H 4-CNC6H4  4-3m 85 > 19:1 97 
13 H 3-CNC6H4  4-3n 87 > 19:1 92 
14 H 2-furan 4-3o 90 > 19:1 92 
15[e] H n-propanyl  4-3p 81  > 19:1 80 
16[e] H i-butyl 4-3q 65  > 19:1 81 
17 5-Br Ph 4-3r 90 > 19:1 98 
a Reactions were carried out using 4-1 (0.05 mmol), 4-2 (0.06 mmol), catalyst (0.005 mmol) in 2.5 ml solvent 
at room temperature. b Isolated yield c Determined by chiral HPLC analysis. d Reaction time is 60h. 
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4.2.3 Synthetic manipulations 
The vinylogous Michael reaction described here represents a novel asymmetric 
preparation of chiral phthalides which are of biological significance. In addition, the 
Michael products are versatile chiral building blocks, and their synthetic values are 
illustrated in Scheme 4.4. Treatment of compound 4-3a with TFA followed by 
methylation gave intermediate 4-4, which could be easily transformed to a bicyclic latam 





















4-3a 4-4 4-5  




In conclusion, we have developed a novel vinylogous Michael addition of phthalide 
derivative to nitroolefins, catalyzed by a quinine-derived trifunctional catalyst. The 
Michael product was obtained in high yield with virtually one diastereomer and excellent 
enantioselectivity.  The described synthetic method provides an easy access to 
biologically important substituted phthalides and it could be easily transformed into a 
bicyclic lactam.  
4.3 Vinylogous Michael addition to chalcones 
4.3.1 Reaction optimization 
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4.3.1.1 Iminium activation 
We initially selected the vinylogous Michael addition of phthalide derivative to -
unsaturated ketone as the model reaction, employing quinidine derived primary amine as 
the catalyst. It is believed that -unsaturated ketone was activated through iminium 
formation with the primary amine in the catalyst (Table 4.3). The reaction could be 
complete in one day without any additive, however, the product was obtained as a 
racemic mixture (entry 1). Different acid additives did not induce high enantioselectivity 
and chemical yield (entries 2-7).  
 
Table 4.3  Initial screening results employing primary amine as the catalyst[a] 
 
 
entry R additive time conersion[b] d.r[c] ee/%[d] 
1  Ph - 1d >90% > 19:1 0 
2  Ph (+)-CSA 4d <50% > 19:1 60 
3  Ph  (-)-CSA  4d <50% > 19:1 53 
4 Ph  TFA  4d <50% > 19:1 - 
5 Me (+)-CSA 4d <50% > 19:1 - 
6 Me (-)-CSA  4d <50% > 19:1 - 
7 Me TFA  4d <50% > 19:1 - 
[a] Reactions were carried out using 4-1a (0.05 mmol), ketone (0.06 mmol), catalyst (0.01 mmol), in 0.3 ml 
solvent at room temperature. [b] Yield of isolated product. [c] Determined by 1H NMR analysis. [d] 
Determined by chiral HPLC analysis. 
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4.3.1.2 Base-catalyzed method 
    It seems that the iminium activation could not effect the vinylogous Michael reaction 
of phthalide dirivatives in a stereoselective manner. We next screened different 
bifunctional and trifunctional catalysts (Scheme 4.5), and the results are shown in Table 
4.4.  
 
Scheme 4.5 Catalysts screened in the vinylogous Michael addition to chalcones 
When L-tryptophan derived thiourea catalyst was employed, the vinylogous Michael 
reaction could be complete around one day to afford the product with 80% ee (entry 1). 
Natural quinidine as well as quinidine-derived sulfonamide catalyst failed to give better 
results (entries 2-3). A series of cinchona derived thiourea and squaramide catalysts were 
then synthesized and employed in the reaction (entries 4-8). Among them, the quinine 
derived catalyst Q-1 gave the best result. The product was formed as a single 
diastereomer and with 88% ee (entry 6). We also tested cinchona derived trifuctional 
catalyst, which did not further improve the results (entries 9-10). 
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4-1a 4-6a 4-7a  
entry catalyst time/h conersion[b] d.r[c] ee/%[d] 
1 Trp-1 30h > 95 % > 19:1 80 
2 QD-1 30h > 95 % > 19:1 -77 
3 QD-2 30h < 50% - - 
4 QD-3 30h > 95 % > 19:1 -80 
5 C-1 30h > 95 % > 19:1 -80 
6 Q-1 30h > 95 % > 19:1 88 
7 CD-1 30h > 95 % > 19:1 86 
8 Q-2 30h > 95 % > 19:1 82 
9 QD-4 30h > 95 % > 19:1 -23 
10 QD-5 30h > 95 % > 19:1 -53 
[a] Reactions were carried out using 4-1a (0.05 mmol), 4-6a (0.06 mmol), catalyst (0.01 mmol), in 0.3 ml 
solvent at room temperature. [b] Yield of isolated product. [c] Determined by 1H NMR analysis. [d] 
Determined by chiral HPLC analysis. 
 
   Further screening on the solvent and additive were then preformed (Table 4.5). The 
reaction was carried out in different solvent, with Q-2 as the catalyst (entries 1-8). 
Compared to dichloromethane, toluene gave slightly better result with 85% ee (entry 1). 
Chloroform, dichloroethane, and polar solvent THF and ether, failed to yield better 
selectivity (entries 2-5). Running the reaction in a number of other aromatic 
hydrocarbons did not offer further improvement (entries 6-8).  
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   However, the combination of Q-1 and toluene did not turn out to be fruitful, the 
results were inferior to employing Q-1 in CH2Cl2 (entry 9). With the addition of 4Å 
molecular sieves, performing the reaction in the presence of Q-1 in CH2Cl2 was found to 
be the best reaction conditions (entry 11). 
 














4-1a 4-6a 4-7a  
entry cat solvent time/h conversion/%[b] d.r[c] ee/%[d] 
1  Q-2 toluene  30h > 95 % > 19:1 85 
2  Q-2 CHCl3 48h > 95 % > 19:1 67 
3  Q-2 ClCH2CH2Cl 30h > 95 % > 19:1 83 
4  Q-2 THF 30h > 95 % > 19:1 28 
5  Q-2 Et2O  48h > 95 % > 19:1 66 
6 Q-2 p-F-toluene 30h > 95 % > 19:1 80 
7 Q-2 p-CF3-toluene 30h > 95 % > 19:1 80 
8 Q-2 mesitylene 30h > 95 % > 19:1 81 
9 Q-1 toluene 30h > 95 % > 19:1 82 
10[e] Q-1 CH2Cl2 30h > 95 % > 19:1 90 
11[f] Q-1 CH2Cl2 30h > 95 % > 19:1 92 
12[g] Q-1 CH2Cl2 30h > 95 % > 19:1 88 
[a] Reactions were carried out using 4-1a (0.05 mmol), 4-6a (0.06 mmol), catalyst (0.01 mmol), in 0.3 ml 
solvent at room temperature. [b] Yield of isolated product. [c] Determined by 1H NMR analysis. [d] 
Determined by chiral HPLC analysis. [e] With 3Å molecular sieves. [f] With 4Å molecular sieves. [g] With 5Å 
molecular sieves. 
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4.3.2 Substrate scope 
With the best reaction conditions in hand, we next studied the substrate scope (Table 
4.6). A wide range of chalcones were employed in the Q-1-promoted organocatalytic 
Michael reactions, and the Michael adducts were obtained in high yield with virtually 
single diastereomers and and excellent enantioselectivities. 
 
















4-1a 4-6b to 4-6n 4-7b to 4-7n  
entry R1/R2 4-7 yield/%[b]  d.r.[c] ee/%[d]  
1  4-BrPh/Ph 4-7b 87 > 19:1 88 
2  3-NO2Ph/Ph 4-7c 92 > 19:1 86 
3  4-MeOPh/Ph 4-7d 85 > 19:1 97 
4  2-FPh/Ph 4-7e 86 > 19:1 93 
5  3-ClPh/Ph 4-7f 88 > 19:1 90 
6 3-MeOPh/Ph 4-7g 87 > 19:1 91 
7 2-naphthyl/Ph 4-7h 89 > 19:1 81 
8 2-ClPh/Ph  4-7i 91 > 19:1 92 
9 Ph/4-NO2Ph  4-7j 93 > 19:1 85 
10 3-MePh/Ph 4-7k 85 > 19:1 89 
11 2-thiophenyl/Ph 4-7l 86 > 19:1 91 
12 3-BrPh/Ph  4-7m 89 > 19:1 87 
13 1-naphthyl/Ph  4-7n 81 > 19:1 84 
[a] Reactions were carried out using 4-1a (0.05 mmol), 4-6 (0.06 mmol), catalyst (0.01 mmol), in 0.3 ml 
solvent at room temperature. [b] Yield of isolated product. [c] Determined by 1H NMR analysis. [d] 
Determined by chiral HPLC analysis. 
 




In conclusion, we have developed a novel vinylogous Michael addition of phthalide 
derivative to chalcones, catalyzed by a quinine-derived thiourea catalyst. The Michael 
products were obtained in high yields with virtually one diastereomer and excellent 
enantioselectivity. The method reported here provided a convenient method to access 
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4.4 Experimental section 
4.4.1 Vinylogous addition to nitroolefins 
4.4.1.1 General information 
1H and 13C NMR spectra were recorded on a Bruker ACF300 or DPX300 (300 MHz) 
or AMX500 (500 MHz) spectrometer. Chemical shifts were reported in parts per million 
(ppm), and the residual solvent peak was used as an internal reference. Multiplicity was 
indicated as follows: s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), dd 
(doublet of doublet), br s (broad singlet). Coupling constants were reported in Hertz (Hz). 
Low resolution mass spectra were obtained on a Finnigan/MAT LCQ spectrometer in ESI 
mode, and a Finnigan/MAT 95XL-T mass spectrometer in FAB mode. All high 
resolution mass spectra were obtained on a Finnigan/MAT 95XL-T spectrometer. Flash 
chromatography separation was performed on Merck 60 (0.040 - 0.063 mm) mesh silica 
gel. 
The enantiomeric excesses of products were determined by chiral-phase HPLC 
analysis, using a Daicel Chiralcel AD-H column (250 x 4.6 mm), or Chiralpak IB column, 
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4.4.1.2 Representative procedure 
Addition of tert-butyl 3-oxo-1,3-dihydroisobenzofuran-1-carboxylate 4-1a with (E)-(2-






To a solution of tert-butyl 3-oxo-1,3-dihydroisobenzofuran-1-carboxylate 4-1a (11.7 mg, 
0.05 mmol), (E)-(2-nitrovinyl)benzene 4-2a (8.9 mg, 0.06 mmol) in dichloroethane (0.5 
mL) was added Q-2 (3.5 mg, 0.005 mmol) at room temperature. The resulting mixture 
stirred for 30h, and the residue was purified by flash column chromatography 
(hexane/AcOEt = 10/1 as eluent) to afford vinylgous michael product 4-3a (17.4 mg, 
91% yield). The diastereomeric ratio was determined by crude NMR analysis and the 
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4.4.1.3 X-ray cryatllographic analysis of 4-3f 
 
 
Figure 4.1 ORTEP structure of Michael adduct 4-3f 
 
Table   Crystal data and structure refinement. 
Identification code  A613 
Empirical formula  C21 H20 Br N O6 
Formula weight  462.29 
Temperature  223(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1) 
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 b = 10.1806(6) Å = 91.922(2)°. 
 c = 15.1958(9) Å  = 90°. 
Volume 2179.6(2) Å3 
Z 4 
Density (calculated) 1.409 Mg/m3 
Absorption coefficient 1.921 mm-1 
F(000) 944 
Crystal size 0.70 x 0.24 x 0.12 mm3 
Theta range for data collection 1.94 to 27.49°. 
Index ranges -15<=h<=18, -13<=k<=13, -19<=l<=19 
Reflections collected 15450 
Independent reflections 9245 [R(int) = 0.0384] 
Completeness to theta = 27.49° 99.6 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.8022 and 0.3465 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 9245 / 33 / 539 
Goodness-of-fit on F2 0.972 
Final R indices [I>2sigma(I)] R1 = 0.0552, wR2 = 0.1119 
R indices (all data) R1 = 0.0916, wR2 = 0.1254 
Absolute structure parameter 0.017(8) 
Largest diff. peak and hole 0.779 and -0.317 e.Å-3 
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To a solution of 4-3a (38 mg, 0.1 mmol) in CH2Cl2 (0.5 mL) at 0 oC was added slowly 
TFA (0.1 mL). The reaction mixture was allowed to warm to room temperature and 
stirred for 10 hours. The solvent was removed, and the crude 4-4a was obtained as a 
white solid, which was used directly in the next reaction without further purification. 
 
A white solid; 1H NMR (500 MHz, CDCl3) δ7.77 – 7.70 (m, 1H), 7.69 – 7.67 (br, 1H), 
7.66 – 7.53 (m, 2H), 7.38 (t, J = 7.5 Hz, 1H), 7.06 (s, 5H), 5.17 (dd, J = 13.3, 10.8 Hz, 
1H), 5.06 (dd, J = 13.4, 3.8 Hz, 1H), 4.75 (dd, J = 10.5, 4.0 Hz, 1H); 13C NMR (126 MHz, 
CDCl3) δ 170.65, 168.81, 154.21, 145.49, 134.78, 131.69, 130.56, 128.93, 128.61, 125.84, 
124.97, 123.06, 87.46, 75.79, 49.30; HRMS (ESI) m/z calcd for C17H13NO6 [M+Na]+ 
350.0636, found 350.0647. 
 











TMSCHN2 (0.10 mL, 2 M in hexane, 0.2 mmol) was added dropwise to a solution of 4-
4a in MeOH (1.0 mL) at 0 °C, and the mixture was stirred for another 0.5 h at the same 
temperature. Water was then added to the mixture, and the layers were separated. The 
aqueous phase was extracted with CH2Cl2 twice, and the combined organic extracts were 
washed with water and brine, and dried with MgSO4. After filtration, the solvent was 
removed and the residue was purified by flash column chromatography on silica 
(hexane/EtOAc = 5/1 as eluent) to afford 4-4 (17.7 mg, 52%) as a white solid. 
 
A white solid; 1H NMR (500 MHz, CDCl3) δ 7.70 – 7.56 (m, 3H), 7.39 (t, J = 7.4 Hz, 
1H), 7.13 – 6.97 (m, 5H), 5.10 (dd, J = 13.4, 10.3 Hz, 1H), 4.94 (dd, J = 13.5, 4.4 Hz, 
1H), 4.72 (dd, J = 10.2, 4.4 Hz, 1H), 3.85 (s, 3H); 13C NMR (126 MHz, CDCl3) δ 168.48, 
168.24, 153.88, 145.70, 134.44, 131.94, 130.38, 128.92, 128.60, 128.56, 125.81, 122.72, 
87.36, 75.91, 53.91, 49.29; [α]Drt = -86.3 (c = 0.90, CHCl3); HRMS (ESI) m/z calcd for 














To a solution of 4-4 (17.7 mg, 0.05 mmol) in ethanol (0.5 mL), Zn (65 mg, 0.25 mmol) 
and acetic acid (0.1 mL) were added. After stirring at 50 oC for 12 h, the reaction mixture 
was cooled to room temperature, and saturated NH4Cl was added. The aqueous phase 
was extracted with CH2Cl2 twice, and the combined organic extracts were washed with 
brine, and dried with MgSO4. After filtration, the solvent was removed and the residue 
was purified by flash column chromatography on silica (hexane/EtOAc = 3/1 as eluent) 
to afford 4-5 (13.3 mg, 92%) as a white solid. 
 
A white solid; 1H NMR (500 MHz, CDCl3) δ 7.83 – 7.73 (m, 2H), 7.68 – 7.51 (m, 2H), 
7.24 - 7.15 (m, 3H), 7.15 – 7.05 (m, 2H), 6.48 (s, 1H), 4.12 – 3.97 (m, 2H), 3.85 (t, J = 
7.3 Hz, 1H); 13C NMR (126 MHz, CDCl3) δ 171.03, 168.24, 146.05, 134.59, 131.95, 
130.19, 129.15, 128.52, 128.34, 127.27, 125.99, 121.83, 87.48, 51.39, 45.00; HRMS (ESI) 
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A white solid; 1H NMR (500 MHz, CDCl3) δ 7.69 – 7.55 (m, 3H), 7.43 – 7.33 (m, 1H), 
7.08 – 7.02 (m, 5H), 5.12 (dd, J = 13.3, 10.7 Hz, 1H), 4.91 (dd, J = 13.3, 3.9 Hz, 1H), 
4.69 (dd, J = 10.6, 3.9 Hz, 1H), 1.49 (s, 9H)；13C NMR (75 MHz, CDCl3) δ 168.52, 
166.39, 146.08, 134.23, 132.15, 130.16, 128.92, 128.52, 128.44, 125.75, 122.44, 122.32, 
87.73, 85.30, 76.04, 49.20, 27.73; [α]Drt = -64.5 (c = 0.87, CHCl3); HRMS (ESI) m/z 
calcd for C21H21NO6 [M+Na]+ 406.1261, found 406.1269; the ee value of the major 
isomer was 94%, tR = 22.4 min and 24.0 min (Chiralcel IC, λ = 220 nm, 15% 
















A white solid; 1H NMR (500 MHz, CDCl3) δ 7.61 (ddt, J = 7.2, 6.2, 3.8 Hz, 3H), 7.43 – 
7.35 (m, 1H), 6.92 (d, J = 8.1 Hz, 2H), 6.85 (d, J = 8.0 Hz, 2H), 5.09 (dd, J = 13.2, 10.7 
Hz, 1H), 4.89 (dd, J = 13.2, 3.9 Hz, 1H), 4.64 (dd, J = 10.7, 3.9 Hz, 1H), 2.12 (s, 3H), 
1.48 (s, 9H); 13C NMR (126 MHz, CDCl3) δ 168.62, 166.46, 146.19, 138.22, 134.20, 
130.13, 129.24, 128.93, 128.76, 125.78, 125.36, 122.32, 87.84, 85.22, 76.17, 48.93, 27.74, 
20.90; [α]Drt = -80.0 (c = 0.53, CHCl3); HRMS (ESI) m/z calcd for C22H23NO6 [M+Na]+ 
420.1418, found 420.142; the ee value of the major isomer was 93%, tR = 24.1 min and 













A white solid; 1H NMR (500 MHz, CDCl3) δ 8.25 (d, J = 8.7 Hz, 1H), 7.62 (d, J = 8.0 Hz, 
1H), 7.59 – 7.45 (m, 5H), 7.39 (t, J = 7.5 Hz, 1H), 7.27 (dd, J = 9.9, 5.6 Hz, 1H), 7.16 
(tdd, J = 14.8, 10.6, 4.2 Hz, 2H), 5.92 (dd, J = 10.1, 4.2 Hz, 1H), 5.23 (dd, J = 13.5, 10.1 
Hz, 1H), 5.10 (dd, J = 13.5, 4.1 Hz, 1H), 1.51 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 
168.82, 166.75, 145.34, 133.58, 133.53, 131.93, 130.00, 129.27, 129.13, 128.79, 126.43, 
125.71, 125.19, 125.12, 125.08, 125.02, 122.56, 122.31, 88.13, 85.35, 76.88, 41.06, 27.73; 
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[α]Drt = -68.7 (c = 0.86, CHCl3); HRMS (ESI) m/z calcd for C25H23NO6 [M+Na]+ 
456.1418, found 456.1436; the ee value of the major isomer was 87%, tR = 27.9 min and 








A white solid; 1H NMR (500 MHz, CDCl3) δ 7.73 – 7.44 (m, 7H), 7.43 – 7.34 (m, 2H), 
7.28 (dd, J = 15.5, 7.9 Hz, 1H), 7.17 (dd, J = 8.5, 1.7 Hz, 1H), 5.24 (dd, J = 13.3, 10.7 Hz, 
1H), 4.99 (dd, J = 13.3, 3.8 Hz, 1H), 4.88 (dd, J = 10.7, 3.8 Hz, 1H), 1.50 (s, 9H); 13C 
NMR (126 MHz, CDCl3) δ 168.51, 166.44, 146.00, 134.23, 132.80, 130.21, 129.74, 
128.70, 128.44, 127.90, 127.42, 126.45, 126.32, 125.95, 125.82, 125.22, 122.27, 122.06, 
87.86, 85.35, 76.24, 49.25, 27.74; [α]Drt = +29.5 (c = 0.73, CHCl3); HRMS (ESI) m/z 
calcd for C25H23NO6 [M+Na]+ 456.1418, found 456.1430; the ee value of the major 
isomer was 85%, tR = 30.6 min and 34.3 min (Chiralcel IC, λ = 220 nm, 15% 
iPrOH/hexanes, flow rate = 1.0 mL/min). 
 
 















A white solid; 1H NMR (500 MHz, CDCl3) δ 7.61 (dq, J = 14.9, 7.6 Hz, 3H), 7.43 – 7.36 
(m, 1H), 6.59 (dd, J = 8.3, 2.0 Hz, 1H), 6.53 (dd, J = 5.1, 3.1 Hz, 2H), 5.07 (dd, J = 13.1, 
10.8 Hz, 1H), 4.88 (dd, J = 13.1, 3.9 Hz, 1H), 4.61 (dd, J = 10.7, 3.9 Hz, 1H), 3.71 (s, 
3H), 3.70 (s, 3H), 1.49 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 168.68, 166.38, 148.86, 
148.62, 146.20, 134.16, 130.20, 125.88, 125.33, 124.24, 122.22, 121.72, 111.44, 110.77, 
87.86, 85.26, 76.22, 55.77, 55.57, 49.01, 27.73; [α]Drt = -52.1 (c = 0.75, CHCl3); HRMS 
(ESI) m/z calcd for C23H25NO8 [M+Na]+ 466.1472, found 466.1478; the ee value of the 
major isomer was 88%, tR = 30.2 min and 40.3 min (Chiralcel IC, λ = 220 nm, 25% 
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A white solid; 1H NMR (500 MHz, CDCl3) δ 7.67 – 7.56 (m, 3H), 7.47 – 7.39 (m, 1H), 
7.20 (d, J = 8.5 Hz, 2H), 6.94 (d, J = 8.5 Hz, 2H), 5.07 (dd, J = 13.4, 10.9 Hz, 1H), 4.90 
(dd, J = 13.4, 3.8 Hz, 1H), 4.66 (dd, J = 10.8, 3.8 Hz, 1H), 1.47 (s, 9H); 13C NMR (126 
MHz, CDCl3) δ 168.32, 166.19, 145.79, 134.48, 131.79, 131.25, 130.49, 130.47, 126.08, 
125.20, 122.80, 122.10, 87.33, 85.53, 75.82, 48.65, 27.72; [α]Drt = -64.5 (c = 0.87, 
CHCl3); [α]Drt = -84.1 (c = 0.43, CHCl3); HRMS (ESI) m/z calcd for C21H20BrNO6 
[M+Na]+ 484.0366, found 484.0389; the ee value of the major isomer was 91%, tR = 19.1 









A white solid; 1H NMR (500 MHz, CDCl3) δ 7.69 – 7.59 (m, 3H), 7.47 – 7.40 (m, 1H), 
7.23 – 7.14 (m, 2H), 7.06 (d, J = 7.9 Hz, 1H), 6.97 (t, J = 7.9 Hz, 1H), 5.08 (dd, J = 13.5, 
10.6 Hz, 1H), 4.91 (dd, J = 13.5, 3.8 Hz, 1H), 4.65 (dd, J = 10.6, 3.8 Hz, 1H), 1.48 (s, 
9H); 13C NMR (126 MHz, CDCl3) δ 168.27, 166.14, 145.72, 134.53, 134.46, 132.58, 
131.69, 130.48, 130.12, 126.89, 126.00, 125.19, 122.47, 122.21, 87.37, 85.57, 75.69, 
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48.77, 27.73; [α]Drt = -17.7 (c = 0.64, CHCl3); HRMS (ESI) m/z calcd for C21H20BrNO6 
[M+Na]+ 484.0366, found 484.0379; the ee value of the major isomer was 91%, tR = 9.4 









A white solid; 1H NMR (500 MHz, CDCl3) δ 7.90 (d, J = 7.8 Hz, 1H), 7.65 – 7.54 (m, 
2H), 7.43 – 7.27 (m, 3H), 7.14 (t, J = 7.6 Hz, 1H), 6.93 (td, J = 7.8, 1.6 Hz, 1H), 5.65 (dd, 
J = 10.3, 4.0 Hz, 1H), 5.03 (dd, J = 13.3, 10.3 Hz, 1H), 4.94 (dd, J = 13.4, 4.1 Hz, 1H), 
1.50 (s, 9H); 13C NMR (126 MHz, CDCl3) δ 168.57, 166.04, 145.22, 134.08, 133.43, 
132.88, 130.43, 129.95, 128.11, 128.06, 126.12, 125.45, 125.10, 123.10, 88.03, 85.42, 
76.45, 46.02, 27.71; HRMS (ESI) m/z calcd for C21H20BrNO6 [M+Na]+ 484.0366, found 
484.0376; the ee value of the major isomer was 86%, tR = 27.6 min and 31.1 min 
(Chiralcel IC, λ = 220 nm, 15% iPrOH/hexanes, flow rate = 1.0 mL/min). 
 
 














A white solid; 1H NMR (500 MHz, CDCl3) δ 7.67 – 7.56 (m, 3H), 7.47 – 7.39 (m, 1H), 
7.02 (dd, J = 23.7, 8.5 Hz, 4H), 5.07 (dd, J = 13.3, 10.9 Hz, 1H), 4.90 (dd, J = 13.4, 3.8 
Hz, 1H), 4.67 (dd, J = 10.8, 3.8 Hz, 1H), 1.48 (s, 9H); 13C NMR (126 MHz, CDCl3) δ 
168.33, 166.21, 145.83, 134.60, 134.46, 130.72, 130.45, 130.20, 128.84, 126.06, 125.22, 
122.11, 87.42, 85.52, 75.88, 48.61, 27.72; [α]Drt = -87.3 (c = 0.70, CHCl3); HRMS (ESI) 
m/z calcd for C21H20ClNO6 [M+Na]+ 440.0871, found 440.0890; the ee value of the 
major isomer was 93%, tR = 18.9 min and 20.9 min (Chiralcel IC, λ = 220 nm, 15% 
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A white solid; 1H NMR (500 MHz, CDCl3) δ 7.82 (d, J = 7.8 Hz, 1H), 7.64 – 7.54 (m, 
2H), 7.43 – 7.32 (m, 2H), 7.14 – 7.05 (m, 2H), 7.05 – 6.97 (m, 1H), 5.64 (dd, J = 10.4, 
4.0 Hz, 1H), 5.04 (dd, J = 13.4, 10.4 Hz, 1H), 4.95 (dd, J = 13.5, 4.0 Hz, 1H), 1.50 (s, 
9H); 13C NMR (75 MHz, CDCl3) δ 168.59, 166.09, 145.25, 134.87, 134.12, 131.02, 
130.43, 129.96, 129.69, 128.06, 127.41, 125.45, 125.06, 122.81, 87.92, 85.42, 76.20, 
43.24, 27.70; [α]Drt = -16.1 (c = 0.56, CHCl3); HRMS (ESI) m/z calcd for C21H20ClNO6 
[M+Na]+ 440.0871, found 440.0881; the ee value of the major isomer was 99%, tR = 24.4 









A white solid; 1H NMR (500 MHz, CDCl3) δ 7.67 – 7.56 (m, 3H), 7.49 – 7.35 (m, 1H), 
7.04 (dd, J = 8.4, 5.2 Hz, 2H), 6.76 (t, J = 8.5 Hz, 2H), 5.08 (dd, J = 13.2, 11.0 Hz, 1H), 
4.90 (dd, J = 13.3, 3.8 Hz, 1H), 4.68 (dd, J = 10.8, 3.8 Hz, 1H), 1.48 (s, 9H); 13C NMR 
(126 MHz, CDCl3) δ 168.38, 166.26, 162.46 (J = 248.8 Hz), 145.94, 134.41, 130.65, 
130.58, 130.35, 127.96, 125.95, 125.25, 122.15, 115.73, 115.55, 87.55, 85.46, 76.02, 
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48.54, 27.72; [α]Drt = -77.3 (c = 0.66, CHCl3); HRMS (ESI) m/z calcd for C21H20FNO6 
[M+Na]+ 424.1167, found 424.1184; the ee value of the major isomer was 92%, tR = 17.7 















A white solid; 1H NMR (500 MHz, CDCl3) δ 7.76 – 7.68 (m, 1H), 7.61 (t, J = 7.3 Hz, 
2H), 7.41 (t, J = 7.5 Hz, 1H), 7.34 – 7.19 (m, 1H), 7.05 (dd, J = 13.8, 6.6 Hz, 1H), 6.96 (t, 
J = 7.6 Hz, 1H), 6.77 – 6.68 (m, 1H), 5.28 (dd, J = 10.6, 3.9 Hz, 1H), 5.10 (dd, J = 13.4, 
10.8 Hz, 1H), 4.94 (dd, J = 13.6, 3.9 Hz, 1H), 1.49 (s, 9H); 13C NMR (126 MHz, CDCl3) 
δ 168.49, 166.09, 160.17 (J = 247.9 Hz), 145.63, 134.31, 130.37, 130.33, 130.27, 128.17, 
125.50, 125.13, 124.57, 124.54, 122.43, 122.41, 115.52, 115.33, 87.59, 85.44, 75.27, 
40.14, 27.72; [α]Drt = -84.7 (c = 0.86, CHCl3); HRMS (ESI) m/z calcd for C21H20FNO6 
[M+Na]+ 424.1167, found 424.1180; the ee value of the major isomer was 92%, tR = 14.9 
min and 16.4 min (Chiralcel IB, λ = 220 nm, 3% iPrOH/hexanes, flow rate = 1.0 
mL/min). 







A white solid; 1H NMR (500 MHz, CDCl3) δ 7.65 – 7.60 (m, 3H), 7.46 – 7.41 (m, 1H), 
7.37 (d, J = 8.2 Hz, 2H), 7.20 (d, J = 8.2 Hz, 2H), 5.11 (dd, J = 13.3, 10.8 Hz, 1H), 4.94 
(dd, J = 13.3, 3.8 Hz, 1H), 4.75 (dd, J = 10.7, 3.8 Hz, 1H), 1.47 (s, 9H); 13C NMR (126 
MHz, CDCl3) δ 168.01, 165.92, 145.43, 137.71, 134.67, 132.23, 130.69, 129.72, 126.19, 
126.19, 125.02, 121.99, 117.79, 122.69, 86.99, 85.85, 75.40, 48.97, 27.69; [α]Drt = -121.2 
(c = 0.58, CHCl3); HRMS (ESI) m/z calcd for C22H20N2O6 [M+Na]+ 431.1214, found 
431.1225; the ee value of the major isomer was 97%, tR = 25.3 min and 36.2 min 
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A white solid; 1H NMR (500 MHz, CDCl3) δ 7.72 – 7.60 (m, 3H), 7.49 – 7.35 (m, 3H), 
7.31 – 7.22 (m, 2H), 5.12 (dd, J = 13.7, 10.9 Hz, 1H), 4.95 (dd, J = 13.7, 3.8 Hz, 1H), 
4.73 (dd, J = 10.9, 3.8 Hz, 1H), 1.48 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 167.98, 
165.89, 145.43, 134.82, 134.03, 133.21, 132.33, 132.21, 130.72, 129.58, 126.16, 124.99, 
122.00, 117.71, 112.79, 87.00, 85.87, 75.37, 48.68, 27.70; [α]Drt = -64.5 (c = 0.87, 
CHCl3); [α]Drt = -62.4 (c = 0.80, CHCl3); HRMS (ESI) m/z calcd for C22H20N2O6 
[M+Na]+ 431.1214, found 431.1226; the ee value of the major isomer was 92%, tR = 52.3 















A white solid; 1H NMR (500 MHz, CDCl3) δ 7.75 – 7.60 (m, 3H), 7.53 – 7.46 (m, 1H), 
7.03 (d, J = 0.8 Hz, 1H), 6.07 – 6.01 (m, 2H), 5.03 (dd, J = 13.2, 10.4 Hz, 1H), 4.88 (dd, 
J = 10.4, 3.6 Hz, 1H), 4.81 (dd, J = 13.2, 3.6 Hz, 1H), 1.47 (s, 9H); 13C NMR (126 MHz, 
CDCl3) δ 168.36, 165.85, 146.53, 145.61, 142.99, 134.30, 130.41, 125.76, 125.25, 122.55, 
110.37, 109.94, 87.01, 85.43, 74.50, 43.56, 27.72; [α]Drt = -48.3 (c = 0.52, CHCl3); 
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HRMS (ESI) m/z calcd for C19H19NO7 [M+Na]+ 396.1054, found 396.1063; the ee value 
of the major isomer was 92%, tR = 12.5 min and 14.6 min (Chiralcel IB, λ = 220 nm, 5% 








A white solid; 1H NMR (500 MHz, CDCl3) δ 7.92 (d, J = 7.9 Hz, 1H), 7.74 (t, J = 7.5 Hz, 
1H), 7.62 (dt, J = 7.3, 3.5 Hz, 2H), 4.67 (dd, J = 13.8, 4.0 Hz, 1H), 4.49 (dd, J = 13.8, 6.9 
Hz, 1H), 3.48 (qd, J = 8.2, 4.0 Hz, 1H), 1.42 (s, 9H), 1.39 – 0.95 (m, 5H), 0.95 – 0.87 (m, 
1H), 0.69 (t, J = 6.9 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 168.79, 166.40, 146.31, 
134.73, 130.61, 126.23, 125.72, 122.26, 89.04, 85.11, 76.42, 42.29, 28.71, 27.60, 27.17, 
22.34, 13.52; [α]Drt = -62.5 (c = 0.59, CHCl3); HRMS (ESI) m/z calcd for C19H25NO6 
[M+Na]+ 386.1574, found 386.1580; the ee value of the major isomer was 80%, tR = 9.0 


















A white solid; 1H NMR (500 MHz, CDCl3) δ 7.92 (d, J = 7.7 Hz, 1H), 7.74 (t, J = 7.5 Hz, 
1H), 7.62 (dd, J = 14.8, 7.6 Hz, 2H), 4.70 (dd, J = 13.6, 4.5 Hz, 1H), 4.43 (dd, J = 13.6, 
6.0 Hz, 1H), 3.58 – 3.49 (m, 1H), 1.42 (s, 9H), 1.37 – 1.27 (m, 1H), 1.15 (ddd, J = 14.2, 
9.6, 4.5 Hz, 1H), 0.73 (dd, J = 13.5, 6.5 Hz, 6H), 0.67 – 0.57 (m, 1H); 13C NMR (126 
MHz, CDCl3) δ 168.76, 166.43, 146.36, 134.69, 130.62, 126.22, 125.85, 122.24, 89.12, 
85.16, 76.89, 40.52, 36.70, 27.60, 25.17, 23.21, 21.34; [α]Drt = -56.3 (c = 0.77, CHCl3); 
HRMS (ESI) m/z calcd for C19H25NO6 [M+Na]+ 386.1574, found 386.1583; the ee value 
of the major isomer was 81%, tR = 18.0 min and 20.3 min (Chiralcel IC, λ = 220 nm, 15% 



















A white solid; 1H NMR (500 MHz, CDCl3) δ 7.80 (s, 1H), 7.51 (dd, J = 8.1, 1.2 Hz, 1H), 
7.42 (d, J = 8.1 Hz, 1H), 7.21 – 7.01 (m, 5H), 5.10 (dd, J = 13.3, 10.6 Hz, 1H), 4.89 (dd, 
J = 13.4, 4.0 Hz, 1H), 4.63 (dd, J = 10.5, 3.9 Hz, 1H), 1.51 (s, 9H); 13C NMR (75 MHz, 
CDCl3) δ 167.48, 165.86, 147.73, 133.79, 131.74, 129.44, 128.87, 128.73, 128.66, 128.19, 
126.89, 125.82, 124.18, 87.14, 85.90, 75.76, 49.29, 27.76; [α]Drt = -71.1 (c = 1.04, 
CHCl3); HRMS (ESI) m/z calcd for C21H20BrNO6 [M+Na]+ 484.0366, found 484.0375; 
the ee value of the major isomer was 98%, tR = 18.3 min and 22.9 min (Chiralcel AD-H, 














A white solid; 1H NMR (500 MHz, CDCl3) δ 7.67 (d, J = 7.6 Hz, 1H), 7.59 – 7.42 (m, 
4H), 7.37 (ddd, J = 11.5, 9.2, 4.2 Hz, 2H), 7.22 (t, J = 7.6 Hz, 1H), 5.39 (dd, J = 8.6, 4.9 
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Hz, 1H), 5.06 (dd, J = 12.4, 4.9 Hz, 1H), 4.92 (dd, J = 12.3, 8.6 Hz, 1H), 1.51 (s, 9H); 
13C NMR (126 MHz, CDCl3) δ 168.56, 165.76, 145.37, 134.33, 132.62, 132.47, 130.34, 
129.52, 129.29, 128.66, 128.20, 126.85, 126.81, 125.59, 125.47, 123.30, 123.27, 88.02, 
85.62, 77.56, 43.25, 27.61; [α]Drt = -6.3 (c = 0.64, CHCl3); HRMS (ESI) m/z calcd for 
C22H20F3NO6 [M+Na]+ 474.1135, found 474.1153; the ee value of the major isomer was 
73%, tR = 24.7 min and 34.8 min (Chiralcel IC, λ = 220 nm, 15% iPrOH/hexanes, flow 
rate = 1.0 mL/min). 
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4.4.2 Vinylogous Michael addition to chalcones 
4.4.2.1 General information 
1H and 13C NMR spectra were recorded on a Bruker ACF300 or DPX300 (300 MHz) 
or AMX500 (500 MHz) spectrometer. Chemical shifts were reported in parts per million 
(ppm), and the residual solvent peak was used as an internal reference. Multiplicity was 
indicated as follows: s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), dd 
(doublet of doublet), br s (broad singlet). Coupling constants were reported in Hertz (Hz). 
Low resolution mass spectra were obtained on a Finnigan/MAT LCQ spectrometer in ESI 
mode, and a Finnigan/MAT 95XL-T mass spectrometer in FAB mode. All high 
resolution mass spectra were obtained on a Finnigan/MAT 95XL-T spectrometer. Flash 
chromatography separation was performed on Merck 60 (0.040 - 0.063 mm) mesh silica 
gel. 
The enantiomeric excesses of products were determined by chiral-phase HPLC 
analysis, using a Daicel Chiralcel AD-H column (250 x 4.6 mm), or Chiralpak IA column 
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4.4.2.2 Representative procedure 
Addition of tert-butyl 3-oxo-1,3-dihydroisobenzofuran-1-carboxylate 4-1a with (E)-






To a solution of tert-butyl 3-oxo-1,3-dihydroisobenzofuran-1-carboxylate 4-1a (11.7 mg, 
0.05 mmol), (E)-chalcone 4-6b (12.5 mg, 0.06 mmol) in dichloromethane (0.3 mL) was 
added Q-1 (5.95 mg, 0.01 mmol) at room temperature. The resulting mixture stirred for 
40h, and the residue was purified by flash column chromatography (hexane/AcOEt = 
10/1 as eluent) to afford vinylgous michael product 4-7a (20.6 mg, 93% yield). The 
diastereomeric ratio was determined by crude NMR analysis and the enantiomeric excess 
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4.4.2.3 X-ray cryatllographic analysis of 4-7b 
 
Figure 4.2 ORTEP structure of Michael adduct 4-7b 
 
Table  Crystal data and structure refinement for A772. 
Identification code  a772 
Empirical formula  C28 H25 Br O5 
Formula weight  521.39 
Temperature  293(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
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Unit cell dimensions a = 10.4115(5) Å a= 90°. 
 b = 12.5129(6) Å b= 90°. 
 c = 20.2574(10) Å g = 90°. 
Volume 2639.1(2) Å3 
Z 4 
Density (calculated) 1.312 Mg/m3 
Absorption coefficient 1.591 mm-1 
F(000) 1072 
Crystal size 0.60 x 0.60 x 0.36 mm3 
Theta range for data collection 1.91 to 27.48°. 
Index ranges -13<=h<=13, -16<=k<=14, -26<=l<=21 
Reflections collected 18649 
Independent reflections 6037 [R(int) = 0.0408] 
Completeness to theta = 27.48° 100.0 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.5981 and 0.4485 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6037 / 6 / 310 
Goodness-of-fit on F2 1.011 
Final R indices [I>2sigma(I)] R1 = 0.0433, wR2 = 0.0914 
R indices (all data) R1 = 0.0697, wR2 = 0.0999 
Absolute structure parameter 0.012(8) 
Largest diff. peak and hole 0.618 and -0.254 e.Å-3 
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4.4.2.4 Analytical data of products 
(R)-tert-butyl 3-oxo-1-((R)-3-oxo-1,3-diphenylpropyl)-1,3-dihydroisobenzofuran-1-





A white solid; 1H NMR (500 MHz, CDCl3) δ 7.99 – 7.90 (m, 2H), 7.70 (d, J = 7.7 Hz, 
1H), 7.64 – 7.51 (m, 3H), 7.44 (t, J = 7.7 Hz, 2H), 7.34 (t, J = 7.5 Hz, 1H), 7.13 – 6.86 
(m, 5H), 4.64 (dd, J = 10.4, 2.8 Hz, 1H), 4.08 (dd, J = 17.7, 10.4 Hz, 1H), 3.40 (dd, J = 
17.7, 2.8 Hz, 1H), 1.46 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 196.63, 169.17, 167.16, 
147.08, 136.63, 136.24, 133.88, 133.27, 129.67, 129.12, 128.63, 128.07, 127.98, 127.21, 
125.35, 122.74, 122.43, 90.16, 84.28, 46.45, 39.90, 27.78; [α]Drt = +112.2 (c = 0.95, 
CHCl3); HRMS (ESI) m/z calcd for C28H26O5 [M+Na]+ 465.1673, found 465.1689; the ee 
value of the major isomer was 95%, tR = 11.8 min and 17.4 min (Chiralcel IA, λ = 254 











A white solid; 1H NMR (500 MHz, CDCl3) δ 7.98 – 7.90 (m, 2H), 7.68 (d, J = 8.2 Hz, 
1H), 7.66 – 7.52 (m, 3H), 7.51 – 7.37 (m, 3H), 7.10 (d, J = 8.4 Hz, 2H), 6.97 (d, J = 8.5 
Hz, 2H), 4.60 (dd, J = 10.6, 2.7 Hz, 1H), 4.03 (dd, J = 17.7, 10.6 Hz, 1H), 3.38 (dd, J = 
17.7, 2.7 Hz, 1H), 1.45 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 196.37, 169.01, 166.94, 
146.77, 136.37, 135.38, 134.14, 133.48, 131.18, 130.71, 129.99, 128.71, 128.04, 125.68, 
125.52, 122.49, 121.37, 89.73, 84.50, 45.87, 39.79, 27.76; [α]Drt = +134.1 (c = 1.08, 
CHCl3); HRMS (ESI) m/z calcd for C28H25BrO5 [M+Na]+ 543.0778, found 543.0792; the 
ee value of the major isomer was 88%, tR = 10.1 min and 19.3 min (Chiralcel IA, λ = 254 
















A white solid; 1H NMR (500 MHz, CDCl3) δ 7.93 (dd, J = 5.0, 3.9 Hz, 3H), 7.87 – 7.79 
(m, 1H), 7.75 (d, J = 7.3 Hz, 1H), 7.69 – 7.55 (m, 3H), 7.48 (dt, J = 15.5, 7.7 Hz, 3H), 
7.38 (t, J = 7.5 Hz, 1H), 7.20 (t, J = 8.0 Hz, 1H), 4.74 (dd, J = 10.7, 2.7 Hz, 1H), 4.11 (dd, 
J = 18.0, 10.7 Hz, 1H), 3.49 (dd, J = 18.0, 2.7 Hz, 1H), 1.47 (s, 9H); 13C NMR (75 MHz, 
CDCl3) δ 195.96, 168.58, 166.58, 147.51, 146.37, 138.61, 136.08, 134.48, 134.26, 133.69, 
130.22, 129.06, 128.79, 128.01, 125.73, 125.28, 124.77, 122.46, 122.34, 89.32, 84.82, 
46.11, 39.56, 27.75; [α]Drt = +135.5 (c = 1.07, CHCl3); HRMS (ESI) m/z calcd for 
C28H25NO7 [M+Na]+ 510.1523, found 510.1523; the ee value of the major isomer was 
86%, tR = 8.7 min and 10.9 min (Chiralcel IA, λ = 254 nm, 30% iPrOH/hexanes, flow 














A white solid; 1H NMR (500 MHz, CDCl3) δ 7.99 – 7.91 (m, 2H), 7.69 (d, J = 7.7 Hz, 
1H), 7.58 (ddd, J = 23.0, 12.2, 4.1 Hz, 3H), 7.44 (t, J = 7.6 Hz, 2H), 7.41 – 7.32 (m, 1H), 
6.98 (d, J = 8.7 Hz, 2H), 6.50 (d, J = 8.7 Hz, 2H), 4.58 (dd, J = 10.6, 2.8 Hz, 1H), 4.03 
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(dd, J = 17.5, 10.6 Hz, 1H), 3.58 (s, 3H), 3.36 (dd, J = 17.5, 2.8 Hz, 1H), 1.46 (s, 9H); 
13C NMR (75 MHz, CDCl3) δ 196.76, 169.26, 167.22, 158.40, 147.16, 136.60, 133.91, 
133.26, 130.86, 130.08, 129.67, 128.62, 128.07, 125.64, 125.43, 122.63, 113.36, 90.33, 
84.21, 54.89, 45.78, 39.97, 27.78; [α]Drt = +139.6 (c = 0.98, CHCl3); HRMS (ESI) m/z 
calcd for C29H28O6 [M+Na]+ 495.1778, found 495.1787; the ee value of the major isomer 
was 97%, tR = 8.3 min and 18.8 min (Chiralcel IA, λ = 254 nm, 30% iPrOH/hexanes, 








A white solid; 1H NMR (500 MHz, CDCl3) δ 7.93 (d, J = 7.5 Hz, 2H), 7.69 (d, J = 7.7 Hz, 
1H), 7.64 – 7.52 (m, 3H), 7.45 (t, J = 7.7 Hz, 2H), 7.38 (t, J = 7.5 Hz, 1H), 7.06 (dd, J = 
8.7, 5.4 Hz, 2H), 6.66 (t, J = 8.7 Hz, 2H), 4.62 (dd, J = 10.6, 2.8 Hz, 1H), 4.02 (dd, J = 
17.6, 10.6 Hz, 1H), 3.39 (dd, J = 17.6, 2.8 Hz, 1H), 1.46 (s, 9H); 13C NMR (75 MHz, 
CDCl3) δ 196.50, 169.05, 167.02, 161.71 (J = 244.7 Hz), 146.91, 136.43, 134.07, 133.42, 
132.01, 130.85, 130.64, 130.54, 129.85, 128.69, 128.03, 127.84, 125.54, 122.53, 115.08, 
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114.80, 89.97, 84.42, 45.74, 39.92, 27.76; [α]Drt = +131.7 (c = 0.94, CHCl3); HRMS (ESI) 
m/z calcd for C28H25FO5 [M+Na]+ 483.1578, found 483.1590; the ee value of the major 
isomer was 93%, tR = 8.2 min and 12.8 min (Chiralcel IA, λ = 254 nm, 30% 








A white solid; 1H NMR (500 MHz, CDCl3) δ 7.95 (d, J = 7.5 Hz, 2H), 7.75 – 7.68 (m, 
1H), 7.67 – 7.52 (m, 3H), 7.46 (t, J = 7.7 Hz, 2H), 7.39 (t, J = 7.4 Hz, 1H), 7.10 – 6.96 
(m, 2H), 6.93 (d, J = 4.5 Hz, 2H), 4.61 (dd, J = 10.4, 2.6 Hz, 1H), 4.03 (dd, J = 17.8, 10.5 
Hz, 1H), 3.41 (dd, J = 17.8, 2.7 Hz, 1H), 1.45 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 
196.25, 168.95, 166.89, 146.70, 138.42, 136.36, 134.12, 133.74, 133.48, 129.97, 129.70, 
129.28, 128.72, 128.06, 127.49, 126.78, 125.57, 125.50, 122.62, 89.74, 84.51, 46.03, 
39.74, 27.76; [α]Drt = +132.5 (c = 0.92, CHCl3); HRMS (ESI) m/z calcd for C28H25ClO5 
[M+Na]+ 499.1283, found 499.1307; the ee value of the major isomer was 90%, tR = 6.4 
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A white solid; 1H NMR (500 MHz, CDCl3) δ 7.95 (d, J = 7.5 Hz, 2H), 7.70 (d, J = 7.6 Hz, 
1H), 7.57 (dt, J = 15.7, 7.9 Hz, 3H), 7.45 (t, J = 7.7 Hz, 2H), 7.36 (t, J = 7.5 Hz, 1H), 
6.88 (t, J = 7.9 Hz, 1H), 6.72 – 6.60 (m, 2H), 6.48 (dd, J = 8.2, 2.3 Hz, 1H), 4.62 (dd, J = 
10.3, 2.7 Hz, 1H), 4.05 (dd, J = 17.6, 10.3 Hz, 1H), 3.60 (s, 3H), 3.39 (dd, J = 17.6, 2.8 
Hz, 1H), 1.46 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 196.58, 169.25, 167.14, 159.00, 
147.04, 137.76, 136.58, 133.86, 133.31, 129.73, 128.92, 128.65, 128.10, 125.65, 125.40, 
122.78, 121.69, 114.27, 113.32, 90.13, 84.31, 55.05, 46.40, 39.89, 27.78; [α]Drt = +144.2 
(c = 1.06, CHCl3); HRMS (ESI) m/z calcd for C29H28O6 [M+Na]+ 495.1778, found 
495.1791; the ee value of the major isomer was 91%, tR = 7.1 min and 9.7 min (Chiralcel 
IA, λ = 254 nm, 30% iPrOH/hexanes, flow rate = 1.0 mL/min). 
 













A white solid; 1H NMR (500 MHz, CDCl3) δ 8.49 (d, J = 8.6 Hz, 1H), 7.97 – 7.89 (m, 
2H), 7.61 – 7.49 (m, 5H), 7.49 – 7.39 (m, 4H), 7.35 (t, J = 7.4 Hz, 1H), 7.22 – 7.04 (m, 
3H), 5.82 (dd, J = 10.1, 2.8 Hz, 1H), 4.23 (dd, J = 17.8, 10.1 Hz, 1H), 3.61 (dd, J = 17.8, 
2.8 Hz, 1H), 1.50 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 196.73, 169.48, 167.45, 146.22, 
136.46, 133.69, 133.51, 133.41, 133.26, 133.11, 132.21, 129.49, 128.59, 128.44, 128.12, 
127.92, 125.81, 125.47, 125.28, 124.90, 124.75, 123.65, 122.75, 90.48, 84.36, 41.41, 
38.43, 27.81; [α]Drt = +42.7 (c = 1.13, CHCl3); HRMS (ESI) m/z calcd for C32H28O5 
[M+Na]+ 515.1829, found 515.1825; the ee value of the major isomer was 77%, tR = 5.6 

















A white solid; 1H NMR (500 MHz, CDCl3) δ 7.97 – 7.90 (m, 2H), 7.68 (d, J = 7.7 Hz, 
1H), 7.64 – 7.53 (m, 3H), 7.50 – 7.35 (m, 3H), 7.03 (d, J = 8.5 Hz, 2H), 6.95 (d, J = 8.5 
Hz, 2H), 4.61 (dd, J = 10.6, 2.7 Hz, 1H), 4.03 (dd, J = 17.7, 10.6 Hz, 1H), 3.39 (dd, J = 
17.7, 2.8 Hz, 1H), 1.46 (s, 9H); 13C NMR (126 MHz, CDCl3) δ 196.41, 169.00, 166.99, 
146.85, 136.46, 134.90, 134.10, 133.46, 133.16, 130.39, 129.96, 128.72, 128.25, 128.06, 
125.66, 125.60, 122.53, 89.84, 84.48, 45.87, 39.88, 27.79; [α]Drt = +135.8 (c = 1.04, 
CHCl3); HRMS (ESI) m/z calcd for C28H25ClO5 [M+Na]+ 499.1283, found 499.1288; the 
ee value of the major isomer was 85%, tR = 8.8 min and 16.3 min (Chiralcel IA, λ = 254 



















A white solid; 1H NMR (500 MHz, CDCl3) δ 8.29 (d, J = 8.8 Hz, 2H), 8.07 (d, J = 8.8 Hz, 
2H), 7.68 (d, J = 7.7 Hz, 1H), 7.64 – 7.54 (m, 2H), 7.36 (t, J = 7.4 Hz, 1H), 7.06 (dd, J = 
7.8, 1.2 Hz, 2H), 7.02 – 6.92 (m, 3H), 4.61 (dd, J = 10.3, 3.0 Hz, 1H), 4.06 (dd, J = 17.6, 
10.3 Hz, 1H), 3.46 (dd, J = 17.6, 3.0 Hz, 1H), 1.46 (s, 9H); 13C NMR (75 MHz, CDCl3) 
δ 195.48, 169.07, 167.19, 150.42, 146.80, 140.90, 135.75, 134.02, 129.83, 129.12, 128.97, 
128.16, 127.51, 125.78, 125.48, 123.90, 122.60, 89.82, 84.51, 46.36, 40.59, 27.77; [α]Drt 
= +138.2 (c = 1.03, CHCl3); HRMS (ESI) m/z calcd for C28H25NO7 [M+Na]+ 510.1523, 
found 510.1537; the ee value of the major isomer was 92%, tR = 22.5 min and 37.6 min 















A white solid; 1H NMR (500 MHz, CDCl3) δ 7.95 (d, J = 7.3 Hz, 2H), 7.70 (d, J = 7.7 Hz, 
1H), 7.57 (dt, J = 18.2, 6.4 Hz, 3H), 7.45 (t, J = 7.7 Hz, 2H), 7.34 (t, J = 7.5 Hz, 1H), 
6.92 – 6.80 (m, 3H), 6.73 (d, J = 7.0 Hz, 1H), 4.59 (dd, J = 10.3, 2.8 Hz, 1H), 4.06 (dd, J 
= 17.7, 10.3 Hz, 1H), 3.39 (dd, J = 17.7, 2.8 Hz, 1H), 2.07 (s, 3H), 1.46 (s, 9H); 13C 
NMR (75 MHz, CDCl3) δ 196.70, 169.24, 167.19, 147.09, 137.41, 136.61, 136.04, 
133.75, 133.26, 130.00, 129.63, 128.62, 128.09, 127.94, 127.80, 126.08, 125.65, 125.30, 
122.81, 90.20, 84.23, 46.35, 39.81, 27.78, 21.13; [α]Drt = +123.6 (c = 1.11, CHCl3); 
HRMS (ESI) m/z calcd for C29H28O5 [M+Na]+ 479.1829, found 479.1842; the ee value 
of the major isomer was 90%, tR = 5.8 min and 8.5 min (Chiralcel IA, λ = 254 nm, 30% 
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A white solid; 1H NMR (500 MHz, CDCl3) δ 7.99 – 7.91 (m, 2H), 7.74 – 7.51 (m, 4H), 
7.50 – 7.38 (m, 3H), 6.88 – 6.83 (m, 1H), 6.72 (dd, J = 3.4, 0.7 Hz, 1H), 6.59 (dd, J = 5.1, 
3.6 Hz, 1H), 4.97 (dd, J = 10.5, 2.5 Hz, 1H), 4.03 (dd, J = 17.5, 10.5 Hz, 1H), 3.35 (dd, J 
= 17.4, 2.6 Hz, 1H), 1.46 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 196.22, 169.19, 166.81, 
146.80, 138.60, 136.45, 134.08, 133.41, 129.95, 128.67, 128.14, 126.93, 126.25, 125.81, 
125.48, 124.79, 122.65, 89.74, 84.48, 41.93, 41.50, 27.77; [α]Drt = +112.9 (c = 1.01, 
CHCl3); HRMS (ESI) m/z calcd for C26H24O5S [M+Na]+ 471.1237, found 471.1245; the 
ee value of the major isomer was 91%, tR = 7.2 min and 9.2 min (Chiralcel IA, λ = 254 














A white solid; 1H NMR (500 MHz, CDCl3) δ 7.99 – 7.91 (m, 2H), 7.73 – 7.52 (m, 4H), 
7.46 (t, J = 7.7 Hz, 2H), 7.39 (t, J = 7.5 Hz, 1H), 7.21 (s, 1H), 7.07 (ddd, J = 6.2, 3.5, 2.0 
Hz, 2H), 6.87 (t, J = 7.9 Hz, 1H), 4.59 (dd, J = 10.4, 2.7 Hz, 1H), 4.02 (dd, J = 17.8, 10.4 
Hz, 1H), 3.41 (dd, J = 17.8, 2.8 Hz, 1H), 1.45 (s, 9H); 13C NMR (126 MHz, CDCl3) δ 
196.25, 168.92, 166.89, 146.73, 138.71, 136.43, 134.10, 133.46, 132.68, 130.42, 129.97, 
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129.56, 128.72, 128.07, 127.20, 125.57, 125.55, 122.64, 121.96, 89.75, 84.51, 46.08, 
39.75, 27.78; [α]Drt = +119.5 (c = 1.13, CHCl3); HRMS (ESI) m/z calcd for C28H25BrO5 
[M+Na]+ 543.0778, found 543.0786; the ee value of the major isomer was 87%, tR = 8.1 









A white solid; 1H NMR (500 MHz, CDCl3) δ 8.49 (d, J = 8.6 Hz, 1H), 7.97 – 7.88 (m, 
2H), 7.61 – 7.48 (m, 5H), 7.48 – 7.38 (m, 4H), 7.35 (t, J = 7.4 Hz, 1H), 7.22 – 7.04 (m, 
3H), 5.82 (dd, J = 10.1, 2.7 Hz, 1H), 4.23 (dd, J = 17.8, 10.1 Hz, 1H), 3.61 (dd, J = 17.8, 
2.8 Hz, 1H), 1.50 (s, 9H); 13C NMR (126 MHz, CDCl3) δ 196.75, 169.46, 167.46, 146.27, 
136.53, 133.74, 133.44, 133.24, 133.09, 132.24, 129.48, 128.59, 128.44, 128.12, 127.92, 
125.80, 125.52, 125.28, 124.94, 124.91, 124.75, 123.68, 122.77, 90.49, 84.35, 41.44, 
38.48, 27.82; [α]Drt = +39.2 (c = 1.07, CHCl3); HRMS (ESI) m/z calcd for C32H28O5 
[M+Na]+ 515.1829, found 515.1842; the ee value of the major isomer was 90%, tR = 5.7 
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Annex: Asymmetric Michael Addition Mediated by Novel 





The past two decades have witnessed a terrific advancement of chiral bifunctional 
catalysts.161 Over the years, chemists have designed and developed many elegant and 
remarkably effective bifunctional catalytic systems for asymmetric synthesis, such as 
Corey’s CBS catalysts,162 Noyori’s DAIB for dialkyl zinc addition,163 Shibasaki’s hetero- 
and homobimetallic catalysts,164 Jacobsen’s metal-salen complexes,165 and Trost’s 
dialkylzinc complex.166 
Asymmetric organocatalysis has progressed astonishingly in the past few years, and 
many impressive bifunctional organocatalysts have emerged. In particular, the utilization 
of thiourea in bifunctional oragnocatalysts has been shown to be extremely effective,167 
presumably due to the favorable double-hydrogen-bonding interactions between thiourea 
moieties and the substrates. Very recently, Rawal and co-workers disclosed the use of a 
novel cinchona alkaloid-based squaramide as an effective hydrogen bond donor catalyst 
for the conjugate addition of 1,3-dicarbonyl compounds to nitroolefins.168 N-
sulfonamides, containing an acidic hydrogen, represent a versatile structural scaffold that 
can be used for fine tuning of the structures of organocatalysts. Validity of single 
hydrogen-bonding interactions of N-sulfonamide in asymmetric organocatalysis has been 
demonstrated recently. Wang and co-workers reported that pyrrolidine sulfonamide was 
an efficient catalyst in -aminoxylation, aldol and Mannich reactions, -sulfenylations, 
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-selenenylation, and Michael addition of aldehydes to nitrostyrenes.169 Berkessel170 and 
Adolfsson171 also reported the use of proline N-sulfonamide catalyst in aldol and 
amination reactions, respectively. 
Given the proven ability of thiourea-containing bifunctional catalysts and efficient 
catalysis involving hydrogen bonding interaction in N-sulfonamides, we became 
interested in developing novel bifunctional organocatalysts combining a tertiary amino 
group and N-sulfonamide moiety. Cinchona alkaloids are privileged organic catalysts,172 
which are remarkably effective and versatile in asymmetric catalysis;173 quinidine was 
therefore chosen as a chiral structural scaffold in our studies. We hypothesize that 
incorporating N-sulfonamides into quinidine structural scaffold could result in 
bifunctional organocatalysts with novel and interesting activities.174 
Construction of quaternary stereocenters is considered to be one of the most 
challenging tasks in organic synthesis, and significant progress has been made in this 
field over the years.105 The conjugate addition of -substituted dicarbonyl compounds to 
suitable acceptor represents an important approach to generate all-carbon quaternary 
stereocenters. Recently, Takemoto and co-workers applied their bifunctional thiourea 
catalyst in enantio- and diastereoselective Michael addition of dicarbonyl compounds to 
nitroolefins.54 In another elegant organocatalytic approach, Deng et al. reported the 
construction of quaternary stereocenters by conjugate addition of -ketoesters mediated 
by cinchona alkaloid catalyst.175 Herein, we wish to report a highly enantioselective 
organocatalytic Michael addition of bicyclic -substituted -ketoesters to nitroolefins for 
the asymmetric construction of all-carbon quaternary stereocenters promoted by novel 
cinchona alkaloid-derived N-tosylsulfonamide containing organocatalysts. 
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5.2 Results and discussions 
5.2.1 Catalyst design 
Although various bifunctional catalysts derived from cinchona alkaloid have been 
reported recently, they could be mainly divided into three groups: 
i) The first type focuses on the modification at the C’6 position in the cinchona 
scaffold, usually demethylation to hydroxyl group or conversion into thiourea group, 
which could be served as H-bonding during the reaction; 
ii) Conversion of the 9-hydroxyl group into amine. The primary amine could 
facilitate the enamine or iminium activation of carbonyl substrate; 
iii) Replacement of 9-hydroxyl group by thiourea group. It’s believed that the 








Demethylation or convert to 






Replacement to NH2: 
facilitate the enamine or 
iminium formation






Scheme 5.1 Strategies employed in the cinchona derived bifunctional catalysts 
Inspired by the previous work by Wang, Berkessel and Adolfsson, where the 
pyrrolidine sulfonamide was an efficient catalyst in α-aminoxylation, aldol and Mannich 
reactions, α-sulfenylations, α-selenenylation, and Michael addition of aldehydes to 
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nitrostyrenes, we are interested in incorporating the N-sulfonamides into quinidine 
structural scaffold, hoping to generate bifunctional organocatalysts with novel and 
interesting activities. 
 
5.2.2 Reaction optimization 
5.2.2.1 Catalyst screening 
In our initial study, the Michael addition of -substituted cyclic -ketoester (5-1a) to 
nitrostyrene (5-2a) was selected as a model reaction (Table 5.1). Natural quinidine, 
quinine, cinchonidine, and cinchonine were not effective, affording products with very 
low enantioselectivity (entries 1-4). When quinidine-derived thiourea (QD-1) was used as 
the catalyst, only moderate enantioselectivity was attainable (entry 5). The 6′-
demethylated quinidine (QD-2), proven to be a powerful catalyst in a number of 
enantioselective transformations, led to only moderate enantioselectivity (entry 6). When 
the C9 hydroxy function in quinidine was protected as a bulky tert-butyl ester, both the 
rate of reaction and enantioselectivity dropped (entry 7). The fact that QD-1 and QD-2 
were better catalysts in promoting asymmetric Michael addition seemed to indicate the 
importance of hydrogen bonding in the chiral induction. When N-tosylsulfonamide-
containing catalyst QD-4 was tested, we were delighted to find the desired Michael 
product was obtained in quantitative yield and with good enantioselectivity (entry 8). A 
number of novel quinidine-based N-sulfonamides were prepared and examined. Whereas 
QD-6 and QD-4 showed similar catalytic effects, catalysts QD-5 and QD-7 were less 
effective (entries 9-11). Further screening on other cinchona-derived silyl protection 
catalysts didn’t afford better results (entries 12-14).  
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Table 5.1 Catalyst screening of Michael addition of ketoester to nitrostyrene [a] 
 
 
entry catalyst t /h yield/%[b] dr[c] ee/%[d] 
1 QD 24 99 1:1.6 3/5 
2 Q 20 99 1:1.4 7/-1 
3 CD 20 99 1:1.6 39/-4 
4 C 20 99 1:1.6 -26/9 
5 QD-1 20 99 1:1.2 10/51 
6 QD-2 20 99 1:1.3 47/65 
7 QD-3 20 71 1:1.1 41/19 
8 QD-4 20 99 1.6:1 74/66 
9 QD-5 20 95 1.8:1 64/59 
10 QD-6 20 96 1.6:1 78/66 
11 QD-7 20 95 1:1 9/10 
12 QD-8 20 90 1:1.4 27/12 
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[a] Reactions were performed with 0.05 mmol of ketoester, 0.055 mmol of nitrostyrene, and 0.005 mmol of 
catalyst in 0.15 mL of toluene at room temperature. [b] Isolated yield. [c] Determined by 1H NMR analysis of 
the crude products. [d] Determined by Chiral HPLC analysis. 
 
 
5.2.2.2 Solvent screening 
We next studied the influence of solvent on the reaction selectivity (Table 5.2). The 
polar solvent such as MeOH and DMSO gave very disappointing enantioselectivities 
(entries 3 and 4). When the reaction was performed in dichlomethane, the ee was 
improved to 78% (entry 5). Upon lowering the reaction temperature, good 
diastereoselectivity and excellent enantioselectivity were achieved (entry 6). 
Table 5.2 Influence of solvent on the Michael addition to nitrostyrene[a] 
 
entry catalyst t /h yield/%[b] dr[c] ee/%[d] 
1 CH3CN 20 98 2.3:1 66/ 45 
2 DMF 14 99 1.3:1 16/ 10 
3 DMSO 19 98 1.3:1 14/ 6 
4 MeOH 19 99 1.1:1 25/ 13 
5 CH2Cl2 22 95 2.6:1 78/ 60 
6[e] CH2Cl2 48 98 5.1:1 92/76 
13 QD-9 40 96 1:1.3 18/8 
14 QD-10 45 95 1:1.1 37/-8 
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7 THF 26 96 1.7:1 73/ 62 
8 CH3COOEt 26 95 1.8:1 72/ 61 
9 CHCl3 27 98 1.7:1 68/ 48 
[a] Reactions were performed with 0.05 mmol of ketoester, 0.055 mmol of nitrostyrene, and 0.005 mmol of 
catalyst in 0.15 mL of solvent at room temperature. [b] Isolated yield. [c] Determined by 1H NMR analysis of 
the crude products. [d] Determined by Chiral HPLC analysis. [e] Reaction carried under -40 oC. 
 
 
5.2.2.3 Donors screening 
Other cyclic ketoesters were also screened with our cinchona-derived sulfonamide 
catalyst. Monocyclic -ketoester 5-1b was an excellent substrate, the Michael addition of 
which to nitroolefin yielded adducts with exceptional diastereoselectivity and excellent 
enantioselectivity (entries 2-4). The ester moiety in ketoester seemed to have little 
influence on stereoselectivity (entry 5). QD-6 could also effect the asymmetric additions 
of -ketonitrile and -ketothioester to nitroolefin although only modest 
enantioselectivities were obtained (entries 6 and 8). 
 
Table 5.3 Screening of other donors for the Michael addition to nitrostyrene[a] 
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entry donor catalyst t /h yield/%[b] dr[c] ee/%[d] 
1 5-1a QD-4 48 98 5.1:1 92 
2 5-1b QD-4 40 90 >50:1 90 
3 5-1b QD-5 40 92 >50:1 85 
4 5-1b QD-6 40 95 >50:1 91 
5 5-1c QD-6 40 96 >50:1 90 
6 5-1d QD-4 40 30 - - 
7 5-1d QD-6 40 83 >50:1 63 
8 5-1e QD-6 40 72 >50:1 57 
[a] Reactions were performed with 0.05 mmol of ketoester, 0.055 mmol of nitrostyrene, and 0.005 mmol of 
catalyst in 0.15 mL of solvent at -40 oC. [b] Isolated yield. [c] Determined by 1H NMR analysis of the crude 
products. [d] Determined by Chiral HPLC analysis. 
 
 
5.2.3 Substrate scope 
After the initial screening of the catalysts and examination of different reactions, we 
next focused on Michael reactions involving bicyclic -ketoesters of type 5-1a as donors, 
since the Michael addition of such substrates to nitroolefin remained to be largely 
unexplored. A wide range of aryl nitroolefins and bicyclic -substituted -ketoesters 
were employed in the QD-4-promoted organocatalytic Michael reactions, and the 
Michael adducts were obtained in virtually quantitative yield, with moderate to good 
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99 4.1:1 94 
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[a] Reactions were performed with 0.05 mmol of ketoester, 0.055 mmol of nitroolefin, 0.005 mmol of QD-4 in 
0.15 mL of CH2Cl2. [b] Isolated yield. [c] Determined by 1H NMR analysis of the crude products. [d] 
Enantiomeric excess of the major isomer, determined by chiral HPLC analysis. 
 
 
5.2.4 Proposed transition model 
Based on the observed reactivity and experimental results of the described reactions, 
we propose that the reaction proceeds via a dual activation model. As shown in Figure 1, 
the ketoester and nitroolefin may get activated simultaneously through their interactions 






















In summary, new bifunctional organocatalysts (QD-4 to QD-7) derived from 
cinchona alkaloid incorporating N-sulfonamide were prepared. QD-4 was utilized to 
promote the Michael addition of bicyclic -substituted -ketoesters to nitroolefins, 
yielding highly functionalized all-carbon quaternary Michael adducts with excellent 
enantioselectivity. The studies carried out in this report demonstrated that single 
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hydrogen-bonding activation is a powerful approach in asymmetric organocatalysis, and 
we believe this finding can contribute to the design of novel bifunctional catalysts.  
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5.3 Experimental section 
5.3.1 General Information 
1H and 13C NMR spectra were recorded on a Bruker ACF300 or DPX300 (300 MHz) 
or AMX500 (500 MHz) spectrometer. Chemical shifts were reported in parts per million 
(ppm), and the residual solvent peak was used as an internal reference. Multiplicity was 
indicated as follows: s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), dd 
(doublet of doublet), br s (broad singlet). Coupling constants were reported in Hertz (Hz). 
Low resolution mass spectra were obtained on a Finnigan/MAT LCQ spectrometer in 
ESI mode, and a Finnigan/MAT 95XL-T mass spectrometer in FAB mode. All high 
resolution mass spectra were obtained on a Finnigan/MAT 95XL-T spectrometer. Flash 
chromatography separation was performed on Merck 60 (0.040 - 0.063 mm) mesh silica 
gel.  
The enantiomeric excesses of products were determined by chiral-phase HPLC 
analysis, using a Daicel Chiralcel OD-H column (250 x 4.6 mm), or Chiralpak AD-H 
column, or IA column (250 x 4.6 mm).  
Chemicals and solvents were purchased from commercial suppliers and used as 
received. QD-1,176 QD-2177 and QD-3178 were prepared according to the literature 
procedure, and all the -substituted cyclic -ketoesters179 and nitroolefins180 were 
prepared according to the literature procedures. 
The absolute configuration of 5-3b was assigned by comparing its specific rotation 
and HPLC data with those of the known compound reported in the literature181 (page S6), 
and configurations of other Michael adducts were assigned by analogy. 
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5.3.2 Preparation of cinchona alkaloid-derived catalysts 
General procedure for the preparation of catalysts 
 
9-Amino(9-deoxy)epihydroquinine was prepared from quinidine according to the 
literature procedure.176 
 
Preparation of QD-4 
To a solution of 9-amino(9-deoxy)epihydroquinine (1.0 g, 3.09 mmol) in anhydrous 
dichloromethane (15 mL) at 0 oC was added triethylamine (1.3 mL, 9.27 mmol) under 
nitrogen atmosphere, followed by TsCl (0.62 g, 3.25 mmol). The reaction mixture was 
then stirred overnight at room temperature, and the solvent was removed in vacuo. The 
residue was purified by column chromatography to afford QD-4 as a light yellow powder 
(1.2 g, 81%).  
 
QD-4: a light yellow powder; [α]25D = + 58.7 (c 0.95, CHCl3); 1H NMR (500 MHz, 
CD3OD) δ 8.47 (d, J = 4.4 Hz, 1H), 7.83 (d, J = 8.8 Hz, 1H), 7.47 (d, J = 4.4 Hz, 1H), 
7.36 (m, 3H), 7.23 (s, 1H), 6.99 (d, J = 7.5 Hz, 2H), 5.77 (m, 1H), 5.02 (d, J = 10.7 Hz, 
1H), 4.84 (m, 2H), 3.94 (s, 3H), 2.96 (m, 3H), 2.84 (m, 1H), 2.54 (m, 1H), 2.29 (s, 3H), 
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2.25 (br, 1H), 1.09 (m, 3H), 0.95 (m, 1H), 0.85 (m, 1H); 13C NMR (125 MHz, CD3OD) δ 
158.3, 146.7, 145.5, 143.4, 143.3, 140.6, 136.5, 130.0, 128.8, 128.6, 127.1, 122.3, 120.3, 
113.6, 100.4, 60.6, 54.9, 51.9, 48.5, 45.9, 38.2, 27.3, 25.8, 24.2, 19.9; HRMS (ESI) m/z 
calcd for C27H31N3O3S [M+H]+ 478.2164, found: 478.2141. 
 
QD-5: a white powder (86% yield); [α]25D = + 89.2 (c 0.61, CHCl3); 1H NMR (500 MHz, 
CD3OD) δ 8.39 (d, J = 5.1 Hz, 1H), 7.64-7.78 (m, 4H), 7.36 (d, J = 5.1 Hz, 1H), 7.30 (m, 
2H), 5.83 (m, 1H), 5.12-5.17 (m, 3H), 3.93 (s, 3H), 3.88 (m, 1H), 3.35 (m, 1H), 3.05–
3.10 (m, 3H), 2.45 (m, 1H), 1.66 (br, 3H), 1.03 (m, 1H); 13C NMR (125 MHz, CD3OD) δ 
160.6, 148.0, 147.0, 146.0, 144.7, 140.7, 132.6, 132.4, 131.4, 129.4, 127.9, 125.6, 124.9, 
123.9, 122.8, 121.2, 115.9, 101.6, 62.1, 56.2, 53.9, 49.9, 47.1, 38.9, 28.4, 26.2, 25.4; 
HRMS (IT-TOF) m/z calcd for C28H27N3O3SF6 [M+H]+ 600.1756, found: 600.1407. 
 
QD-6: a white powder (89% yield); [α]25D = + 92.3 (c 0.69, CHCl3); 1H NMR (500 MHz, 
CD3OD) δ 8.47 (s, 1H), 7.85 (d, J = 8.8 Hz, 1H), 7.31–7.47 (m, 5H), 6.85–6.88 (m, 2H), 
5.82 (m, 1H), 4.97-5.08 (m, 3H), 3.97 (s, 3H), 2.67–3.04 (m, 5H), 2.27 (br, 1H), 1.56 (br, 
3H), 1.04 (m, 1H), 0.83 (m, 1H); 13C NMR (125 MHz, CD3OD) δ 167.0, 165.0, 159.8, 
148.1, 146.6, 144.7, 141.9, 137.8, 131.5, 131.1, 131.0, 130.0, 123.8, 121.6, 116.5, 116.4, 
116.3, 116.2, 115.1, 101.8, 79.5, 61.7, 56.3, 53.3, 49.9, 47.5, 39.6, 28.6, 27.2, 25.7; 
HRMS (IT-TOF) m/z calcd for C26H28N3O3SF [M+H]+ 482.1914, found: 482.1612. 
 
QD-7: a slightly yellow powder (76% yield); [α]25D = + 55.0 (c 0.32, CHCl3); 1H NMR 
(300 MHz, d6-DMSO) δ 8.77 (d, J = 4.7 Hz, 1H), 7.99 (d, J = 9.1 Hz, 1H), 7.57–7.63 (m,  
Annex: Michael Addition Mediated by Cinchona-Derived Sulfonamides 
184 
 
2H), 7.48 (d, J = 9.1 Hz, 1H), 7.38 (s, 1H), 7.27 (d, J = 2.6 Hz, 1H), 5.88 (m, 1H), 5.47 (d, 
J = 10.8 Hz, 1H), 5.11–5.17 (m, 2H), 4.14 (m, 1H), 3.99 (s, 3H), 3.42 (m, 4H), 2.71 (br, 
1H), 1.74–1.99 (m, 3H), 1.48 (br, 1H), 0.79 (m, 1H); 13C NMR (75 MHz, d6-DMSO) δ 
158.7, 148.5, 145.2, 141.5, 139.3, 133.7, 132.4, 128.7, 128.2, 128.1, 126.5, 122.8, 121.4, 
117.0, 112.0, 102.8, 80.2, 60.7, 56.6, 49.8, 49.3, 46.2, 37.1, 27.4, 24.8, 23.8; HRMS (IT-
TOF) m/z calcd for C26H27N3O4Cl2 [M+H]+ 548.1178, found: 548.0946. 
 
 
5.3.3 Representative procedure  












QD-4 (10 mol %)




To a solution of aryl nitroolefin (0.055 mmol) and catalyst QD-4 (0.005 mmol) in 
dichloromethane (0.15 mL) was added -substituted cyclic -ketoesters (0.05 mmol) at -
40 oC. The reaction mixture was kept stirring at that temperature for the time specified. 
The mixture was then filtered through a short pad of silica gel, and the filtrate was 
concentrated in vacuo. Purification of the residue by flash chromatography afforded the 
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5.3.4 Analytical data of Michael adducts 
Methyl 2,3-dihydro-2-(2-nitro-1-phenylethyl)-1-oxo-1H-indene-2-carboxylate (5-3a) 
 
  
A yellow oil; diastereomeric ratio: 5.1 to 1, and the diastereomers could not be separated; 
the characterization data were in agreement with the literature value;182 the ee value of 
the major isomer was 92%, tR (major) = 23.4 min, 112.7 min, tR (minor) = 26.5 min, 62.4 




Methyl 1-(2-nitro-1-phenylethyl)-2-oxocyclopentanecarboxylate (5-3b) 
 
  
A colorless oil; the diastereomeric ratio was greater than 50 to 1, and the major 
diastereomer was obtained in pure form; [α]25D = -33.6 (c 0.79, CHCl3), (lit181: [α]25D = 
+36.5 (c, 0.84, CHCl3)). 1H NMR (500 MHz, CDCl3) δ 7.20-7.34 (m, 5H), 5.18 (dd, J = 
13.8 Hz, 3.8 Hz, 1H), 5.03 (dd, J = 13.8 Hz, 10.7 Hz, 1H), 4.09 (dd, J = 10.8 Hz, 3.8 Hz, 
1H), 3.78 (s, 3H), 2.32-2.42 (m, 2H), 1.85-2.07 (m, 4H). The 1H NMR data were in 
agreement with the literature values;181 The ee value of the major isomer was 90% 
(catalyzed by QD-4) and 91% (catalyzed by QD-6), tR (major) = 9.9 min, 14.0 min 
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(Chiralcel OD-H, λ = 220 nm, 20% iPrOH/hexanes, flow rate = 1.0 mL/min). For the 
minor diastereomers, tR (minor) = 8.5 min, 12.5 min. (literature181: tR (major) = 11.0 min, 
17.0 min, tR (minor) = 9.3 min, 13.0 min (Chiralcel OD-H, λ = 220 nm, 20% 
iPrOH/hexanes, flow rate = 1.0 mL/min)).  
 
 









A colorless oil; diastereomeric ratio was greater than 50 to 1, and the major diastereomer 
was obtained in pure form; 1H NMR (500 MHz, CDCl3) δ 7.25 – 7.30 (m, 5H), 5.17 (dd, 
J = 13.25, 3.8 Hz, 1H), 5.01 (dd, J = 13.25, 3.8 Hz, 1H), 4.21 (m, 2H), 4.07 (dd, J = 
11.35, 3.8 Hz, 1H), 2.36 (m, 2H), 2.01 (m, 2H), 1.85 (m, 1H), 1.27 (t, J = 7.6, 3H); 13C 
NMR (125 MHz, CDCl3) δ 212.3, 169.3, 135.4, 129.3, 128.8, 128.3, 76.5, 62.5, 62.2, 
46.2, 37.9, 31.3, 19.3, 14.0; HRMS (ESI) m/z calcd for C16H19NO5 [M+Na]+ 328.1161, 
found 328.1056; the ee value of the major isomer was 90%, tR (major) = 8.0 min, 10.6 
min, tR (minor) = 6.9 min, 9.9 min (Chiralcel OD-H, λ = 220 nm, 20% iPrOH/hexanes, 
flow rate = 1.0 mL/min). 
 
 







A light yellow oil; diastereomeric ratio: 4.1 to 1, and the diastereomers could not be 
separated; 1H NMR (500 MHz, CDCl3) the major isomer: δ 7.65 – 7.43 (m, 3H), 7.28 -
7.15 (m, 5H), 5.42 – 5.16 (m, 2H), 4.26 (dd, J = 10.7 Hz, 3.8 Hz, 1H), 3.78 (s, 3H), 3.65 
(d, J = 17.7 Hz, 1H), 3.22 (d, J = 17.7 Hz, 1H); the minor isomer: δ 7.65 – 7.43 (m, 3H), 
7.28 -7.15 (m, 5H), 5.25 – 5.09 (m, 2H), 4.48 (dd, J = 10.7 Hz, 3.8 Hz, 1H), 3.73 (s, 3H), 
3.47 (d, J = 17.7 Hz, 1H), 3.17 (d, J = 17.7 Hz, 1H); 13C NMR (75 MHz, CDCl3) δ 
200.91, 198.61, 169.38, 153.90, 153.73, 135.34, 134.99, 134.52, 132.83, 131.78, 131.46, 
131.31, 129.42, 128.96, 128.92, 128.80, 128.50, 128.45, 126.26, 125.82, 125.52, 76.63, 
62.92, 61.70, 53.35, 52.87, 47.43, 46.92, 36.22, 34.65; HRMS (ESI) m/z calcd for 
C19H16BrNO5 [M+Na]+ 440.0110, found 440.0103; the ee value of the major isomer was 
92%, tR (major) = 20.4 min and 141.3 min, tR (minor) = 29.2 min, 51.2 min (Chiralcel 














A colorless oil; diastereomeric ratio: 3.3 to 1, and the diastereomers could not be 
separated; 1H NMR (500 MHz, CDCl3): the major isomer, δ 7.29 – 7.10 (m, 8H), 5.46 – 
5.42 (m, 1H), 5.22 – 5.17 (m, 1H), 4.27 – 4.24 (m, 1H), 3.82 (s, 3H), 3.76 (s, 3H), 3.58 (d, 
J = 17.0 Hz, 1H), 3.16 (d, J = 17.7 Hz, 1H); the minor isomer, δ 7.63 – 7.47 (m, 3H), 
7.30 -7.10 (m, 5H), 5.31 – 5.06 (m, 2H), 4.51 – 4.48 (m, 1H), 3.86 (s, 3H), 3.73 (s, 3H), 
3.42 (d, J = 17.0 Hz, 1H), 3.10 (d, J = 17.7 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 
201.97, 199.82, 171.29, 169.96, 159.82, 145.44, 145.35, 139.06, 137.38, 135.80, 135.24, 
134.82, 132.14, 129.41, 129.14, 129.06, 129.00, 128.84, 128.65, 128.33, 126.80, 125.48, 
125.30, 106.03, 105.37, 76.92, 63.59, 62.51, 55.63, 53.21, 47.61, 47.12, 35.95, 34.50; (75 
MHz, CDCl3) HRMS (ESI) m/z calcd for C20H19NO6 [M+Na]+ 392.1110, found 392.1101; 
the ee value of the major isomer was 90%, tR (major) = 49.3 min and 52.1 min, tR (minor) 
= 64.7 min, 82.5 min (Chiralcel AD-H, λ = 210 nm, 5% iPrOH/hexanes, flow rate = 0.5 
mL/min). 









A colorless oil; diastereomeric ratio: 3.3 to 1, and the diastereomers could not be 
separated; 1H NMR (500 MHz, CDCl3): the major isomer, δ 7.64 (d, J = 8.9 Hz, 1H), 
7.28 – 7.18 (m, 5H), 6.91 – 6.62 (m, 2H), 5.50 – 5.47 (m, 1H), 5.24 – 5.20 (m, 1H), 4.23 
– 4.20 (m, 1H), 3.89 (s, 3H), 3.77 (s, 3H), 3.60 (d, J = 17.7 Hz, 1H), 3.16 (d, J = 17.5 Hz, 
1H); the minor isomer, δ 7.72 (d, J = 9.5  Hz, 1H), 7.28 – 7.15 (m, 5H), 6.91 -6.62 (m, 
2H), 5.20 – 5.07 (m, 2H), 4.51 – 4.49 (m, 1H), 3.84 (s, 3H), 3.72 (s, 3H), 3.42 (d, J = 
17.5 Hz, 1H), 3.11 (d, J = 17.5 Hz, 1H); 13C NMR (75 MHz, CDCl3) δ 197.71, 170.07, 
166.19, 155.54, 135.95, 129.39, 129.01, 128.80, 128.61, 128.24, 126.97, 126.55, 126.24, 
116.19, 109.18, 109.07, 77.19, 63.00, 55.72, 53.15, 47.43, 47.23, 36.35, 35.18; HRMS 
(ESI) m/z calcd for C20H19NO6 [M+Na]+ 392.1110, found 392.1115; the ee value of the 
major isomer was 95%, tR (major) = 91.8 min and 147.3 min, tR (minor) = 96.2 min, 










A colorless oil; diastereomeric ratio: 5.9 to 1, and the diastereomers could not be 
separated; 1H NMR (500 MHz, CDCl3): the major isomer, δ 7.50 – 7.14 (m, 8H), 5.49 – 
5.44 (m, 1H), 5.27 – 5.18 (m, 1H), 4.26 – 4.21 (m, 1H), 3.77 (s, 3H), 3.62 (d, J = 17.4 Hz, 
1H), 3.19 (d, J = 17.4 Hz, 1H), 2.40 (s, 3H); the minor isomer, δ 7.58 – 7.14 (m, 8H), 
5.23 – 5.06 (m, 2H), 4.54 – 4.26 (m, 1H), 3.73 (s, 3H), 3.45 (d, J = 10.5 Hz, 1H), 3.13 (d, 
J = 10.5 Hz, 1H), 2.42 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 199.82, 171.24, 169.92, 
149.80, 149.74, 138.08, 138.03, 137.12, 137.00, 135.80, 134.82, 134.11, 129.00, 128.94, 
128.75, 128.57, 128.20, 125.68, 124.99, 124.25, 76.87, 63.07, 62.01, 53.09, 47.46, 47.06, 
36.14, 34.82, 20.93; HRMS (ESI) m/z calcd for C20H19NO5 [M+Na]+ 376.1161, found 
376.1170; the ee value of the major isomer was 93%, tR (major) = 38.8 min and 44.6 min, 
tR (minor) = 41.5 min, 57.3 min (Chiralcel IA, λ = 210 nm, 2% iPrOH/hexanes, flow rate 










A colorless oil; diastereomeric ratio: 2.4 to 1, and the diastereomers could not be 
separated; 1H NMR (300 MHz, CDCl3): the major isomer, δ 7.82 – 7.18 (m, 8H), 5.76 – 
5.70 (m, 1H), 5.42 – 5.34 (m, 1H), 4.62 – 4.57 (m, 1H), 3.72 (s, 3H), 3.53 (d, J = 17.4 Hz, 
1H), 3.14 (d, J = 17.4 Hz, 1H); the minor isomer, δ 7.77 – 6.90 (m, 8H), 5.35 – 5.22 (m, 
3H), 3.73 (s, 3H), 3.45 (d, J = 17.8 Hz, 1H), 3.13 (d, J = 17.8 Hz, 1H); 13C NMR (75 
MHz, CDCl3) δ 200.07, 171.49, 169.93, 152.53, 152.45, 136.13, 135.73, 135.38, 133.50, 
132.82, 130.21, 130.10, 129.45, 129.31, 128.89, 128.32, 128.20, 127.94, 127.77, 127.06, 
126.24, 125.98, 125.46, 124.30, 76.65, 62.81, 61.17, 53.25, 53.05, 41.89, 36.62, 36.48; 
HRMS (ESI) m/z calcd for C19H16NO5Cl [M+Na]+ 396.0615, found 396.0622; the ee 
value of the major isomer was 93%, tR (major) = 16.2 min and 17.1 min, tR (minor) = 




Methyl 2,3-dihydro-2-(2-nitro-1-p-tolylethyl)-1-oxo-1H-indene-2-carboxylate (5-4f) 
 




A colorless oil; diastereomeric ratio: 7.1 to 1, and the diastereomers could not be 
separated; 1H NMR (300 MHz, CDCl3): the major isomer, δ 7.70 – 7.01 (m, 8H), 5.44 – 
5.38 (m, 1H), 5.21 – 5.13 (m, 1H), 4.18 – 4.13 (m, 1H), 3.73 (s, 3H), 3.63 (d, J = 17.8 Hz, 
1H), 3.20 (d, J = 17.8 Hz, 1H), 2.24 (s, 3H); the minor isomer, δ 7.78 – 6.92 (m, 8H), 
5.20 – 5.00 (m, 2H), 4.47 – 4.42 (m, 1H), 3.69 (s, 3H), 3.48 (d, J = 17.7 Hz, 1H), 3.16 (d, 
J = 17.7 Hz, 1H), 2.19 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 199.83, 171.15, 169.80, 
152.43, 152.36, 138.00, 135.75, 135.60, 133.98, 132.61, 131.57, 129.47, 129.30, 128.83, 
128.75, 127.95, 127.90, 126.03, 125.16, 124.38, 77.19, 62.85, 61.82, 53.11, 47.16, 46.76, 
36.45, 35.21, 20.89; HRMS (ESI) m/z calcd for C20H19NO5 [M+Na]+ 376.1161, found 
376.1165; the ee value of the major isomer was 93%, tR (major) = 11.6 min and 52.2 min, 
tR (minor) = 12.5 min, 30.0 min (Chiralcel OD-H, λ = 210 nm, 15% iPrOH/hexanes, flow 









A light yellow oil; diastereomeric ratio: 3.5 to 1, and the diastereomers could not be 
separated; 1H NMR (300 MHz, CDCl3): the major isomer, δ 7.70 – 7.14 (m, 8H), 5.42 – 
5.36 (m, 1H), 5.18 – 5.10 (m, 1H), 4.22 – 4.17 (m, 1H), 3.72 (s, 3H), 3.63 (d, J = 17.4 Hz, 
1H), 3.15 (d, J = 17.4 Hz, 1H); the minor isomer, δ 7.80 – 7.01 (m, 8H), 5.19 – 5.01 (m, 
2H), 4.47 – 4.43 (m, 1H), 3.69 (s, 3H), 3.49 (d, J = 17.1 Hz, 1H), 3.11 (d, J = 17.1 Hz, 
1H); 13C NMR (75 MHz, CDCl3) δ 199.56, 170.92, 169.72, 152.15, 152.07, 135.98, 
135.92, 134.70, 133.86, 132.68, 131.95, 131.81, 130.73, 130.58, 130.30, 128.18, 126.11, 
126.05, 125.26, 124.47, 122.49, 76.80, 62.46, 61.43, 53.25, 46.90, 46.41, 36.48, 35.11; 
HRMS (ESI) m/z calcd for C19H16NO5Br [M+Na]+ 440.0110, found 440.0095; the ee 
value of the major isomer was 93%, tR (major) = 17.7 min and 129.6 min, tR (minor) = 












A light yellow oil; diastereomeric ratio: 4.4 to 1, and the diastereomers could not be 
separated; 1H NMR (300 MHz, CDCl3): the major isomer, δ 7.71 – 7.00 (m, 8H), 5.47 – 
5.41 (m, 1H), 5.21 – 5.12 (m, 1H), 4.16 – 4.11 (m, 1H), 3.73 (s, 3H), 3.63 (d, J = 17.8 Hz, 
1H), 3.14 (d, J = 17.8 Hz, 1H); the minor isomer, δ 7.79 – 6.98 (m, 8H), 5.10 – 5.01 (m, 
2H), 4.47 – 4.42 (m, 1H), 3.70 (s, 3H), 3.50 (d, J = 17.1 Hz, 1H), 3.11 (d, J = 17.1 Hz, 
1H); 13C NMR (75 MHz, CDCl3) δ 201.63, 199.65, 170.87, 169.75, 152.20, 152.14, 
138.23, 136.05, 135.95,  133.85, 132.26, 132.01, 131.54, 130.35, 130.14, 128.22, 127.88, 
127.39, 126.13, 125.31,  124.52, 122.86, 122.64, 76.53, 62.47, 61.57, 53.31, 46.98, 46.66, 
36.48, 35.39; HRMS (ESI) m/z calcd for C19H16NO5Br [M+Na]+ 440.0110, found 
440.0092; the ee value of the major isomer was 95%, tR (major) = 15.3 min and 67.4 min, 
tR (minor) = 17.8 min, 40.0 min (Chiralcel OD-H, λ = 210 nm, 15% iPrOH/hexanes, flow 










A colorless oil; diastereomeric ratio: 4.6 to 1, and the diastereomers could not be 
separated; 1H NMR (300 MHz, CDCl3): the major isomer, δ 7.69 – 7.15 (m, 6H), 6.75 (d, 
J = 8.7 Hz, 2H ), 5.39 – 5.34 (m, 1H), 5.18 – 5.10 (m, 1H), 4.20 – 4.15 (m, 1H), 3.74 (s, 
3H), 3.72 (s, 3H), 3.63 (d, J = 17.7 Hz, 1H), 3.20 (d, J = 17.8 Hz, 1H); the minor isomer, 
δ 7.77 – 7.04 (m, 6H), 6.65 (d, J = 8.7 Hz, 2H ), 5.20 – 4.99 (m, 2H), 4.44 – 4.39 (m, 1H), 
3.69 (s, 3H), 3.68 (s, 3H), 3.47 (d, J = 17.4 Hz, 1H), 3.16 (d, J = 17.4 Hz, 1H); 13C NMR 
(75 MHz, CDCl3) δ 202.10, 199.86, 171.21, 169.85, 159.28, 152.40, 152.33, 136.12, 
135.75, 135.65, 134.02, 130.12, 130.03, 127.98, 127.91, 127.42, 126.43, 126.05, 126.02, 
125.14, 124.36, 114.13, 113.97, 77.14, 62.95, 61.83, 55.08, 55.03, 53.11, 46.85, 46.37, 
36.54, 35.07; HRMS (ESI) m/z calcd for C20H19NO6 [M+Na]+ 392.1110, found 392.1099; 
the ee value of the major isomer was 96%, tR (major) = 30.5 min and 31.9 min, tR (minor) 













A light yellow oil; diastereomeric ratio: 3.5 to 1, and the diastereomers could not be 
separated; 1H NMR (300 MHz, CDCl3): the major isomer, δ 7.68 – 6.88 (m, 8H), 5.41 – 
5.35 (m, 1H), 5.18 – 5.09 (m, 1H), 4.27 – 4.22 (m, 1H), 3.73 (s, 3H), 3.63 (d, J = 17.8 Hz, 
1H), 3.17 (d, J = 17.8 Hz, 1H); the minor isomer, δ 7.78 – 6.80 (m, 8H), 5.21 – 5.02 (m, 
2H), 4.49 – 4.44 (m, 1H), 3.70 (s, 3H), 3.49 (d, J = 17.4 Hz, 1H), 3.11 (d, J = 17.4 Hz, 
1H); 13C NMR (75 MHz, CDCl3) δ 201.92, 199.76, 171.09, 169.84, 164.05, 160.76, 
152.28, 135.96, 135.90, 135.45, 133.97, 131.34, 131.29, 130.85, 130.74, 130.62, 128.17, 
126.07, 125.23, 124.47, 115.92, 115.79, 115.54, 115.51, 76.74, 62.68, 61.59, 53.27, 46.80, 
46.25, 36.59, 35.01; HRMS (ESI) m/z calcd for C19H16NO5F [M+Na]+ 380.0910, found 
380.0909; the ee value of the major isomer was 94%, tR (major) = 13.5min, 94.1 min, tR 
(minor) = 17.2 min, 46.1 min (Chiralcel OD-H, λ = 210 nm, 15% iPrOH/hexanes, flow 









A light yellow oil; diastereomeric ratio: 3.3 to 1, and the diastereomers could not be 
separated; 1H NMR (300 MHz, CDCl3): the major isomer, δ 7.56 – 6.96 (m, 7H), 5.38 – 
5.32 (m, 1H), 5.17 – 5.09 (m, 1H), 4.22 – 4.17 (m, 1H), 3.74 (s, 3H), 3.61 (d, J = 17.8 Hz, 
1H), 3.19 (d, J = 17.8 Hz, 1H), 2.25 (s, 3H); the minor isomer, δ 7.63 – 6.93 (m, 7H), 
5.22 – 5.01 (m, 2H), 4.26 – 4.38 (m, 1H), 3.70 (s, 3H), 3.42 (d, J = 17.8 Hz, 1H), 3.14 (d, 
J = 17.8 Hz, 1H), 2.21 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 201.52, 198.63, 170.92, 
169.38, 153.96, 153.82, 138.23, 135.02, 132.86, 132.22, 131.74, 131.53, 131.42, 131.24, 
130.13, 129.62, 129.51, 129.44, 128.82, 128.76, 127.79, 126.28, 125.82, 125.51, 77.11, 
63.03, 61.79, 53.33, 47.13, 46.62, 36.22, 34.65, 20.96; HRMS (ESI) m/z calcd for 
C20H18NO5Br [M+Na]+ 454.0266, found 454.0271; the ee value of the major isomer was 
90%, tR (major) = 15.8 min, 27.6 min, tR (minor) = 17.2 min, 19.0 min (Chiralcel AD-H, 











A yellow oil; diastereomeric ratio: 3.1 to 1, and the diastereomers could not be separated; 
1H NMR (300 MHz, CDCl3): the major isomer, δ 7.67 (d, J = 8.5 Hz, 1H), 7.18 – 7.17 (m, 
1H), 6.97 – 6.85 (m, 4H),  5.44 – 5.40 (m, 1H), 5.15 – 5.10 (m, 1H), 4.597 – 4.56 (m, 1H), 
3.91 (s, 3H), 3.78 (s, 3H), 3.65 (d, J = 17.7 Hz, 1H), 3.26 (d, J = 17.7 Hz, 1H); the minor 
isomer, δ 7.73 (d, J = 8.5 Hz, 1H), 7.15 – 7.13 (m, 1H), 6.96 – 6.80 (m, 4H),  5.06 – 5.01 
(m, 1H), 4.94 – 4.90 (m, 2H), 3.88 (s, 3H), 3.73 (s, 3H), 3.57 (d, J = 17.7 Hz, 1H), 3.24 
(d, J = 17.7 Hz, 1H); 13C NMR (75 MHz, CDCl3) δ 198.63, 197.42, 170.52, 169.90, 
166.26, 166.17, 155.67, 155.59, 138.09, 137.28, 128.94, 128.53, 127.85, 127.07, 127.00, 
126.72, 126.62, 126.44, 125.87, 125.60, 116.32, 116.27, 109.26, 77.88, 63.03, 62.78, 
55.70, 53.20, 53.17, 43.24, 42.74, 35.99, 35.74; HRMS (ESI) m/z calcd for C18H17NO6S 
[M+Na]+ 398.0674, found 398.0682; the ee value of the major isomer was 90%, tR (major) 
= 23.2 min, 40.4 min, tR (minor) = 25.4 min, 49.0 min (Chiralcel AD-H, λ = 210 nm, 











A colorless oil; diastereomeric ratio: 8.8 to 1, and the diastereomers could not be 
separated; 1H NMR (500 MHz, CDCl3): the major isomer, δ 7.51 (s, 1H), 7.44 – 7.04 (m, 
6H), 5.44 – 5.41 (m, 1H), 5.22 – 5.17 (m, 1H), 4.19 – 4.16 (m, 1H), 3.75 (s, 3H), 3.59 (d, 
J = 17.7 Hz, 1H), 3.18 (d, J = 17.7 Hz, 1H), 2.39 (s, 3H), 2.27 (s, 3H); the minor isomer, 
δ 7.59 (s, 1H), 7.38 – 6.96 (m, 6H), 5.20 – 5.02 (m, 2H), 4.48 – 4.45 (m, 1H), 3.71 (s, 
3H), 3.44 (d, J = 17.7 Hz, 1H), 3.14 (d, J = 17.7 Hz, 1H), 2.41 (s, 3H), 2.22 (s, 3H); 13C 
NMR (75 MHz, CDCl3) δ 199.91, 169.97, 149.91, 138.09, 137.99, 137.15, 137.02, 
136.29, 134.16, 132.76, 129.51, 129.36, 128.90, 128.80, 126.17, 125.76, 125.05, 124.30,  
77.04, 63.22, 53.40, 53.14, 47.18, 46.81, 36.11, 34.91, 21.00, 20.96; HRMS (ESI) m/z 
calcd for C21H21NO5 [M+Na]+ 390.1317, found 390.1312; the ee value of the major 
isomer was 91%, tR (major) = 16.2 min, 17.0 min, tR (minor) = 14.2 min, 18.9 min 














A colorless oil; diastereomeric ratio: 4.1 to 1, and the diastereomers could not be 
separated; 1H NMR (500 MHz, CDCl3): the major isomer, δ 7.49 (s, 1H), 7.43 (d, J = 8.5 
Hz, 1H), 7.31 – 7.25 (m, 3H), 6.96 – 6.92 (m, 2H), 5.41 – 5.37 (m, 1H), 5.18 – 5.13 (m, 
1H), 4.28 – 4.25 (m, 1H), 3.75 (s, 3H), 3.60 (d, J = 17.7 Hz, 1H), 3.15 (d, J = 17.7 Hz, 
1H), 2.39 (s, 3H); the minor isomer, δ 7.58 (s, 1H), 7.38 (d, J = 8.5 Hz, 1H), 7.17 – 7.14 
(m, 3H), 6.88 – 6.85 (m, 2H), 5.22 – 5.05 (m, 2H), 4.50 – 4.47 (m, 1H), 3.72 (s, 3H), 3.45 
(d, J = 17.7 Hz, 1H), 3.09 (d, J = 17.7 Hz, 1H), 2.41 (s, 3H); 13C NMR (75 MHz, CDCl3) 
δ 201.97, 199.78, 171.23, 169.97, 164.02, 160.74, 149.72, 149.64, 138.29, 137.30, 137.25, 
136.25, 134.14, 131.41, 131.36, 130.86, 130.75, 130.63, 125.74, 125.05, 124.31, 115.91, 
115.79, 115.62, 115.51, 77.11, 62.99, 61.87, 53.23, 46.79, 46.23, 36.24, 34.62, 20.99; 
HRMS (ESI) m/z calcd for C20H18NO5F [M+Na]+ 394.1067, found 394.1059; the ee 
value of the major isomer was 94%, tR (major) = 41.4 min, 44.9 min, tR (minor) = 39.1 
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